
<html lang="en"     class="pb-page"  data-request-id="313bc19f-e097-4848-9832-e224d26dd297"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/acs.jmedchem.1c00758;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-12;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein" /></meta><meta name="dc.Creator" content="Yanmei  Hu" /></meta><meta name="dc.Creator" content="Naoya  Kitamura" /></meta><meta name="dc.Creator" content="Rami  Musharrafieh" /></meta><meta name="dc.Creator" content="Jun  Wang" /></meta><meta name="dc.Description" content="The enterovirus genus of the picornavirus family contains many important human pathogens. EV-D68 primarily infects children, and the disease manifestations range from respiratory illnesses to neuro..." /></meta><meta name="Description" content="The enterovirus genus of the picornavirus family contains many important human pathogens. EV-D68 primarily infects children, and the disease manifestations range from respiratory illnesses to neuro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 4, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00758" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00758" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00758" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00758" /></link>
        
    
    

<title>Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00758" /></meta><meta property="og:title" content="Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0014.jpeg" /></meta><meta property="og:description" content="The enterovirus genus of the picornavirus family contains many important human pathogens. EV-D68 primarily infects children, and the disease manifestations range from respiratory illnesses to neurological complications such as acute flaccid myelitis (AFM). EV-A71 is a major pathogen for the hand, foot, and mouth disease (HFMD) in children and can also lead to AFM and death in severe cases. CVB3 infection can cause cardiac arrhythmias, acute heart failure, as well as type 1 diabetes. There is currently no FDA-approved antiviral for any of these enteroviruses. In this study, we report our discovery and development of pyrazolopyridine-containing small molecules with potent and broad-spectrum antiviral activity against multiple strains of EV-D68, EV-A71, and CVB3. Serial viral passage experiments, coupled with reverse genetics and thermal shift binding assays, suggested that these molecules target the viral protein 2C. Overall, the pyrazolopyridine inhibitors represent a promising class of candidates for the urgently needed nonpolio enterovirus antivirals." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00758"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00758">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00758&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00758&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00758&amp;href=/doi/10.1021/acs.jmedchem.1c00758" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 12</span><span class="cit-fg-pageRange">, 8755-8774</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/12" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.1c00748" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00763" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Yanmei Hu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yanmei Hu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yanmei++Hu">Yanmei Hu</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Naoya Kitamura</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Naoya Kitamura</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Naoya++Kitamura">Naoya Kitamura</a></span></div></div></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor">Rami Musharrafieh</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rami Musharrafieh</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rami++Musharrafieh">Rami Musharrafieh</a></span></div></div></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor">Jun Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jun Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona, Tucson, Arizona 85721, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#cea4bba0b9afa0a98ebea6afbca3afadb7e0afbca7b4a1a0afe0abaabb"><span class="__cf_email__" data-cfemail="7319061d04121d1433031b12011e12100a5d12011a091c1d125d161706">[emailÂ protected]</span></a>. Tel: 520-626-1366. Fax: 520-626-0749.</span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jun++Wang">Jun Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-4845-4621" title="Orcid link">https://orcid.org/0000-0002-4845-4621</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00758&amp;href=/doi/10.1021%2Facs.jmedchem.1c00758" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 12</span><span class="cit-pageRange">, 8755â8774</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 April 2021</li><li><span class="item_label"><b>Published</b> online</span>4 June 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 24 June 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00758" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00758</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8755%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYanmei%2BHu%252C%2BNaoya%2BKitamura%252C%2BRami%2BMusharrafieh%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D12%26contentID%3Dacs.jmedchem.1c00758%26title%3DDiscovery%2Bof%2BPotent%2Band%2BBroad-Spectrum%2BPyrazolopyridine-Containing%2BAntivirals%2Bagainst%2BEnteroviruses%2BD68%252C%2BA71%252C%2Band%2BCoxsackievirus%2BB3%2Bby%2BTargeting%2Bthe%2BViral%2B2C%2BProtein%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8774%26publicationDate%3DJune%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00758"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">542</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00758" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Potent and Broad-Spectrum Pyrazolopyridine-Containing Antivirals against Enteroviruses D68, A71, and Coxsackievirus B3 by Targeting the Viral 2C Protein&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yanmei&quot;,&quot;last_name&quot;:&quot;Hu&quot;},{&quot;first_name&quot;:&quot;Naoya&quot;,&quot;last_name&quot;:&quot;Kitamura&quot;},{&quot;first_name&quot;:&quot;Rami&quot;,&quot;last_name&quot;:&quot;Musharrafieh&quot;},{&quot;first_name&quot;:&quot;Jun&quot;,&quot;last_name&quot;:&quot;Wang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;12&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;8755-8774&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00758&quot;},&quot;abstract&quot;:&quot;The enterovirus genus of the picornavirus family contains many important human pathogens. EV-D68 primarily infects children, and the disease manifestations range from respiratory illnesses to neurological complications such as acute flaccid myelitis (AFM). EV-A71 is a major pathogen for the hand, foot, and mouth disease (HFMD) in children and can also lead to AFM and death in severe cases. CVB3 infection can cause cardiac arrhythmias, acute heart failure, as well as type 1 diabetes. There is currently no FDA-approved antiviral for any of these enteroviruses. In this study, we report our discovery and development of pyrazolopyridine-containing small molecules with potent and broad-spectrum antiviral activity against multiple strains of EV-D68, EV-A71, and CVB3. Serial viral passage experiments, coupled with reverse genetics and thermal shift binding assays, suggested that these molecules target the viral protein 2C. Overall, the pyrazolopyridine inhibitors represent a promising class of candidates for the urge&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00758&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00758" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00758&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00758" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00758&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00758" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00758&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00758&amp;href=/doi/10.1021/acs.jmedchem.1c00758" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00758" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00758" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (9 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00758%26sid%3Dliteratum%253Aachs%26pmid%3D34085827%26genre%3Darticle%26aulast%3DHu%26date%3D2021%26atitle%3DDiscovery%2Bof%2BPotent%2Band%2BBroad-Spectrum%2BPyrazolopyridine-Containing%2BAntivirals%2Bagainst%2BEnteroviruses%2BD68%252C%2BA71%252C%2Band%2BCoxsackievirus%2BB3%2Bby%2BTargeting%2Bthe%2BViral%2B2C%2BProtein%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D12%26spage%3D8755%26epage%3D8774%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291362" title="Antimicrobial agents">Antimicrobial agents</a>,</li><li><a href="/action/doSearch?ConceptID=292035" title="Viruses">Viruses</a>,</li><li><a href="/action/doSearch?ConceptID=291439" title="Genetics">Genetics</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/12" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The <i>enterovirus</i> genus of the picornavirus family contains many important human pathogens. EV-D68 primarily infects children, and the disease manifestations range from respiratory illnesses to neurological complications such as acute flaccid myelitis (AFM). EV-A71 is a major pathogen for the hand, foot, and mouth disease (HFMD) in children and can also lead to AFM and death in severe cases. CVB3 infection can cause cardiac arrhythmias, acute heart failure, as well as type 1 diabetes. There is currently no FDA-approved antiviral for any of these enteroviruses. In this study, we report our discovery and development of pyrazolopyridine-containing small molecules with potent and broad-spectrum antiviral activity against multiple strains of EV-D68, EV-A71, and CVB3. Serial viral passage experiments, coupled with reverse genetics and thermal shift binding assays, suggested that these molecules target the viral protein 2C. Overall, the pyrazolopyridine inhibitors represent a promising class of candidates for the urgently needed nonpolio enterovirus antivirals.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23674" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23674" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Enteroviruses such as D68 (EV-D68), EV-A71, and coxsackievirus B3 (CVB3) are important human pathogens that have a significant impact on human health, especially in children.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> EV-D68, EV-A71, and CVB3 along with poliovirus and rhinovirus belong to the <i>Enterovirus</i> genera of the <i>Piconaviridae</i> virus family. Although poliovirus infection was nearly eliminated by the Global Polio Eradication Initiative through effective vaccination, no vaccines are available in the United States for the nonpolio enteroviruses such as EV-D68, EV-A71, and CVB3. Three inactivated EV-A71 vaccines are available in China.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2â4)</a> However, their efficacy is limited to certain strains and is not broadly protective.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Therefore, it is imperative to develop small molecule antivirals as therapeutics.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5â8)</a> Drug discovery efforts on nonpolio enterovirus antivirals gained momentum in recent years due to the increasing number of infections and severity of the disease outcomes caused by EV-D68, EV-A71, and CVB3.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9â11)</a> EV-D68 infection typically leads to moderate flu-like respiratory illness and it is self-limiting.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12,13)</a> EV-D68 spreads through the respiratory tract, similar to rhinoviruses. However, contemporary EV-D68 strains appear to evolve and become more virulent compared to historic strains.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> For example, recent EV-D68 outbreaks in 2014, 2016, and 2018 coincided with increasing numbers of severe respiratory illnesses and neurological complications such as acute flaccid myelitis (AFM), meningitis, and encephalitis.<a onclick="showRef(event, 'ref13 ref15 ref16 ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref13 ref15 ref16 ref17 ref18">(13,15â18)</a> It has been shown in cell culture that contemporary EV-D68 strains, but not historic strains, were able to infect neuronal cells and cause cytopathic effects.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In studies carried out using a mouse model, the EV-D68 virus was shown to infiltrate the bloodâbrain barrier and infect the central nervous system (CNS) such as the spinal cord.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22 ref23">(19â23)</a> Although EV-D68 virus is rarely detected in the human patient CNS tissues, there is nevertheless a positive correlation between EV-D68 infection and neurological complications as shown by a number of studies.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> Recent studies have shown that antibodies reacting to the EV-D68 viral capsid protein VP1 have been detected in high frequency in the CSF fluid samples from AFM patients.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> EV-A71 is one of the etiological agents for hand, foot, and mouth disease (HFMD) and spreads through the fecalâoral route. Several EV-A71 outbreaks in the Asia-Pacific region have resulted in thousands of deaths.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Similar to EV-D68, EV-A71 is also a neurotropic virus, and in rare cases, EV-A71 infection can cause severe neurological complications with a high mortality and morbidity rate in infants and young children.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26,27)</a> CVB3 virus is the causative agent for viral myocarditis.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In addition, CVB3 infection is also linked to type 1 diabetes mellitus and idiopathic chronic pancreatitis due to chronic pancreatic inflammation induced by the virus.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_p">Several compounds have been reported in the literature as nonpolio antivirals with varying degrees of potency, selectivity index, and antiviral spectrum.<a onclick="showRef(event, 'ref1 ref5 ref7 ref30'); return false;" href="javascript:void(0);" class="ref ref1 ref5 ref7 ref30">(1,5,7,30)</a> Prominent examples include viral capsid inhibitors such as pleconaril, the viral protease inhibitor rupintrivir, the 3D polymerase inhibitors ribavirin and gemcitabine, as well as the viral 2C inhibitors dibucaine and fluoxetine.<a onclick="showRef(event, 'ref31 ref32 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref31 ref32 ref33 ref34 ref35 ref36">(31â36)</a> Most of these reported compounds are either repurposed from rhinovirus antivirals (pleconaril and rupintrivir) or FDA-approved drugs for other disease indications (fluoxetine, dibucaine, and ribavirin).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> As these compounds were not specifically developed for EV-D68, EV-A71, or CVB3, their antiviral specificity, potency, and selectivity index need to be significantly improved for clinical use as nonpolio enterovirus antivirals. Notably, EV-D68 antiviral development is left far behind compared to EV-A71 and CVB3,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> possibly because it is an emerging pathogen that only comes to public attention in recent years.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Our primary interest is therefore to develop broad-acting nonpolio enterovirus antivirals against EV-D68, EV-A71, and CVB3.</div><div class="NLM_p">In this study, we have identified a class of pyrazolopyridine analogues that have shown broad-spectrum antiviral activity against EV-D68, EV-A71, and CVB3. The primary hit, compound <b>7a</b>, was identified through a cytopathic effect (CPE) assay screening against the EV-D68 virus.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> Encouragingly, compound <b>7a</b> was also active against EV-A71. Subsequent structureâactivity relationship (SAR) studies yielded several lead compounds including <b>7d</b> that inhibited different strains of EV-D68, EV-A71, and CVB3 with EC<sub>50</sub> values in the nanomolar range and a cellular selectivity index of over 500. The antiviral activity was also consistent between the rhabdomyosarcoma (RD) cell (muscle cell) and the SH-SY5Y cell (neuronal cell). Mechanistic studies have shown that the pyrazolopyridine analogues target the conserved viral 2C protein. The EV-A71 2C protein was proposed to form a hexamer according to the X-ray crystal structure and has been shown to have ATPase activity and helicase activity.<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Additional recognized functions of 2C include viral RNA binding and replication, membrane remodeling, and encapsidation.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Structurally diverse compounds have been identified as 2C inhibitors (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref30 ref31 ref32 ref33 ref35 ref36 ref38'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32 ref33 ref35 ref36 ref38">(30â33,35,36,38)</a> The pyrazolopyridine compounds discovered in this study represent one of the most potent classes of compounds with broad-spectrum antiviral activity against nonpolio enteroviruses reported so far.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structurally diverse enterovirus 2C inhibitors. The hit compound <b>7a</b> identified from our high-throughput screening served as a starting point for the lead optimization in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Chemistry</h3><div class="NLM_p">The synthesis of 1<i>H</i>-pyrazolo[3,4,-<i>b</i>]pyridine-4-carboxylic acid <b>4</b> followed the previously reported procedures (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).<a onclick="showRef(event, 'ref30 ref43'); return false;" href="javascript:void(0);" class="ref ref30 ref43">(30,43)</a> Briefly, condensation of 1-alkylpyrazole-5-amine or 1,3-dialkylpyrazole-5-amine <b>1</b> with the 4-alkyl-2,4-diketoester <b>2</b> in the presence of acetic acid gave the 1<i>H</i>-pyrazolo[3,4,-<i>b</i>]pyridine-4-carboxylic ester intermediate <b>3</b>. Subsequent hydrolysis using potassium hydroxide in isopropanol gave the key intermediate 1<i>H</i>-pyrazolo[3,4,-<i>b</i>]pyridine-4-carboxylic acid <b>4</b>. Next, for final compounds that contain tertiary amine (<b>7g</b> as an example), a one-step HATU-mediated amide coupling was used (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B). For final compounds that contain either primary amine or secondary amine (<b>7k</b> as an example), a two-step process was applied: the first step was HATU-mediated amide coupling with the mono-Boc-protected diamine, and this was followed by TFA deprotection to give the final product (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesis of pyrazolopyridine analogues. (A) Synthesis of 1<i>H</i>-pyrazolo[3,4,-<i>b</i>]pyridine-4-carboxylic acid. (B) Representative synthesis of pyrazolopyridines with either tertiary amine (<b>7g</b>), secondary, or primary amine (<b>7k</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> StructureâActivity Relationship Studies</h3><div class="NLM_p">The initial hit compound <b>7a</b> was identified as an EV-D68 antiviral through a CPE-based phenotypic screening of the enamine compound library.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> It inhibited the contemporary EV-D68 US/KY/14-18953 strain with an EC<sub>50</sub> value of 16.7 Î¼M and a selectivity index of 10.6 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Gratifyingly, compound <b>7a</b> also inhibited the closely related EV-A71 (Tainan/4643/1998) virus with an EC<sub>50</sub> value of 8.1 Î¼M. To further optimize the antiviral potency, selectivity index, and spectrum of antiviral activity of <b>7a</b>, we subsequently initiated a structureâactivity relationship study. Specifically, we focused on diversifying the 1-alkyl R<sub>1</sub>, 3-alkyl R<sub>3</sub>, 4-amide R<sub>4</sub>, and 6-alkyl R<sub>6</sub> substitutions on the 1<i>H</i>-pyrazolo[3,4,-<i>b</i>]pyridine core (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Study of Pyrazolopyridine Analogues against EV-D68, EV-A71, and CVB3<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0009.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0010.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0011.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0012.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Antiviral potency was determined in the CPE assay with EV-D68 US/KY/14-18953 virus and EV-A71 Tainan/4643/1998 virus in RD cells. For antiviral assay with CVB3 virus, Vero cells were used.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Cytotoxicity was determined using the neutral red uptake method.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">N.T., not tested. The results are the mean Â± standard deviation of three repeats. SI, selectivity index (CC<sub>50</sub>/EC<sub>50</sub>).</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last"><b>JX040</b> also inhibited the EV-D68 US/MO/14-18947 strain with an EC<sub>50</sub> of 0.1 Â± 0.04 Î¼M.</p></div></div><div></div></div><div class="NLM_p">For the initial screening, all compounds were titrated to determine the antiviral efficacy and cellular cytotoxicity in the viral CPE assay and neutral red uptake cell viability assay, respectively. Human rhabdomyosarcoma (RD) cells were used for EV-D68 and EV-A71 antiviral assays, and Vero cells were used for the CVB3 antiviral assay. For the CPE assay, virus-infected cells were treated with serial dilutions of compounds for 3 days, and cell viability was determined by neutral red uptake assay. For compound <b>7</b> series with 1-isoproyl and 6-cyclopropyl substitutions (<b>7a</b>â<b>7m</b>), it was found that the 4-position amide substitution had a profound effect on the antiviral activity and selectivity index (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Replacing the neutral ester in <b>7a</b> with pyrrolidine gave compound <b>7b</b>, which had significantly improved antiviral efficacy. Compound <b>7c</b> with diethylamine also had submicromolar EC<sub>50</sub> values against all three viruses. Changing diethylamine to dimethylamine gave compound <b>7d</b>, which had increased selectivity index. Compound <b>7e</b> with a shorter linker between the amide and the terminal amine was less active (<b>7e</b> vs <b>7d</b>). Compound <b>7g</b> with a cyclized liker was highly potent (EC<sub>50</sub> = 0.02 Î¼M) but was less selective than <b>7f</b> as shown by its low CC<sub>50</sub> values (CC<sub>50</sub> = 20.7 and 33.8 Î¼M in RD and Vero cells, respectively). Compounds containing secondary or primary amine were less potent than the compounds containing tertiary amine (<b>7h</b>, <b>7i</b> vs <b>7d</b>, and <b>7j</b> vs <b>7f</b>). Extending the linker between the amide and terminal amine from ethyl to propyl gave compounds <b>7k</b>, <b>7l</b>, and <b>7m</b>, which had a reduced antiviral activity compared with corresponding compounds with the ethyl linker (<b>7k</b> vs <b>7c</b>, <b>7l</b> vs <b>7d</b>, <b>7m</b> vs <b>7h</b>). Overall, the most potent and selective compounds from compound 7 series were <b>7b</b>, <b>7d</b>, <b>7f</b>, <b>7g</b>, and <b>7h</b>, which had more than 100-fold improvement in antiviral efficacy compared to the original hit <b>7a</b> against EV-D68 virus.</div><div class="NLM_p">For compound <b>10</b> series (<b>10a</b>â<b>10f</b>) with 6-isopropyl substitution, we selected the favorable amide substitutions from compound <b>7</b> series, and compounds <b>10a</b> and <b>10c</b>â<b>10f</b> turned out to have high antiviral potency and selectivity index (EC<sub>50</sub> < 1 Î¼M and SI<sub>50</sub> > 120). Compounds <b>10b</b> with a neutral terminal hydroxyl group had drastically reduced antiviral activity (EC<sub>50</sub> = 9.8 Î¼M) against EV-D68, which is similar to the antiviral activity of the screening hit <b>7a</b>. These results suggest that the terminal positive charge is critical for the potent antiviral activity. The most potent and selective compound from this series was compound <b>10a</b>. Compounds with 6-tert-butyl substitutions <b>11a</b> and <b>11b</b> also had potent antiviral efficacy but the selectivity index was lower compared to compounds with 6-isopropyl substitution (<b>11a</b> vs <b>10a</b> and <b>11b</b> vs <b>10e</b>). Compounds with 6-methyl substitution <b>12a</b>â<b>12e</b>, <b>13</b>, <b>14</b>, and <b>15a</b>â<b>15b</b> were generally less active, except compound <b>12a</b>. Next, the 1-position substitution was examined. Compound <b>16</b> with 1-ethyl substitution was less active than analogue <b>7d</b> with 1-isopropyl substitution. Nevertheless, the EC<sub>50</sub> values were still at the single-digit micromolar range across three different viruses. Compound <b>17</b> with 1-methyl substitution was less active, showing an EC<sub>50</sub> value of 9.8 Î¼M against the EV-D68 virus. Compounds <b>18a</b> and <b>18b</b> with 1-<i>tert</i>-butyl and 3-methyl substitutions also had potent antiviral activity but with low CC<sub>50</sub> values. Compound <b>19</b> had similar antiviral activity as compound <b>18a</b> against EV-D68 but had a higher selectivity index. Compound <b>20</b> with 1-propyl substitution, compound <b>21</b> with 1-isobutyl substitution, and compound <b>22</b> with 1-cyclopropylethyl substitution all had low single-digit or submicromolar EC<sub>50</sub> values against all three viruses, but their cellular cytotoxicity was higher than compound <b>7d</b>, which had 1-isopropyl substitution.</div><div class="NLM_p last">It is noted that an earlier study similarly reported the pyrazolopyridine derivatives such as <b>JX040</b> (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, last row) as antiviral drugs specific for enteroviruses.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Those compounds had antiviral activity against EV-A71, CVB3, and poliovirus-1, but their antiviral activity was not tested against the EV-D68. Our study showed that <b>JX040</b> also had potent antiviral activity against two EV-D68 strains US/KY/14-18953 and US/MO/14-18947 with EC<sub>50</sub> values of 0.2 and 0.1 Î¼M, respectively. An earlier study from the same group showed that similar compounds inhibited the CVB3 virus by targeting the viral 2C protein.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Although the compounds described in our study such as <b>7d</b> share the same pyrazolopyridine core with those reported earlier such as <b>JX040</b>, the structureâactivity relationships appear to be different. For example, compounds in the earlier study such as <b>JX040</b> had aromatic amide substitutions at the 4-position, while compounds from our study such as <b>7d</b> prefer a positively charged amine with a hydrophobic alkyl linker at the same position. In addition, compounds reported earlier had aromatic substitutions at the 6-position, while our compounds contain hydrophobic alkyl substitutions. Given that both subtypes of compounds showed broad-spectrum antiviral activity against nonpolio enteroviruses, further structural studies are needed to delineate their binding sites in the 2C protein.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Summary of StructureâActivity Relationship</h3><div class="NLM_p">The summary of the SAR results is shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>. For position 1 substitution, branched alkyl substitutions such as isopropyl, <i>tert</i>-butyl, isobutyl, and 1-cyclopropylethyl were favored over methyl, ethyl, propyl, and cyclopentyl, and compounds with 1-isobutyl and 1-(1-cyclopropylethyl) substitution had a lower selectivity index (highlighted in red). For position 3 substitution, both methyl and hydrogen were tolerated. For the 4-position amide, the ethyl linker was preferred over the propyl linker. The terminal amine could be tertiary, secondary, or primary amine. For the 6-position substitution, both small and bulky alkyl substitutions were tolerated, and tert-butyl substitution led to lower selectivity index (highlighted in red).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of SAR studies of pyrazolopyridine. Substitutions led to compounds with a low selectivity index (SI) are labeled in red. Potent leads have each of the shown substituents R<sub>1</sub>, R<sub>3</sub>, R<sub>4</sub>, and R<sub>6</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Broad-Spectrum Antiviral Activity</h3><div class="NLM_p">Encouraged by the potent and broad-spectrum antiviral activity of these pyrazolopyridine analogues, we selected four lead candidates <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> with the highest potency and selectivity index from the primary screening and tested their antiviral activity against several other contemporary EV-D68 and EV-A71 strains (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). The EV-D68 strains selected were from the 2014 outbreak and have been linked with AFM.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Compound <b>7d</b> is the most potent lead compound with EC<sub>50</sub> values ranging from 0.04 to 0.1 Î¼M against all EV-D68 and EV-A71 strains tested as well as a high selectivity index of over 2000. Compounds <b>7h</b> and <b>10a</b> had similar antiviral activity against different strains of EV-D68 and EV-A71 with EC<sub>50</sub> values ranging from 0.06 to 0.3 Î¼M and a selectivity index of over 700. Compound <b>19</b> was less active compared to <b>7d</b>, <b>7h</b>, and <b>10a</b>, but it remains a potent inhibitor with broad-acting activity against all strains tested (EC<sub>50</sub> = 0.4 to 7.4 Î¼M; SI<sub>50</sub> > 100). Overall, consistent antiviral efficacy was observed across different strains of EV-D68 and EV-A71, suggesting that these pyrazolopyridine compounds might target a conserved viral protein among enteroviruses or a common host signaling pathway that is essential for the viral replication.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Antiviral Activity of Potent Leads against Different Serotypes of EV-D68 and EV-A71 in RD Cells<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0013.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Antiviral efficacy EC<sub>50</sub> was determined using the CPE assay in RD cells.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Cytotoxicity CC<sub>50</sub> was determined using the neutral red uptake method.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">N.T., not tested. The results are the mean Â± standard deviation of three repeats. SI<sub>50</sub>, selectivity index (CC<sub>50</sub>/EC<sub>50</sub>).</p></div></div><div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Antiviral Activity in Secondary Plaque Assay</h3><div class="NLM_p">The antiviral activity of compounds <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> against EV-D68 US/MO/14-18947 was further confirmed by the secondary plaque assay (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). Telaprevir, an EV-D68 2A protease inhibitor,<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> was included as a positive control and showed complete inhibition of plaque formation at 3 Î¼M. All four compounds showed dose-dependent inhibition of plaque formation, and the EC<sub>50</sub> values for <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> were 0.025, 0.077, 0.023, and 0.13 Î¼M, respectively. These results were consistent with the primary CPE assay results shown in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antiviral activity of compounds <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> against EV-D68 US/MO/14-18947 in plaque assay. The plaque areas were quantified in Image J, and EC<sub>50</sub> values were determined through curve fittings in Graphpad Prism 8 using log (concentration of inhibitors) vs percentage of plaque area with variable slopes. The results are the mean Â± standard deviation of two repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Antiviral Activity against EV-D68 in Neuronal Cells</h3><div class="NLM_p">As contemporary EV-D68 viruses are neurotropic, we are interested in testing whether the pyrazolopyridine compounds can inhibit EV-D68 virus replication in neuronal cells. For this, four lead compounds <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> were tested against the neurotropic EV-D68 strain US/MO/14-18947 in neuronal cell line SH-SY5Y (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). Viral replication was quantified by immunofluorescence staining using an anti-VP1 antibody. Pleconaril was included as a positive control. Pleconaril is a known viral capsid protein VP1 inhibitor and has potent antiviral activity against multiple EV-D68 strains. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, pleconaril completely abolished viral replication at 50 Î¼M as shown by the lack of VP1 fluorescence signal. All four compounds <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> inhibited viral replication in a doseâresponse manner with EC<sub>50</sub> values of 0.03, 0.07, 0.03, and 0.34 Î¼M, respectively, which is consistent with their antiviral efficacy in RD cells (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In summary, all four pyrazolopyridine compounds potently inhibit the neurotropic EV-D68 virus replication in neuronal cells.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antiviral activity of compounds <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> against EV-D68 US/MO/14-18947 in neuronal cell line SH-SY5Y using immunofluorescence assay. The immunofluorescence signals were quantified in Image J, and EC<sub>50</sub> values were determined through curve fittings in Graphpad Prism 8 using log (concentration of inhibitors) vs percentage of positive control with variable slopes. The results are the mean Â± standard deviation of two repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Mechanism of Action</h3><div class="NLM_p">To delineate the mechanism of action of these pyrazolopyridine analogues, we first attempted to select drug-resistant mutant viruses through serial viral passage experiments. For this, we chose compound <b>7d</b> as a chemical probe and the EV-D68 US/MO/14-18947 virus as a representative nonpolio enterovirus. Compound <b>7d</b> inhibited EV-D68 US/MO/14-18947 virus with an EC<sub>50</sub> value of 0.07 Â± 0.02 Î¼M in CPE assay. EV-D68 US/MO/14-18947 virus was amplified in RD cells with escalating drug selection pressure, starting from â¼1 Ã EC<sub>50</sub> at passages 1 and 2 and increased to 2 Ã EC<sub>50</sub>, 4 Ã EC<sub>50</sub>, and 8 Ã EC<sub>50</sub> at passages 3, 4, and 5, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). The drug sensitivity of passage 5 (P5) virus was tested against compound <b>7d</b> in CPE assay. The EC<sub>50</sub> of compound <b>7d</b> against P5 virus was 1.9 Â± 0.2 Î¼M, a 27-fold increase compared to that of P0 virus, suggesting that resistance might have emerged. We then sequenced the whole viral genome and identified two mutations in the viral 2C protein, D183V and D323G. To validate the resistance phenotype, we generated recombinant viruses that harbor these 2C mutations and test their drug sensitivity against compound <b>7d</b>.<a onclick="showRef(event, 'ref38 ref44'); return false;" href="javascript:void(0);" class="ref ref38 ref44">(38,44)</a> Because the P5 virus was sequenced as a mixture, it was unknown whether these two mutations emerged from the same virus or different viruses. As such, we generated three mutant recombinant viruses, the single mutant EV-D68/2CâD183V (rD183V) and EV-D68/2CâD323G (rD323G) viruses and the double mutant EV-D68/2CâD183V+D323G (rD183V/D323G) virus using the reverse genetics system we developed earlier.<a onclick="showRef(event, 'ref38 ref44'); return false;" href="javascript:void(0);" class="ref ref38 ref44">(38,44)</a> In brief, we introduced 2CâD183V, 2CâD323G, or 2CâD183V+D323G into the EV-D68 US/MO/14-18947 genome individually via a reverse genetics approach using a pHH21 vector. The recombinant WT virus (rWT) was also generated for comparison.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Serial Viral Passage Experiments to Select Drug-Resistant Mutants against <b>7d</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">passageÂ #</th><th class="colsep0 rowsep0" align="center" char=".">drug selection pressure <b>7d</b> (Î¼M)</th><th class="colsep0 rowsep0" align="center">drug sensitivity EC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center">resistant mutant</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P0</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="left">0.07Â Â±Â 0.02</td><td class="colsep0 rowsep0" align="left">WT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P1</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P2</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P3</td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P4</td><td class="colsep0 rowsep0" align="char" char=".">0.4</td><td class="colsep0 rowsep0" align="left">N.D.</td><td class="colsep0 rowsep0" align="left">N.D.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">P5</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="left">1.9Â Â±Â 0.2</td><td class="colsep0 rowsep0" align="left">2C protein D183V/D323G</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">N.D., not determined.</p></div></div></div><div class="NLM_p">To determine which recombinant virus(s) confers the phenotypic drug resistance, we titrated <b>7d</b> against these viruses in the plaque assay (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). It was found that the drug sensitivity of <b>7d</b> against rD183V virus was decreased by 22-fold compared to that of the rWT virus (rD183V EC<sub>50</sub> = 0.66 Î¼M vs rWT EC<sub>50</sub> = 0.03 Î¼M), suggesting that the 2CâD183V is the predominant drug-resistant mutant. In contrast, the 2CâD323G only conferred moderate drug resistance and the drug sensitivity of <b>7d</b> against rD323G virus was decreased by 3-fold (rD323G EC<sub>50</sub> = 0.09 Î¼M vs rWT EC<sub>50</sub> = 0.03 Î¼M). The double mutant virus rD183V/D323G had more profound resistance and decreased the drug sensitivity by 33-fold (rD183V/D323G EC<sub>50</sub> = 1.00 Î¼M vs rWT EC<sub>50</sub> = 0.03 Î¼M). These results suggest that the viral 2C protein might be the drug target of <b>7d</b>, and 2CâD183V mutant and to a less extent 2CâD323G mutant confer the phenotypic drug resistance in cell culture.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mechanism of action of the broad-spectrum antiviral <b>7d</b>. (A) Drug sensitivity of <b>7d</b> against different strains of recombinant EV-D68 viruses in plaque assay. (B) Thermal shift binding assay of <b>7d</b> against purified EV-D68 2C protein and the mutants selected from viral passage experiments. (C) Thermal shift binding assay of <b>7d</b> against EV-D68 2C, EV-A71 2C, and CVB3 2C. (D) Melting temperature <i>T</i><sub>m</sub> and thermal shift Î<i>T</i><sub>m</sub> of EV-D68 2C, EV-A71 2C, and CVB3 2C in the presence of different concentrations of <b>7d</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further confirm that viral 2C protein is the direct drug target of <b>7d</b>, we performed the differential scanning fluorimetry (DSF) assay,<a onclick="showRef(event, 'ref45 ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref45 ref46 ref47 ref48">(45â48)</a> also called thermal shift assay, to characterize the direct binding of <b>7d</b> to 2C protein and its mutants (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). For this, we expressed the EV-D68 US/MO/14-18947 2C protein as well as the 2CâD183V, 2CâD323G, and 2CâD183V/D323G mutants. Binding of <b>7d</b> to WT 2C protein is evident as shown by stabilization of the protein by 4.93 Â°C in <i>T</i><sub>m</sub> shift (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). In contrast, no binding was observed for the 2CâD183V mutant (Î<i>T</i><sub>m</sub> = 0.01 Â°C). The 2CâD323G mutant can also be stabilized by <b>7d</b>, and the Î<i>T</i><sub>m</sub> was 3.92 Â°C, which is comparable to that of the WT 2C protein. The 2CâD183V/D323G double mutant had drastically reduced binding to <b>7d</b> compared to WT 2C (Î<i>T</i><sub>m</sub> = 0.61 vs 4.93 Â°C) (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). Consistent with plaque assay results described above for recombinant EV-D68 viruses (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A), the DSF assay results showed that the 2CâD183V is the predominant drug-resistant mutant, while the 2CâD323G only confers moderate drug resistance, and a combination of these two mutants further increased the degree of drug resistance.</div><div class="NLM_p last">As compound <b>7d</b> and its analogues have broad-spectrum antiviral activity against EV-A71 and CVB3 in addition to EV-D68, we further expressed the EV-A71 and CVB3 2C proteins and performed DSF assay to confirm the direct binding of <b>7d</b> to these 2C proteins (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>C). As expected, <b>7d</b> showed dose-dependent binding to EV-A71 and CVB3 2C proteins, similar to EV-D68 2C (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>D). This result implies that <b>7d</b> inhibits EV-A71 and CVB3 by similarly targeting their viral 2C proteins.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Drug-Resistant rD183V/D323G Virus Had a Reduced Fitness of Replication Compared to WT Virus</h3><div class="NLM_p">To profile the fitness of replication of the rD183V/D323G virus, we conducted viral competition growth assay with the rWT virus. In the viral competition assay, the rWT and rD183V/D323G viruses were mixed at a 1:100 ratio at passage 0 to favor the mutant virus, and the mixture was cocultured in RD cells for several passages. At each passage, the viral 2C protein was sequenced to determine the relevant ratios of the substitutions at residues 183 and 323. It was found that the rWT completely overtook the rD183V/D323G mutant virus at passage 3 (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>A). To rule out the possibility that the rD183V/D323G virus might revert to WT by itself without the selection pressure, we passaged rD183V/D323G virus alone four times and found no change on the viral 2C protein (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>B), suggesting that the mutant virus is stable in the absence of competition from WT virus. Taken together, these results suggest that rD183V/D323G virus had a reduced fitness of replication compared to rWT.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Competition growth assay of rD183V/D323G with the rWT EV-D68 virus. Electropherogram traces of 2C protein coding region were exported from Chromas Lite 2.6, and residues 183 and 323 from viruses at each passage were shown on the left side. Codon GAT is for Asp, condon GTT is for Val, and codon GGT is for Gly. The percentages of the mutant and WT virus populations at both positions were determined by measuring the height of the nucleotide peaks in the sequencing trace and shown on the right side. (B) Stability of recombinant virus rD183V/D323G propagated in cell culture. The recombinant virus rD183V/D323G was propagated in RD cells sequentially for four passages, and 2C protein coding regions from the viruses collected from passages 2, 3, and 4 (P2, P3, P4) were sequenced. Electropherogram traces at residues 183 and 323 from viruses at each passage were shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76486" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76486" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Nonpolio enteroviruses are important human pathogens and present a challenge for public health, especially in children and immunocompromised adults. Therefore, there is a dire need to develop effective antivirals targeting nonpolio enteroviruses including EV-D68, EV-A71, and CVB3. In this study, we report our discovery of a series of pyrazolopyridine compounds with potent and broad-spectrum antiviral activity against nonpolio enteroviruses. Starting from a screening hit <b>7a</b>, we conducted structureâactivity relationship studies, which yielded several lead compounds including <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> with significantly improved antiviral activity and cellular selectivity. The mechanism of action was delineated through resistance selection using compound <b>7d</b> as a chemical probe and the EV-D68 US/MO/14-18947 virus as a representative nonpolio enterovirus. Two mutations at the viral 2C protein were identified, 2CâD183V and 2CâD323G. Using the reverse genetics system we developed earlier, we generated the recombinant EV-D68 viruses with either single or double 2C mutants selected from the passage experiment. It was found that the D183V is the dominant drug-resistant mutant, while D323G only confers moderate resistance. This was further supported by the thermal shift assay results. In addition, we have shown that compound <b>7d</b> similarly binds to EV-A71 and CVB3 2C proteins, implying that its antiviral activity against EV-A71 and CVB3 was through targeting the viral 2C proteins. Although resistance could be isolated in cell culture against <b>7d</b>, it was found that the rD183V/D323G mutant virus had reduced fitness of replication compared with WT, as shown by the competition growth assay results (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><div class="NLM_p last">Despite a number of 2C protein inhibitors being developed including those described here, the high-resolution X-ray crystal structure of the EV-D68 2C protein has not been solved. It is critical to obtain the drug-bound complexes of 2C with different inhibitors, which will greatly facilitate the rational drug design. To the best of our knowledge, the compounds reported herein represent the most potent antivirals against nonpolio enteroviruses with a high cellular selectivity index. Further optimization might yield drug candidates for in vivo animal model studies as well as chemical probes for in vivo drug target validation.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28643" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28643" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Chemical Methods</h3><div class="NLM_p last">All chemicals were purchased from commercial vendors and used without further purification unless otherwise noted. <sup>1</sup>H and <sup>13</sup>C NMR spectra were recorded on a Bruker-400 or -500 NMR spectrometer. Chemical shifts are reported in parts per million referenced with respect to the residual solvent (CD<sub>3</sub>OD) 3.31 ppm, (DMSO-<i>d</i><sub>6</sub>) 2.50 ppm, and (CDCl<sub>3</sub>) 7.26 ppm or from internal standard tetramethylsilane (TMS) 0.00 ppm. The following abbreviations were used in reporting spectra: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of doublets; ddd, doublet of doublet of doublets. All reactions were carried out under a N<sub>2</sub> atmosphere, unless otherwise stated. High-performance liquid chromatography (HPLC)-grade solvents were used for all reactions. Flash column chromatography was performed using silica gel (230â400 mesh, Merck). High-resolution mass spectra were obtained using an OrbitrapTM for all of the compounds obtained in an ion cyclotron resonance (ICR) spectrometer. The purity was assessed by using a Shimadzu UPLC with a Shimadzu C18-AQ column (4.6 mm Ã 150 mm P/N #227-30767-05) at a flow rate of 1 mL/min; Î» = 254 and 220 nm; mobile phase A, 0.1% trifluoroacetic acid in H<sub>2</sub>O; and mobile phase B, 0.1% trifluoroacetic acid in 90% CH<sub>3</sub>CN and 10% H<sub>2</sub>O. The gradients are 0â2 min 10% B, 2â15 min 10â100% B, 15â18 min, 100% B, and 18.1â20 min 10% B. All compounds submitted for testing were confirmed to be >95.0% purity by HPLC traces. All final products were characterized by proton and carbon NMR, HPLC, and electrospray ionization mass spectrometry (ESI-MS).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Synthesis Procedures</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> General Procedure for the Synthesis of 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Ester Intermediate <b>3</b></h4><div class="NLM_p last">The 1-alkylpyrazole-5-amine or the 1,3-dialkylpyrazole-5-amine (1 mmol) and the 4-alkyl-2,4-diketoester (1 mmol) were dissolved in acetic acid (10 mL). The resulting solution was refluxed for 5 h under a nitrogen atmosphere. After cooling down to ambient temperature, the solvent was removed in vacuo and the resulting residue was purified by silica gel flash column chromatography (10â50% ethyl acetate/hexane) to give the final product.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> General Procedure for the Synthesis of 1<i>H</i>-Pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid Intermediate <b>4</b></h4><div class="NLM_p last">Ester <b>3</b> (1 mmol) was dissolved in isopropanol (5 mL). Potassium hydroxide (2 mmol) was added in portion, and the resulting solution was stirred at ambient temperature until complete disappearance of the starting material, as monitored by TLC (2â4 h). The solvent was removed in vacuo, and the resulting residue was extracted with dichloromethane and 3 N HCl. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by flash column chromatography (1â10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to give the final product.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Procedure of Amide Coupling</h3><div class="NLM_p last">To a DMF solution of carboxylic acid (1 mmol) were added HATU (1 mmol) and DIEA (1.2 mmol). After stirring for 2 min, amine (1 mmol) was added. The resulting solution was stirred overnight at ambient temperature. The reaction was diluted with dichloromethane and extracted with aqueous NaHCO<sub>3</sub> solution, followed by brine. The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by flash column chromatography (1â10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>) to give the final product.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> General Procedure of TFA Deprotection of Boc</h3><div class="NLM_p">The Boc-protected amide intermediate (1 mmol) was dissolved in dichloromethane (5 mL), and TFA (2 mL) was added cautiously. The resulting mixture was stirred at ambient temperature for 5 h, and then, the solvent was removed and the final product was purified by flash column chromatography (1â10% CH<sub>3</sub>OH/CH<sub>2</sub>Cl<sub>2</sub>).</div><div class="NLM_p">The following compounds were synthesized using the same procedure as shown for compound <b>7g</b>: <b>7a</b>, <b>7b</b>, <b>7c</b>, <b>7d</b>, <b>7f</b>, <b>7g</b>, <b>7k</b>, <b>7l</b>, <b>10a</b>, <b>10b</b>, <b>10c</b>, <b>11a</b>, <b>12a</b>, <b>12b</b>, <b>12c</b>, <b>13</b>, <b>14</b>, <b>15a</b>, <b>16</b>, <b>17</b>, <b>18a</b>, <b>19</b>, <b>20</b>, <b>21</b>, <b>22</b>, and <b>JX040</b>.</div><div class="NLM_p last">The following compounds were synthesized using the same procedure as shown for compound <b>7k</b>: <b>7e</b>, <b>7h</b>, <b>7i</b>, <b>7j</b>, <b>7m</b>, <b>10d</b>, <b>10e</b>, <b>10f</b>, <b>11b</b>, <b>12d</b>, <b>12e</b>, <b>15b</b>, and <b>18b</b>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Compound Characterization</h3><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 6-Cyclopropyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4a</b>)</h4><div class="NLM_p last">Yield: 35%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.73 (brs, 1H), 8.22 (s, 1H), 7.59 (s, 1H), 5.22â5.02 (m, 1H), 2.44â2.27 (m, 1H), 1.47 (d, <i>J</i> = 6.7 Hz, 6H), 1.15â0.98 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.3, 162.9, 150.2, 131.7, 131.6, 116.3, 111.1, 48.2, 21.8, 17.1, 11.1. C<sub>13</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 244.3 (calculated), 244.3 (found).</div></div><div id="sec4_5_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 1,6-Bis(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4b</b>)</h4><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.75 (s, 1H), 8.27 (s, 1H), 7.60 (s, 1H), 5.33â5.11 (m, 1H), 3.35â3.12 (m, 1H), 1.50 (d, <i>J</i> = 6.7 Hz, 7H), 1.31 (d, <i>J</i> = 6.9 Hz, 7H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.7, 166.3, 149.9, 132.2, 131.6, 115.7, 111.3, 48.2, 35.8, 22.4, 21.9. C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 246.3 (calculated), 246.3 (found).</div></div><div id="sec4_5_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 6-<i>tert</i>-Butyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (4c)</h4><div class="NLM_p last">Yield: 31%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.26 (s, 1H), 7.75 (s, 1H), 5.33â5.08 (m, 1H), 1.52 (d, <i>J</i> = 6.7 Hz, 6H), 1.41 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.4, 166.3, 149.4, 132.2, 131.3, 113.7, 110.9, 48.5, 37.8, 29.9, 21.7. C<sub>14</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 260.3 (calculated), 260.3 (found).</div></div><div id="sec4_5_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-Methyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4d</b>)</h4><div class="NLM_p last">Yield: 27%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.75 (brs, 1H), 8.26 (s, 1H), 7.55 (s, 1H), 5.39â5.09 (m, 1H), 2.67 (s, 3H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.2, 158.1, 149.9, 131.7, 131.6, 117.9, 110.8, 47.8, 24.4, 21.9. C<sub>11</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 218.2 (calculated), 218.3 (found).</div></div><div id="sec4_5_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 1-Cyclopentyl-6-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4e</b>)</h4><div class="NLM_p last">Yield: 41%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.26 (s, 1H), 7.55 (s, 1H), 5.47â5.29 (m, 1H), 2.67 (s, 3H), 2.18â2.06 (m, 2H), 2.06â1.78 (m, 4H), 1.78â1.60 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.2, 158.2, 150.5, 132.0, 131.7, 117.9, 110.8, 56.6, 32.0, 24.4, 24.2. C<sub>13</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 244.3 (calculated), 244.3 (found).</div></div><div id="sec4_5_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-Methyl-1-propyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4f</b>)</h4><div class="NLM_p last">Yield: 38%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.76 (brs, 1H), 8.25 (s, 1H), 7.55 (s, 1H), 4.40 (t, <i>J</i> = 7.0 Hz, 2H), 2.66 (s, 3H), 2.01â1.75 (m, 2H), 0.82 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.1, 158.4, 150.8, 131.8, 131.7, 117.8, 110.6, 47.9, 24.4, 22.5, 11.0. C<sub>11</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 218.2 (calculated), 218.2 (found).</div></div><div id="sec4_5_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-Ethyl-6-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4g</b>)</h4><div class="NLM_p last">Yield: 27%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.77 (brs, 1H), 8.25 (s, 1H), 7.55 (s, 1H), 4.48 (q, <i>J</i> = 7.2 Hz, 2H), 2.67 (s, 3H), 1.42 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.1, 158.4, 150.3, 131.8, 131.7, 117.8, 110.7, 41.4, 24.4, 14.7. C<sub>10</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 204.2 (calculated), 204.2 (found).</div></div><div id="sec4_5_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 6-Cyclopropyl-1-ethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4h</b>)</h4><div class="NLM_p last">Yield: 36%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.78 (brs, 1H), 8.21 (s, 1H), 7.59 (s, 1H), 4.42 (q, <i>J</i> = 7.2 Hz, 2H), 2.44â2.27 (m, 1H), 1.40 (t, <i>J</i> = 7.2 Hz, 3H), 1.19â0.98 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.2, 163.1, 150.4, 131.7, 131.6, 116.2, 110.8, 41.4, 17.1, 14.6, 11.0. C<sub>12</sub>H<sub>13</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 230.3 (calculated), 230.2 (found).</div></div><div id="sec4_5_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 6-Cyclopropyl-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4i</b>)</h4><div class="NLM_p last">Yield: 22%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.80 (brs, 1H), 8.21 (s, 1H), 7.60 (s, 1H), 4.00 (s, 3H), 2.44â2.32 (m, 1H), 1.18â1.00 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.15, 163.23, 150.96, 131.68, 131.62, 116.17, 110.69, 33.51, 17.09, 10.99. C<sub>11</sub>H<sub>11</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 216.2 (calculated), 216.2 (found).</div></div><div id="sec4_5_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1-<i>tert</i>-Butyl-6-cyclopropyl-3-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4j</b>)</h4><div class="NLM_p last">Yield: 21%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.67 (s, 1H), 7.46 (s, 1H), 2.53 (s, 3H), 2.40â2.21 (m, 1H), 1.70 (s, 9H), 1.13â0.94 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.96, 161.25, 151.40, 137.42, 133.83, 114.86, 109.86, 58.78, 28.65, 16.68, 15.45, 11.01. C<sub>15</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 272.3 (calculated), 272.3 (found).</div></div><div id="sec4_5_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 1-<i>tert</i>-Butyl-3,6-dimethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4k</b>)</h4><div class="NLM_p last">Yield: 18%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 7.34 (s, 1H), 2.62 (s, 3H), 2.53 (s, 3H), 1.73 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.97, 156.46, 151.29, 137.34, 134.29, 115.96, 109.75, 59.00, 28.74, 24.52, 15.44. C<sub>13</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 246.3 (calculated), 246.3 (found).</div></div><div id="sec4_5_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-Cyclopropyl-1-propyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4l</b>)</h4><div class="NLM_p last">Yield: 35%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 13.76 (brs, 1H), 8.22 (s, 1H), 7.59 (s, 1H), 4.35 (t, <i>J</i> = 6.8 Hz, 2H), 2.44â2.30 (m, 1H), 1.95â1.76 (m, 2H), 1.18â0.98 (m, 4H), 0.78 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.16, 163.06, 150.98, 131.74, 131.58, 116.23, 110.68, 47.85, 22.42, 17.03, 11.06. C<sub>13</sub>H<sub>15</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 244.3 (calculated), 244.3 (found).</div></div><div id="sec4_5_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 1-(Butan-2-yl)-6-cyclopropyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4m</b>)</h4><div class="NLM_p last">Yield: 38%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.24 (s, 1H), 7.60 (s, 1H), 4.97â4.79 (m, 1H), 2.44â2.30 (m, 1H), 2.03â1.75 (m, 2H), 1.47 (d, <i>J</i> = 6.7 Hz, 3H), 1.18â0.98 (m, 4H), 0.62 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.22, 162.79, 150.90, 131.74, 116.21, 110.79, 53.73, 28.79, 20.04, 17.01, 11.07, 11.05, 10.62. C<sub>14</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 258.3 (calculated), 258.3 (found).</div></div><div id="sec4_5_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 6-Cyclopropyl-1-(1-cyclopropylethyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxylic Acid (<b>4n</b>)</h4><div class="NLM_p last">Yield: 29%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.25 (s, 1H), 7.58 (s, 1H), 4.34â4.15 (m, 1H), 2.44â2.27 (m, 1H), 1.61 (d, <i>J</i> = 6.8 Hz, 3H), 1.46â1.28 (m, 1H), 1.14â0.95 (m, 4H), 0.65â0.49 (m, 1H), 0.47â0.37 (m, 1H), 0.37â0.13 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.36, 162.63, 150.51, 131.72, 116.19, 111.16, 57.16, 19.63, 17.23, 16.98, 10.96, 10.91, 3.70, 3.55. C<sub>15</sub>H<sub>17</sub>N<sub>3</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M â H<sup>+</sup>): 270.3 (calculated), 270.3 (found).</div></div><div id="sec4_5_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-Cyclopropyl-<i>N</i>-(2-methoxyethyl)-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7a</b>)</h4><div class="NLM_p last">Yield: 75%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.80 (s, 1H), 8.20 (d, <i>J</i> = 0.5 Hz, 1H), 7.42 (s, 1H), 5.21â5.00 (m, 1H), 3.57â3.42 (m, 4H), 3.29 (s, 3H), 2.34â2.16 (m, 1H), 1.47 (d, <i>J</i> = 6.7 Hz, 6H), 1.13â1.02 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.45, 164.90, 149.58, 136.33, 131.55, 112.73, 110.96, 59.50, 47.93, 42.08, 36.08, 22.36, 21.81. C<sub>16</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 303.4 (calculated), 303.4 (found). HPLC purity: 100%.</div></div><div id="sec4_5_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 6-Cyclopropyl-1-(propan-2-yl)-<i>N</i>-[2-(pyrrolidin-1-yl)ethyl]-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7b</b>)</h4><div class="NLM_p last">Yield: 72%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.02 (t, <i>J</i> = 5.7 Hz, 1H), 8.24 (s, 1H), 7.56 (s, 1H), 5.21â5.00 (m, 1H), 3.67â3.48 (m, 2H), 3.14â2.79 (m, 6H), 2.32â2.21 (m, 1H), 1.91â1.71 (m, 4H), 1.46 (d, <i>J</i> = 6.7 Hz, 7H), 1.17â1.03 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.90, 162.64, 149.83, 135.37, 131.58, 113.08, 110.70, 53.66, 53.24, 47.89, 36.89, 22.79, 21.74, 17.44, 10.78. C<sub>19</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 342.5 (calculated), 342.5 (found). HPLC purity: 97.8%.</div></div><div id="sec4_5_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 6-Cyclopropyl-<i>N</i>-[2-(diethylamino)ethyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7c</b>)</h4><div class="NLM_p last">Yield: 81%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.69 (s, 1H), 8.22 (s, 1H), 7.40 (s, 1H), 5.20â5.04 (m, 1H), 3.51â3.31 (m, 2H), 2.71â2.61 (m, 2H), 2.61â2.52 (m, 4H), 2.33â2.20 (m, 1H), 1.47 (d, <i>J</i> = 6.7 Hz, 6H), 1.14â1.03 (m, 4H), 0.99 (t, <i>J</i> = 7.1 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.66, 162.56, 149.82, 135.89, 131.49, 112.87, 110.67, 51.10, 47.89, 46.63, 37.22, 21.72, 17.35, 11.58, 10.76. C<sub>19</sub>H<sub>29</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 344.5 (calculated), 344.5 (found). HPLC purity: 98.0%.</div></div><div id="sec4_5_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 6-Cyclopropyl-<i>N</i>-[2-(dimethylamino)ethyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7d</b>)</h4><div class="NLM_p last">Yield: 79%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.73 (t, <i>J</i> = 5.7 Hz, 1H), 8.22 (s, 1H), 7.44 (s, 1H), 5.23â5.02 (m, 1H), 3.53â3.37 (m, 2H), 2.56 (t, <i>J</i> = 6.7 Hz, 2H), 2.28 (s, 7H), 1.47 (d, <i>J</i> = 6.7 Hz, 6H), 1.08 (d, <i>J</i> = 6.4 Hz, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.71, 162.56, 149.83, 135.77, 131.53, 112.97, 110.71, 57.60, 47.88, 44.78, 36.92, 21.73, 17.35, 10.75. C<sub>17</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 316.4 (calculated), 316.4 (found). HPLC purity: 96.9%.</div></div><div id="sec4_5_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> <i>N</i>-(Azetidin-3-yl)-6-cyclopropyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7e</b>)</h4><div class="NLM_p last">TFA salt. Yield: 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.57 (d, <i>J</i> = 6.7 Hz, 1H), 9.16 (s, 2H), 8.25 (s, 1H), 7.52 (s, 1H), 5.24â5.03 (m, 1H), 4.99â4.79 (m, 1H), 4.35â4.05 (m, 4H), 2.37â2.19 (m, 1H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H), 1.18â1.04 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.79, 162.71, 149.88, 134.65, 131.52, 113.24, 110.56, 51.83, 48.02, 41.52, 21.76, 17.40, 10.85. C<sub>16</sub>H<sub>21</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 300.4 (calculated), 300.4 (found). HPLC purity: 98.6%.</div></div><div id="sec4_5_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 6-Cyclopropyl-<i>N</i>-[1-(dimethylamino)propan-2-yl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7f</b>)</h4><div class="NLM_p last">Yield: 86%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.52 (d, <i>J</i> = 8.2 Hz, 1H), 8.22 (s, 1H), 7.46 (s, 1H), 5.24â5.03 (m, 1H), 4.34â4.16 (m, 1H), 2.63â2.50 (m, 1H), 2.42â2.18 (m, 8H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H), 1.19 (d, <i>J</i> = 6.6 Hz, 3H), 1.15â1.04 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.18, 162.48, 149.81, 136.13, 131.60, 113.13, 110.79, 63.65, 47.86, 45.03, 42.83, 21.74, 21.71, 18.73, 17.30, 10.73, 10.71. C<sub>18</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 330.4 (calculated), 330.4 (found). HPLC purity: 98.4%.</div></div><div id="sec4_5_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-Cyclopropyl-<i>N</i>-(1-methylpyrrolidin-3-yl)-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7g</b>)</h4><div class="NLM_p last">Yield: 77%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.27 (s, 1H), 7.97 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (s, 1H), 5.27â5.13 (m, 1H), 5.04â4.84 (m, 1H), 3.56â3.40 (m, 1H), 3.38â3.22 (m, 1H), 2.96â2.83 (m, 1H), 2.67 (s, 3H), 2.65â2.48 (m, 2H), 2.27â2.15 (m, 1H), 2.15â2.02 (m, 1H), 1.55 (d, <i>J</i> = 6.7 Hz, 6H), 1.22â1.13 (m, 2H), 1.10â0.99 (m, 2H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 165.43, 163.48, 150.69, 134.62, 131.61, 113.55, 111.00, 62.30, 54.87, 49.01, 48.64, 41.15, 32.51, 22.08, 17.94, 11.19. C<sub>18</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 328.4 (calculated), 328.4 (found). HPLC purity: 95.6%.</div></div><div id="sec4_5_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 6-Cyclopropyl-<i>N</i>-[2-(methylamino)ethyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7h</b>)</h4><div class="NLM_p last">TFA salt. Yield: 72%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.04 (t, <i>J</i> = 5.7 Hz, 1H), 8.77 (s, 2H), 8.25 (s, 1H), 7.49 (s, 1H), 5.23â5.01 (m, 1H), 3.63 (q, <i>J</i> = 5.9 Hz, 2H), 3.23â3.07 (m, 2H), 2.62 (s, 3H), 2.35â2.18 (m, 1H), 1.47 (d, <i>J</i> = 6.7 Hz, 6H), 1.16â1.01 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.51, 162.60, 149.90, 135.20, 131.68, 113.25, 110.69, 47.97, 47.66, 35.69, 32.59, 21.76, 17.40, 10.77. C<sub>16</sub>H<sub>23</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 302.4 (calculated), 302.4 (found). HPLC purity: 96.9%.</div></div><div id="sec4_5_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> <i>N</i>-(2-Aminoethyl)-6-cyclopropyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7i</b>)</h4><div class="NLM_p last">TFA salt. Yield: 68%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.26 (s, 1H), 7.46 (s, 1H), 5.28â5.10 (m, 1H), 3.77 (t, <i>J</i> = 5.9 Hz, 2H), 3.28 (t, <i>J</i> = 5.9 Hz, 2H), 2.31â2.18 (m, 1H), 1.51 (d, <i>J</i> = 6.8 Hz, 6H), 1.22â1.00 (m, 4H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) Î´ 168.93, 165.18, 151.68, 136.17, 133.00, 132.91, 114.94, 112.00, 49.84, 40.66, 38.69, 22.13, 18.42, 11.57. C<sub>15</sub>H<sub>21</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 288.4 (calculated), 288.4 (found). HPLC purity: 97.6%.</div></div><div id="sec4_5_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-(1-Aminopropan-2-yl)-6-cyclopropyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7j</b>)</h4><div class="NLM_p last">TFA salt. Yield: 81%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.82 (d, <i>J</i> = 8.1 Hz, 1H), 8.24 (s, 1H), 8.13 (s, 3H), 7.56 (s, 1H), 5.21â5.04 (m, 1H), 4.45â4.24 (m, 1H), 3.12â2.93 (m, 2H), 2.35â2.22 (m, 1H), 1.48 (dd, <i>J</i> = 6.7, 1.2 Hz, 6H), 1.26 (d, <i>J</i> = 6.7 Hz, 3H), 1.18â1.04 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.98, 162.54, 149.91, 135.54, 131.75, 113.47, 110.83, 47.96, 43.57, 43.06, 21.78, 21.76, 17.96, 17.38, 10.78, 10.68. C<sub>16</sub>H<sub>23</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 302.4 (calculated), 302.4 (found). HPLC purity: 100.0%.</div></div><div id="sec4_5_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 6-Cyclopropyl-<i>N</i>-[3-(diethylamino)propyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7k</b>)</h4><div class="NLM_p last">Yield: 86%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.24 (s, 1H), 7.46 (s, 1H), 5.34â5.11 (m, 1H), 3.58 (t, <i>J</i> = 6.6 Hz, 2H), 3.30â3.13 (m, 6H), 2.38â2.23 (m, 1H), 2.20â1.98 (m, 2H), 1.55 (d, <i>J</i> = 6.8 Hz, 6H), 1.35 (t, <i>J</i> = 7.3 Hz, 6H), 1.25â1.02 (m, 4H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) Î´ 168.59, 165.26, 151.77, 136.56, 132.85, 132.77, 114.83, 112.06, 50.85, 49.92, 48.43, 37.97, 25.43, 22.15, 18.46, 11.61, 9.27. C<sub>20</sub>H<sub>31</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 358.5 (calculated), 358.5 (found). HPLC purity: 97.8%.</div></div><div id="sec4_5_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 6-Cyclopropyl-<i>N</i>-[3-(dimethylamino)propyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7l</b>)</h4><div class="NLM_p last">Yield: 79%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.78 (t, <i>J</i> = 5.6 Hz, 1H), 8.19 (s, 1H), 7.39 (s, 1H), 5.12 (hept, <i>J</i> = 6.7 Hz, 1H), 3.46â3.20 (m, 2H), 2.36â2.22 (m, 3H), 2.16 (s, 6H), 1.78â1.63 (m, 2H), 1.47 (d, <i>J</i> = 6.7 Hz, 6H), 1.15â1.01 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.68, 162.56, 149.84, 135.85, 131.53, 112.92, 110.71, 56.31, 47.88, 44.46, 37.39, 26.27, 21.73, 17.37, 10.76. C<sub>18</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 330.4 (calculated), 330.4 (found). HPLC purity: 97.4%.</div></div><div id="sec4_5_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 6-Cyclopropyl-<i>N</i>-[3-(methylamino)propyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>7m</b>)</h4><div class="NLM_p last">TFA salt. Yield: 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.98 (t, <i>J</i> = 5.7 Hz, 1H), 8.79 (s, 2H), 8.22 (s, 1H), 7.46 (s, 1H), 5.21â5.03 (m, 1H), 3.40 (q, <i>J</i> = 6.4 Hz, 2H), 3.05â2.89 (m, 2H), 2.65â2.54 (m, 3H), 2.40â2.21 (m, 1H), 1.90 (p, <i>J</i> = 6.9 Hz, 2H), 1.46 (d, <i>J</i> = 6.7 Hz, 6H), 1.08 (d, <i>J</i> = 6.4 Hz, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.13, 162.66, 149.91, 135.59, 131.60, 113.07, 110.73, 47.97, 46.18, 36.32, 32.41, 25.70, 21.76, 17.38, 10.80. C<sub>17</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 316.4 (calculated), 316.4 (found). HPLC purity: 98.3%.</div></div><div id="sec4_5_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> <i>N</i>-[2-(Dimethylamino)ethyl]-1,6-bis(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>10a</b>)</h4><div class="NLM_p last">Yield: 84%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.72 (t, <i>J</i> = 5.7 Hz, 1H), 8.28 (s, 1H), 7.50 (s, 1H), 5.31â5.13 (m, 1H), 3.53â3.39 (m, 2H), 3.27â3.13 (m, 1H), 2.56â2.49 (m, 2H), 2.25 (s, 6H), 1.51 (d, <i>J</i> = 6.7 Hz, 6H), 1.35 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.44, 164.69, 149.57, 136.29, 131.48, 112.69, 110.93, 57.81, 47.92, 45.00, 37.14, 36.04, 22.35, 21.79. C<sub>17</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 318.4 (calculated), 318.4 (found). HPLC purity: 96.3%.</div></div><div id="sec4_5_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> <i>N</i>-(2-Hydroxyethyl)-1,6-bis(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>10b</b>)</h4><div class="NLM_p last">Yield: 73%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.74 (t, <i>J</i> = 5.6 Hz, 1H), 8.26 (d, <i>J</i> = 0.5 Hz, 1H), 7.51 (s, 1H), 5.30â5.08 (m, 1H), 4.79 (t, <i>J</i> = 5.6 Hz, 1H), 3.57 (q, <i>J</i> = 5.9 Hz, 2H), 3.40 (q, <i>J</i> = 6.0 Hz, 2H), 3.19 (h, <i>J</i> = 6.9 Hz, 1H), 1.50 (d, <i>J</i> = 6.7 Hz, 6H), 1.34 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.45, 164.90, 149.58, 136.33, 131.55, 112.73, 110.96, 59.50, 47.93, 42.08, 36.08, 22.36, 21.81. C<sub>15</sub>H<sub>22</sub>N<sub>4</sub>O<sub>2</sub>, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 291.4 (calculated), 291.4 (found). HPLC purity: 100.0%.</div></div><div id="sec4_5_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-[1-(Dimethylamino)propan-2-yl]-1,6-bis(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>10c</b>)</h4><div class="NLM_p last">Yield: 75%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.29 (s, 1H), 7.51 (s, 1H), 5.43â5.24 (m, 1H), 4.53â4.32 (m, 1H), 3.31â3.19 (m, 1H), 2.83â2.65 (m, 1H), 2.51â2.29 (m, 7H), 1.59 (d, <i>J</i> = 6.7, 1.5 Hz, 6H), 1.42 (d, <i>J</i> = 6.9, 1.5 Hz, 6H), 1.31 (d, <i>J</i> = 6.6, 1.5 Hz, 3H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) Î´ 168.93, 167.84, 151.45, 137.96, 132.96, 114.36, 112.48, 65.31, 49.90, 45.74, 44.78, 38.04, 22.91, 22.89, 22.23, 19.34. C<sub>18</sub>H<sub>29</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 332.5 (calculated), 332.4 (found). HPLC purity: 98.8%.</div></div><div id="sec4_5_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> <i>N</i>-[2-(Methylamino)ethyl]-1,6-bis(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>10d</b>)</h4><div class="NLM_p last">TFA salt. Yield: 71%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.18 (t, <i>J</i> = 5.6 Hz, 1H), 9.00 (s, 2H), 8.30 (s, 1H), 7.61 (s, 1H), 5.32â5.08 (m, 1H), 3.65 (q, <i>J</i> = 5.9 Hz, 2H), 3.28â3.09 (m, 3H), 2.62 (s, 3H), 1.49 (d, <i>J</i> = 6.7 Hz, 6H), 1.33 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.55, 165.52, 149.68, 135.63, 131.69, 113.11, 110.97, 48.02, 47.62, 36.14, 35.72, 32.52, 22.35, 21.83. C<sub>16</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 304.4 (calculated), 304.4 (found). HPLC purity: 97.5%.</div></div><div id="sec4_5_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> <i>N</i>-(2-Aminoethyl)-1,6-bis(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>10e</b>)</h4><div class="NLM_p last">TFA salt. Yield: 80%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.09 (t, <i>J</i> = 5.6 Hz, 1H), 8.29 (s, 1H), 8.12 (brs, 3H), 7.59 (s, 1H), 5.35â5.09 (m, 1H), 3.59 (q, <i>J</i> = 6.0 Hz, 2H), 3.29â3.12 (m, 1H), 3.13â2.96 (m, 2H), 1.50 (d, <i>J</i> = 6.7 Hz, 6H), 1.34 (d, <i>J</i> = 6.9 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.53, 165.49, 149.64, 135.72, 131.65, 113.06, 110.93, 48.00, 38.34, 37.10, 36.13, 22.36, 21.84. C<sub>15</sub>H<sub>23</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 290.4 (calculated), 290.4 (found). HPLC purity: 97.2%.</div></div><div id="sec4_5_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> <i>N</i>-(1-Aminopropan-2-yl)-1,6-bis(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>10f</b>)</h4><div class="NLM_p last">TFA salt. Yield: 73%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.78 (d, <i>J</i> = 8.1 Hz, 1H), 8.27 (s, 1H), 8.04 (brs, 3H), 7.57 (s, 1H), 5.31â5.10 (m, 1H), 4.46â4.20 (m, 1H), 3.29â3.13 (m, 1H), 3.11â2.94 (m, 2H), 1.50 (d, <i>J</i> = 6.7, 1.3 Hz, 6H), 1.34 (d, <i>J</i> = 6.9 Hz, 6H), 1.26 (d, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.41, 165.00, 149.63, 135.99, 131.68, 113.10, 111.02, 47.98, 43.56, 43.09, 36.09, 22.36, 21.82, 21.79, 17.94.C<sub>16</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 304.4 (calculated), 304.4 (found). HPLC purity: 99.0%.</div></div><div id="sec4_5_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 6-<i>tert</i>-Butyl-<i>N</i>-[2-(dimethylamino)ethyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>11a</b>)</h4><div class="NLM_p last">Yield: 83%. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 8.27 (s, 1H), 7.68 (s, 1H), 5.38â5.20 (m, 1H), 3.72â3.56 (m, 2H), 2.79 (t, <i>J</i> = 6.6 Hz, 2H), 2.47 (s, 6H), 1.62â1.51 (m, 6H), 1.46 (d, <i>J</i> = 1.4 Hz, 9H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>OD) Î´ 168.93, 165.18, 151.68, 136.17, 133.00, 132.91, 114.94, 112.00, 49.84, 40.66, 38.69, 22.13, 18.42, 11.57. C<sub>18</sub>H<sub>29</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 332.5 (calculated), 332.4 (found). HPLC purity: 97.9%.</div></div><div id="sec4_5_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> <i>N</i>-(2-Aminoethyl)-6-tert-butyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>11b</b>)</h4><div class="NLM_p last">TFA salt. Yield: 78%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.11 (t, <i>J</i> = 5.6 Hz, 1H), 8.29 (s, 1H), 8.06 (brs, 3H), 7.74 (s, 1H), 5.30â5.09 (m, 1H), 3.60 (q, <i>J</i> = 6.1 Hz, 2H), 3.14â2.98 (m, 2H), 1.51 (d, <i>J</i> = 6.7 Hz, 6H), 1.43 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 168.43, 165.62, 149.20, 135.52, 131.50, 111.43, 110.56, 48.33, 38.37, 37.97, 37.09, 29.99, 21.74. C<sub>16</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 304.4 (calculated), 304.4 (found). HPLC purity: 96.8%.</div></div><div id="sec4_5_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-[2-(Dimethylamino)ethyl]-6-methyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>12a</b>)</h4><div class="NLM_p last">Yield: 77%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.73 (t, <i>J</i> = 5.7 Hz, 1H), 8.26 (s, 1H), 7.47 (s, 1H), 5.30â5.08 (m, 1H), 3.52â3.36 (m, 2H), 2.66 (s, 3H), 2.58 (t, <i>J</i> = 6.6 Hz, 2H), 2.30 (s, 6H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.68, 157.80, 149.71, 135.97, 131.57, 114.96, 110.45, 57.49, 47.61, 44.67, 36.81, 24.49, 21.89. C<sub>15</sub>H<sub>23</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 290.4 (calculated), 290.4 (found). HPLC purity: 99.1%.</div></div><div id="sec4_5_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 6-Methyl-<i>N</i>-(1-methylpyrrolidin-3-yl)-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>12b</b>)</h4><div class="NLM_p last">Yield: 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.94 (d, <i>J</i> = 7.0 Hz, 1H), 8.24 (s, 1H), 7.55 (s, 1H), 5.30â5.08 (m, 1H), 4.59â4.41 (m, 1H), 3.02â2.92 (m, 1H), 2.92â2.78 (m, 1H), 2.78â2.69 (m, 1H), 2.69â2.59 (m, 4H), 2.42 (s, 3H), 2.34â2.16 (m, 1H), 2.00â1.82 (m, 1H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.54, 157.76, 149.70, 135.67, 131.61, 115.14, 110.53, 61.04, 54.40, 48.95, 47.60, 41.19, 31.05, 24.46, 21.89. C<sub>16</sub>H<sub>23</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 302.4 (calculated), 302.4 (found). HPLC purity: 100.0%.</div></div><div id="sec4_5_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-Methyl-<i>N</i>-(1-methylazetidin-3-yl)-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>12c</b>)</h4><div class="NLM_p last">Yield: 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.20 (d, <i>J</i> = 7.0 Hz, 1H), 8.24 (s, 1H), 7.53 (s, 1H), 5.33â5.13 (m, 1H), 4.62â4.42 (m, 1H), 3.77â3.60 (m, 2H), 3.23â3.12 (m, 2H), 2.67 (s, 3H), 2.34 (s, 3H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.31, 157.79, 149.71, 135.41, 131.58, 115.05, 110.45, 62.15, 47.62, 45.04, 39.81, 24.48, 21.89. C<sub>15</sub>H<sub>21</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 288.4 (calculated), 288.3 (found). HPLC purity: 98.5%.</div></div><div id="sec4_5_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 6-Methyl-<i>N</i>-[2-(methylamino)ethyl]-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>12d</b>)</h4><div class="NLM_p last">TFA salt. Yield: 74%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.04 (t, <i>J</i> = 5.6 Hz, 1H), 8.86 (brs, 2H), 8.29 (s, 1H), 7.52 (s, 1H), 5.33â5.07 (m, 1H), 3.72â3.55 (m, 2H), 3.22â3.09 (m, 2H), 2.66 (s, 3H), 2.62 (s, 3H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.44, 157.79, 149.79, 135.44, 131.73, 115.21, 110.46, 47.69, 47.61, 35.70, 32.54, 24.48, 21.91. C<sub>14</sub>H<sub>21</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 276.4 (calculated), 276.3 (found). HPLC purity: 97.6%.</div></div><div id="sec4_5_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-(2-Aminoethyl)-6-methyl-1-(propan-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>12e</b>)</h4><div class="NLM_p last">TFA salt. Yield: 65%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.00 (t, <i>J</i> = 5.6 Hz, 1H), 8.29 (s, 1H), 8.09 (s, 3H), 7.52 (s, 1H), 5.29â5.09 (m, 1H), 3.64â3.53 (m, 2H), 3.13â2.98 (m, 2H), 2.66 (s, 3H), 1.48 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.41, 157.81, 149.79, 135.54, 131.72, 115.22, 110.46, 47.70, 38.34, 37.10, 24.49, 21.92. C<sub>13</sub>H<sub>19</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 262.3 (calculated), 262.3 (found). HPLC purity: 98.5%.</div></div><div id="sec4_5_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> 1-Cyclopentyl-<i>N</i>-[2-(dimethylamino)ethyl]-6-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>13</b>)</h4><div class="NLM_p last">Yield: 69%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.75 (t, <i>J</i> = 5.6 Hz, 1H), 8.26 (s, 1H), 7.47 (s, 1H), 5.48â5.25 (m, 1H), 3.53â3.38 (m, 2H), 2.66 (s, 3H), 2.62 (t, <i>J</i> = 6.6 Hz, 2H), 2.32 (s, 6H), 2.16â2.04 (m, 2H), 2.04â1.81 (m, 4H), 1.80â1.59 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.71, 157.85, 150.28, 135.93, 131.67, 115.00, 110.49, 57.41, 56.45, 44.55, 36.71, 31.97, 24.48, 24.22. C<sub>17</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 316.4 (calculated), 316.4 (found). HPLC purity: 100.0%.</div></div><div id="sec4_5_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> <i>N</i>-[2-(Dimethylamino)ethyl]-6-methyl-1-propyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>14</b>)</h4><div class="NLM_p last">Yield: 70%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.73 (t, <i>J</i> = 5.7 Hz, 1H), 8.25 (s, 1H), 7.47 (s, 1H), 4.39 (t, <i>J</i> = 7.0 Hz, 2H), 3.53â3.35 (m, 2H), 2.65 (s, 3H), 2.56 (t, <i>J</i> = 6.7 Hz, 2H), 2.28 (s, 6H), 1.95â1.79 (m, 2H), 0.82 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.64, 158.06, 150.62, 135.98, 131.70, 114.91, 110.25, 57.57, 47.81, 44.74, 36.89, 24.49, 22.48, 11.01. C<sub>15</sub>H<sub>23</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 290.4 (calculated), 290.4 (found). HPLC purity: 100.0%.</div></div><div id="sec4_5_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i>-[2-(Dimethylamino)ethyl]-1-ethyl-6-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>15a</b>)</h4><div class="NLM_p last">Yield: 73%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.80 (t, <i>J</i> = 5.7 Hz, 1H), 8.26 (s, 1H), 7.51 (s, 1H), 4.47 (q, <i>J</i> = 7.2 Hz, 2H), 3.52â3.39 (m, 2H), 2.66 (s, 3H), 2.61 (t, <i>J</i> = 6.6 Hz, 2H), 2.32 (s, 6H), 1.41 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.64, 158.06, 150.11, 135.93, 131.73, 114.97, 110.38, 57.42, 44.56, 41.27, 36.72, 24.47, 14.74. C<sub>14</sub>H<sub>21</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 276.4 (calculated), 276.3 (found). HPLC purity: 98.9%.</div></div><div id="sec4_5_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> 1-Ethyl-6-methyl-<i>N</i>-[2-(methylamino)ethyl]-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>15b</b>)</h4><div class="NLM_p last">TFA salt. Yield: 63%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 9.04 (t, <i>J</i> = 5.5 Hz, 1H), 8.29 (s, 1H), 8.14 (brs, 2H), 7.54 (s, 1H), 4.47 (q, <i>J</i> = 7.2 Hz, 2H), 3.59 (q, <i>J</i> = 6.0 Hz, 2H), 3.16â2.94 (m, 2H), 2.66 (s, 3H), 1.41 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 165.35, 158.06, 150.17, 135.54, 131.87, 115.19, 110.38, 41.34, 38.31, 37.11, 24.46, 14.77. C<sub>13</sub>H<sub>19</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 262.3 (calculated), 262.3 (found). HPLC purity: 98.9%.</div></div><div id="sec4_5_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> 6-Cyclopropyl-<i>N</i>-[2-(dimethylamino)ethyl]-1-ethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>16</b>)</h4><div class="NLM_p last">Yield: 86%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.77 (t, <i>J</i> = 5.7 Hz, 1H), 8.22 (s, 1H), 7.46 (s, 1H), 4.42 (q, <i>J</i> = 7.2 Hz, 2H), 3.52â3.37 (m, 2H), 2.57 (t, <i>J</i> = 6.7 Hz, 2H), 2.35â2.21 (m, 7H), 1.39 (t, <i>J</i> = 7.2 Hz, 3H), 1.12â1.01 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.66, 162.84, 150.19, 135.75, 131.73, 112.96, 110.55, 57.57, 44.73, 41.22, 36.89, 17.38, 14.61, 10.75. C<sub>16</sub>H<sub>23</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 302.4 (calculated), 302.4 (found). HPLC purity: 100%.</div></div><div id="sec4_5_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> 6-Cyclopropyl-<i>N</i>-[2-(dimethylamino)ethyl]-1-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>17</b>)</h4><div class="NLM_p last">Yield: 76%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.73 (t, <i>J</i> = 5.7 Hz, 1H), 8.22 (s, 1H), 7.45 (s, 1H), 4.00 (s, 3H), 3.49â3.39 (m, 2H), 2.56â2.48 (m, 2H), 2.35â2.28 (m, 1H), 2.26 (s, 6H), 1.18â1.04 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.60, 162.98, 150.74, 135.74, 131.70, 112.88, 110.42, 57.76, 44.97, 37.12, 33.41, 17.41, 10.70. C<sub>15</sub>H<sub>21</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 288.4 (calculated), 288.4 (found). HPLC purity: 98.2%.</div></div><div id="sec4_5_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> 1-<i>tert</i>-Butyl-6-cyclopropyl-<i>N</i>-[2-(dimethylamino)ethyl]-3-methyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>18a</b>)</h4><div class="NLM_p last">Yield: 69%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.56 (t, <i>J</i> = 5.7 Hz, 1H), 7.07 (s, 1H), 3.45â3.29 (m, 2H), 2.46 (t, <i>J</i> = 6.7 Hz, 2H), 2.39 (s, 3H), 2.30â2.23 (m, 1H), 2.21 (s, 6H), 1.70 (s, 9H), 1.13â0.96 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.10, 161.15, 150.94, 138.87, 137.32, 112.40, 109.80, 58.62, 57.71, 44.98, 37.01, 28.67, 16.81, 13.87, 10.80. C<sub>19</sub>H<sub>29</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 344.5 (calculated), 344.5 (found). HPLC purity: 98.3%.</div></div><div id="sec4_5_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> 1-<i>tert</i>-Butyl-6-cyclopropyl-3-methyl-<i>N</i>-[2-(methylamino)ethyl]-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>18b</b>)</h4><div class="NLM_p last">TFA salt. Yield: 53%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.92â8.81 (m, 3H), 7.23 (s, 1H), 3.60 (q, <i>J</i> = 6.1 Hz, 2H), 3.15â3.04 (m, 2H), 2.63 (s, 3H), 2.39 (s, 3H), 2.29â2.15 (m, 1H), 1.70 (s, 9H), 1.16â0.87 (m, 4H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.66, 161.17, 151.06, 138.00, 137.46, 112.78, 109.78, 58.71, 48.53, 47.33, 35.49, 32.49, 28.70, 16.91, 14.36, 10.82. C<sub>18</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 330.4 (calculated), 330.4 (found). HPLC purity: 98.0%.</div></div><div id="sec4_5_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> 1-<i>tert</i>-Butyl-<i>N</i>-[2-(dimethylamino)ethyl]-3,6-dimethyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>19</b>)</h4><div class="NLM_p last">Yield: 83%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.60 (t, <i>J</i> = 5.7 Hz, 1H), 7.02 (s, 1H), 3.49â3.37 (m, 3H), 2.60 (s, 3H), 2.54 (t, <i>J</i> = 6.7 Hz, 2H), 2.41 (s, 3H), 2.28 (s, 6H), 1.74 (s, 9H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 166.11, 156.35, 150.88, 139.06, 137.27, 113.62, 109.67, 58.86, 57.46, 44.69, 36.72, 28.77, 24.64, 13.95. C<sub>17</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 318.4 (calculated), 318.4 (found). HPLC purity: 97.8%.</div></div><div id="sec4_5_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> 6-Cyclopropyl-<i>N</i>-[2-(dimethylamino)ethyl]-1-propyl-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>20</b>)</h4><div class="NLM_p last">Yield: 83%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.79 (t, <i>J</i> = 5.7 Hz, 1H), 8.22 (s, 1H), 7.46 (s, 1H), 4.35 (t, <i>J</i> = 6.8 Hz, 2H), 3.47 (q, <i>J</i> = 6.4 Hz, 2H), 2.62 (t, <i>J</i> = 6.7 Hz, 2H), 2.33 (s, 6H), 2.31â2.20 (m, 1H), 1.92â1.78 (m, 2H), 1.17â1.01 (m, 4H), 0.79 (t, <i>J</i> = 7.4 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.74, 162.85, 150.75, 135.70, 131.75, 113.00, 110.38, 57.44, 47.73, 44.57, 36.72, 22.44, 17.37, 11.05, 10.79. C<sub>17</sub>H<sub>25</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 316.4 (calculated), 316.4 (found). HPLC purity: 98.9%.</div></div><div id="sec4_5_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> 1-(Butan-2-yl)-6-cyclopropyl-<i>N</i>-[2-(dimethylamino)ethyl]-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>21</b>)</h4><div class="NLM_p last">Yield: 78%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.71 (t, <i>J</i> = 5.7 Hz, 1H), 8.24 (s, 1H), 7.43 (s, 1H), 5.00â4.79 (m, 1H), 3.45 (q, <i>J</i> = 6.4 Hz, 2H), 2.58â2.48 (m, 2H), 2.36â2.19 (m, 7H), 2.04â1.90 (m, 1H), 1.90â1.73 (m, 1H), 1.47 (d, <i>J</i> = 6.7 Hz, 3H), 1.21â0.95 (m, 4H), 0.63 (t, <i>J</i> = 7.3 Hz, 3H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.72, 162.56, 150.66, 135.84, 131.69, 112.97, 110.47, 57.75, 53.54, 44.95, 37.09, 28.78, 20.07, 17.32, 10.80, 10.76, 10.62. C<sub>18</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 330.4 (calculated), 330.4 (found). Purity: 98.2%.</div></div><div id="sec4_5_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> 6-Cyclopropyl-1-(1-cyclopropylethyl)-<i>N</i>-[2-(dimethylamino)ethyl]-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (<b>22</b>)</h4><div class="NLM_p last">Yield: 71%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 8.70 (t, <i>J</i> = 5.7 Hz, 1H), 8.23 (s, 1H), 7.43 (s, 1H), 4.41â4.18 (m, 1H), 3.50â3.37 (m, 2H), 2.58â2.47 (m, 2H), 2.34â2.19 (m, 7H), 1.62 (d, <i>J</i> = 6.8 Hz, 3H), 1.46â1.29 (m, 1H), 1.13â0.98 (m, 4H), 0.67â0.50 (m, 1H), 0.49â0.36 (m, 1H), 0.36â0.15 (m, 2H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.71, 162.52, 150.24, 135.88, 131.49, 113.11, 110.61, 57.76, 57.03, 44.99, 37.13, 19.63, 17.27, 17.24, 10.79, 10.72, 3.65, 3.57. C<sub>19</sub>H<sub>27</sub>N<sub>5</sub>O, EI-MS: <i>m</i>/<i>z</i> (M + H<sup>+</sup>): 342.5 (calculated), 342.4 (found). HPLC purity: 97.4%.</div></div><div id="sec4_5_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> 1-(Propan-2-yl)-<i>N</i>-(pyridin-2-yl)-6-(thiophen-2-yl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-4-carboxamide (JX040)</h4><div class="NLM_p last">Yield: 85%. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 11.30 (s, 1H), 8.47 (s, 1H), 8.46â8.42 (m, 1H), 8.36 (s, 1H), 8.29 (d, <i>J</i> = 1.0 Hz, 1H), 8.12 (dd, <i>J</i> = 3.8, 1.2 Hz, 1H), 7.96â7.85 (m, 1H), 7.75 (dd, <i>J</i> = 5.0, 1.1 Hz, 1H), 7.28â7.17 (m, 2H), 5.23 (hept, <i>J</i> = 6.6 Hz, 1H), 1.55 (d, <i>J</i> = 6.7 Hz, 6H). <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) Î´ 164.0, 151.7, 151.2, 149.7, 148.1, 144.0, 138.4, 135.9, 132.1, 129.8, 128.6, 128.0, 120.4, 115.0, 111.9, 111.6, 48.5, 21.9. HPLC purity: 100%.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> Cell Lines and Viruses</h3><div class="NLM_p last">Rhabdomyosarcoma (RD, ATCC, CCL-136), A172 (ATCC, CRL-1620), and SH-SY5Y (ATCC, CRL-2266) were maintained in a 37 Â°C incubator in a 5% CO<sub>2</sub> atmosphere. RD cell was cultured in Dulbeccoâs modified Eagleâs medium (DMEM) with 10% fetal bovine serum (FBS) and 1% penicillinâstreptomycin (P/S). SH-SY5Y were cultured in 10% FBS and 1% P/S with 50% DMEM and 50% F-12 medium. All of the following EV-D68 strains used in this study were purchased from ATCC: US/KY/14-18953 (ATCC, NE-49132), US/MO/14-18947 (ATCC, NR-49129), US/MO/14-18949 (ATCC, NR-49130), US/IL/14-18952 (ATCC, NR-49131), and US/IL/14-18956 (ATCC, NR-49133). All of the following EV-A71 strains used in this study were purchased from ATCC or BEI Resources: Tainan/4643/1998 (BEI Resources, NR-471) and enterovirus 71, MP4 (BEI Resources, NR-472). Enterovirus A71 US/CT/2016-19519 was obtained from Dr. William Nix at the Centers for Disease Control and Prevention under a material transfer agreement. All viruses were amplified in RD cells prior to infection assays.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> CPE Assays</h3><div class="NLM_p last">CPE assays were carried out similarly, as previously described.<a onclick="showRef(event, 'ref33 ref49'); return false;" href="javascript:void(0);" class="ref ref33 ref49">(33,49)</a> For EV-D68 CPE assays, RD cells were grown to over 90% confluency after seeding in a 96-well plate for 18â24 h, growth medium was aspirated, and cells were washed with 200 Î¼L of PBS buffer supplemented with magnesium and calcium. Cells were infected with EV-D68 viruses diluted in DMEM with 2% FBS and 30 mM MgCl<sub>2</sub> at an MOI of 0.01 and incubated at a 33 Â°C incubator in a 5% CO<sub>2</sub> atmosphere for 1â2 h. Testing compounds diluted in DMEM with 2% FBS and 30 mM MgCl<sub>2</sub> were added, and cells were incubated in a 33 Â°C incubator in a 5% CO<sub>2</sub> atmosphere for 3 days to develop complete CPE in virus-infected cells. For EV-A71 CPE assays, similar procedures were performed on RD cells except that the 30 mM MgCl<sub>2</sub> was not included in the medium and infected cells were incubated at 37 Â°C instead of 33 Â°C, and the incubation time was typically 2.5 days for EV-A71 virus to develop complete CPE. For the CVB3 virus CPE assay, Vero cells were used for infection with CVB3 Nancy virus at an MOI of 0.3 with a similar procedure as EV-A71. For all CPE assays, growth media was aspirated and 50 Î¼g/mL of neutral red staining solution was used to stain viable cells in each well. Absorbance at 540 nm was measured using a Multiskan FC Microplate Photometer (Thermo Fisher Scientific). The EC<sub>50</sub> values were calculated from best-fit doseâresponse curves using GraphPad Prism 8.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Cytotoxicity Assay</h3><div class="NLM_p last">The cytotoxicity of each compound was determined using the neutral red cell viability assay. The assay was performed under similar conditions (incubation temperature, time, and media) as the CPE assay but excluded viral infection. Data acquisition and analysis (CC<sub>50</sub>) were performed similarly to the antiviral CPE assay, and all values are from triplicate experiments.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> Plaque Assay</h3><div class="NLM_p last">Plaque assay for EV-D68 US/MO/14-18947 was performed as previously described.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> RD cells were grown to more than 90% confluent and washed with PBS supplemented with magnesium and calcium after removing the growth medium. Cells were infected by EV-D68 virus and incubated at a 33 Â°C incubator for 1â2 h to allow virus attachment. After washing the unbound viruses, an overlay containing the indicated concentration of test compounds and 1.2% Avicel (FMC BioPolymer, Philadelphia, PA) in DMEM supplemented with 2% FBS and 30 mM MgCl<sub>2</sub> was added with 4 mL per well. The plates were incubated at a 33 Â°C (5% CO<sub>2</sub>) incubator for 3 days, and the cells were stained with crystal violet after removing the Avicel overlay. Plaque areas were quantified by Image J and plotted with drug concentration for the calculation of EC<sub>50</sub> values.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Differential Scanning Fluorimetry (DSF)</h3><div class="NLM_p last">The binding of compound <b>7d</b> to EV-A71 Tainan/4643/1998, EV-D68 US/MO/14-18947, and CVB3 Nancy 2C proteins was detected in DSF using a Thermal Fisher QuantStudio 5 RealTime PCR System, as previously described.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> EV-A71, EV-D68, and CVB WT 2C proteins (4 Î¼M) were incubated with compound <b>7d</b> at 10, 30, 100, and 300 Î¼M concentrations in a buffer containing 20 mM Hepes (pH7.5), 300 mM NaCl at 37 Â°C for 1 h. For the EV-D68 2CâD183V, D323G, and D183V/D323G mutant 2C proteins, <b>7d</b> was tested at 100 Î¼M. 1 Ã SYPRO orange (Thermal Fisher) was added, and the fluorescent signals were monitored under a temperature gradient ranging from 30 to 90 Â°C (incremental steps of 0.05 Â°C/s). As the temperature increases, test proteins gradually denatured and the melting temperature (<i>T</i><sub>m</sub>) was calculated as the mid-log of the transition phase from the native to the denatured protein using a Boltzmann model in Protein Thermal Shift Software v1.3. Î<i>T</i><sub>m</sub> was calculated by subtracting the reference melting temperature of proteins in the presence of DMSO from the <i>T</i><sub>m</sub> in the presence of an indicated concentration of <b>7d</b>. Curve fittings were performed using the Boltzmann sigmoidal equation in Prism 8 software.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Immunofluorescence Staining Assay</h3><div class="NLM_p last">Immunofluorescence staining was performed similarly, as previously described,<a onclick="showRef(event, 'ref38 ref39 ref45'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref45">(38,39,45)</a> with minor modifications. Neuronal cell line SH-SY5Y growing on coverslips (Nunc Thermanox) was infected with EV-D68 US/MO/14-18947 at an MOI of 1. Viruses were amplified in the presence of DMSO or indicated concentrations of testing compounds. At 18 hpi, cells were fixed with 4% formaldehyde for 10 min, followed by permeabilization with 0.2% Triton X-100 for another 10 min. After blocking with 3% bovine serum albumin (Sigma-Aldrich) at 4 Â°C overnight, cells were stained with a rabbit anti-VP1 antibody at room temperature for 2 h and then with an antirabbit immunoglobulin secondary antibody conjugated to Alexa Fluor 488. The nuclei were stained with 300 nM DAPI after secondary antibody incubation. Fluorescent images were acquired using a ZOE Fluorescent Cell Imager (Bio-Rad).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Serial Viral Passage Experiment and Viral 2C Gene Sequencing</h3><div class="NLM_p last">Serial viral passage experiments were carried out in the presence of compound <b>7d</b> by doubling the concentration from the previous passage, starting with a concentration of â¼1 Ã EC<sub>50</sub> at P1. RD cells were infected with EV-D68 US/MO/14-18947 at an MOI of 0.1, and the amplified virus in the cell culture supernatant was collected after approximately 3 days when a significant cytopathic effect was observed, and viral titer was quantified by plaque assay. Drug sensitivity was tested in the P5 virus by determining the EC<sub>50</sub> value through the CPE assay. The viral genome RNA was purified using the QIAGEN viral RNA mini kit, followed by reverse transcription using SuperScript III first-strand reverse transcriptase (Invitrogen) with an oligo(dT) primer. The whole viral genome was sequenced via 14 sequencing reactions by Eton Biosciences, Inc. The sequencing primers were reported before.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Specifically, the fragment that contains the whole 2C gene was PCR-amplified using primers (forward: 5â²- GTTAGGTACACATATTGTTTGG-3â² and reverse: 5â²-CTTTAGGTTTAG GATTGG GGATTCCTG-3â²) and sequenced by Eton Bioscience, Inc. using primers (5â²-CAAGCCTTATTC AACAACGTCC-3â² and 5â²- CTTTAGGTTTAG GATTGG GGATTCCTG-3â²).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Generation of EV-D68 Virus-Containing 2C Mutants by Reverse Genetics</h3><div class="NLM_p last">A plasmid-based reverse genetic system for EV-D68 US/MO/14-18947 was generated in the pHH21 plasmid, as previously described.<a onclick="showRef(event, 'ref38 ref39 ref44'); return false;" href="javascript:void(0);" class="ref ref38 ref39 ref44">(38,39,44)</a> The 2C mutations were introduced via site-directed mutagenesis using Agilent Technologies QuikChange II XL kit according to the manufacturerâs instructions, and the inserted mutations were confirmed by sequencing. RD cells or HEK293T cells were transfected with the pHH21 plasmids containing US/MO/14-18947 genome (WT or 2CâD183V, D323G, D183V/D323G) using Lipofectamine 3000 Transfection Reagent (Thermo Fisher) according to the manufacturerâs instructions. The generated viruses in the cell culture medium were collected (3â5 days post transfection) and amplified on RD cells. The mutations in the viral 2C genes of the amplified viruses were confirmed by sequencing.</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Virus Growth Competition Assay</h3><div class="NLM_p last">To compare the fitness of replication of WT virus (rWT) with the 2C mutant virus (r2CâD183V/D323G), virus growth competition assay was carried out. RD cells were infected by a virus mixture containing rWT and r2CâD183V/D323G at a ratio of 1:100 (MOI = 0.1). The amplified virus from the culture medium was collected 3 days post infection, and viral titers were quantified by plaque assay and were used for the next round of infection. After 3 passages, the viral 2C gene from each passage of the virus was sequenced as described in the serial passage experiment. The percentages of WT and 2CâD183V and D323G in each passage were estimated by measuring the height of the nucleotide peaks in the sequencing trace, as previously described.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00758" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45521" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45521" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00758?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00758</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">HPLC traces for the final products (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_001.pdf">jm1c00758_si_001.pdf (3.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_002.csv">jm1c00758_si_002.csv (3.98 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00758" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27671" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27671" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jun Wang</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Toxicology, College of Pharmacy, The
University of Arizona, Tucson, Arizona 85721, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-4845-4621" title="Orcid link">https://orcid.org/0000-0002-4845-4621</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#761c03180117181136061e17041b17150f5817041f0c19181758131203"><span class="__cf_email__" data-cfemail="d1bba4bfa6b0bfb691a1b9b0a3bcb0b2a8ffb0a3b8abbebfb0ffb4b5a4">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yanmei Hu</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Toxicology, College of Pharmacy, The
University of Arizona, Tucson, Arizona 85721, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naoya Kitamura</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Toxicology, College of Pharmacy, The
University of Arizona, Tucson, Arizona 85721, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rami Musharrafieh</span> - <span class="hlFld-Affiliation affiliation">Department of Pharmacology
and Toxicology, College of Pharmacy, The
University of Arizona, Tucson, Arizona 85721, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>Y.H. and N.K. contributed equally.</p><span class="author-information-subsection-header">Author Contributions</span><p>J.W. designed the experiments. Y.H. and R.M. performed the CPE assay, plaque assay, immunofluorescence assay, serial passage experiments, thermal shift binding assay, and competition growth assay. N.K. synthesized and characterized the compounds. J.W. wrote the manuscript with the inputs from others.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): J. W. and N. K. are inventors of a pending patent that claimed the use of the described compounds as potential broad-spectrum antivirals against non-polio enteroviruses.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5010-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i90">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38814" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38814" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This research was supported by the National Institute of Allergy and Infectious Diseases of Health (NIH) (grants AI147325 and AI157046) and the Arizona Biomedical Research Commission Centre Young Investigator grant (ADHS18-198859) to J.W. Y.H. was supported by the NIH training grant T32 GM008804.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08200" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08200" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This article published June 4, 2021 with errors throughout the text, in Table 1, and an incorrect version of the Supporting Information. The corrected article published June 10, 2021.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AFM</td><td class="NLM_def"><p class="first last">acute flaccid myelitis</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CVB3</td><td class="NLM_def"><p class="first last">coxsackievirus B3</p></td></tr><tr><td class="NLM_term">DSF</td><td class="NLM_def"><p class="first last">differential scanning fluorimetry</p></td></tr><tr><td class="NLM_term">EV-A71</td><td class="NLM_def"><p class="first last">enterovirus A71</p></td></tr><tr><td class="NLM_term">EV-D68</td><td class="NLM_def"><p class="first last">enterovirus D68</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22228" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22228" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibaut, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J. M.</span></span> <span> </span><span class="NLM_article-title">The life cycle of non-polio enteroviruses and how to target it</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">368</span>â <span class="NLM_lpage">381</span>, <span class="refDoi">Â DOI: 10.1038/s41579-018-0005-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1038%2Fs41579-018-0005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=29626210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=368-381&author=J.+Baggenauthor=H.+J.+Thibautauthor=J.+Stratingauthor=F.+J.+M.+van+Kuppeveld&title=The+life+cycle+of+non-polio+enteroviruses+and+how+to+target+it&doi=10.1038%2Fs41579-018-0005-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The life cycle of non-polio enteroviruses and how to target it</span></div><div class="casAuthors">Baggen, Jim; Jan Thibaut, Hendrik; Strating, Jeroen R. P. M.; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">368-381</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The genus Enterovirus (EV) of the family Picornaviridae includes poliovirus, coxsackieviruses, echoviruses, numbered enteroviruses and rhinoviruses.  These diverse viruses cause a variety of diseases, including non-specific febrile illness, hand-foot-and-mouth disease, neonatal sepsis-like disease, encephalitis, paralysis and respiratory diseases.  In recent years, several non-polio enteroviruses (NPEVs) have emerged as serious public health concerns.  These include EV-A71, which has caused epidemics of hand-foot-and-mouth disease in Southeast Asia, and EV-D68, which recently caused a large outbreak of severe lower respiratory tract disease in North America.  Infections with these viruses are assocd. with severe neurol. complications.  For decades, most research has focused on poliovirus, but in recent years, our knowledge of NPEVs has increased considerably.  In this Review, we summarize recent insights from enterovirus research with a special emphasis on NPEVs.  We discuss virion structures, host-receptor interactions, viral uncoating and the recent discovery of a universal enterovirus host factor that is involved in viral genome release.  Moreover, we briefly explain the mechanisms of viral genome replication, virion assembly and virion release, and describe potential targets for antiviral therapy.  We reflect on how these recent discoveries may help the development of antiviral therapies and vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj0u0CSm-oNLVg90H21EOLACvtfcHk0lgfwgz6QU-7OA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgtLs%253D&md5=b085070903d06c30ba4f444175952921</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41579-018-0005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41579-018-0005-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaggen%26aufirst%3DJ.%26aulast%3DThibaut%26aufirst%3DH.%2BJ.%26aulast%3DStrating%26aufirst%3DJ.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%2BM.%26atitle%3DThe%2520life%2520cycle%2520of%2520non-polio%2520enteroviruses%2520and%2520how%2520to%2520target%2520it%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2018%26volume%3D16%26spage%3D368%26epage%3D381%26doi%3D10.1038%2Fs41579-018-0005-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span> <span> </span><span class="NLM_article-title">EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1038/emi.2016.73</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1038%2Femi.2016.73" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=1-7&author=Q.+Maoauthor=Y.+Wangauthor=L.+Bianauthor=M.+Xuauthor=Z.+Liang&title=EV-A71+vaccine+licensure%3A+a+first+step+for+multivalent+enterovirus+vaccine+to+control+HFMD+and+other+severe+diseases&doi=10.1038%2Femi.2016.73"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Femi.2016.73&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femi.2016.73%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBian%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DZ.%26atitle%3DEV-A71%2520vaccine%2520licensure%253A%2520a%2520first%2520step%2520for%2520multivalent%2520enterovirus%2520vaccine%2520to%2520control%2520HFMD%2520and%2520other%2520severe%2520diseases%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2016%26volume%3D5%26spage%3D1%26epage%3D7%26doi%3D10.1038%2Femi.2016.73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X. L.</span></span> <span> </span><span class="NLM_article-title">Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">2024</span>â <span class="NLM_lpage">2032</span>, <span class="refDoi">Â DOI: 10.1016/S0140-6736(13)61049-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2FS0140-6736%2813%2961049-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=23726161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVGjt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2013&pages=2024-2032&author=F.+C.+Zhuauthor=F.+Y.+Mengauthor=J.+X.+Liauthor=X.+L.+Liauthor=Q.+Y.+Maoauthor=H.+Taoauthor=Y.+T.+Zhangauthor=X.+Yaoauthor=K.+Chuauthor=Q.+H.+Chenauthor=Y.+M.+Huauthor=X.+Wuauthor=P.+Liuauthor=L.+Y.+Zhuauthor=F.+Gaoauthor=H.+Jinauthor=Y.+J.+Chenauthor=Y.+Y.+Dongauthor=Y.+C.+Liangauthor=N.+M.+Shiauthor=H.+M.+Geauthor=L.+Liuauthor=S.+G.+Chenauthor=X.+Aiauthor=Z.+Y.+Zhangauthor=Y.+G.+Jiauthor=F.+J.+Luoauthor=X.+Q.+Chenauthor=Y.+Zhangauthor=L.+W.+Zhuauthor=Z.+L.+Liangauthor=X.+L.+Shen&title=Efficacy%2C+safety%2C+and+immunology+of+an+inactivated+alum-adjuvant+enterovirus+71+vaccine+in+children+in+China%3A+a+multicentre%2C+randomised%2C+double-blind%2C+placebo-controlled%2C+phase+3+trial&doi=10.1016%2FS0140-6736%2813%2961049-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial</span></div><div class="casAuthors">Zhu, Feng-Cai; Meng, Fan-Yue; Li, Jing-Xin; Li, Xiu-Ling; Mao, Qun-Ying; Tao, Hong; Zhang, Yun-Tao; Yao, Xin; Chu, Kai; Chen, Qing-Hua; Hu, Yue-Mei; Wu, Xing; Liu, Pei; Zhu, Lin-Yang; Gao, Fan; Jin, Hui; Chen, Yi-Juan; Dong, Yu-Ying; Liang, Yong-Chun; Shi, Nian-Min; Ge, Heng-Ming; Liu, Lin; Chen, Sheng-Gen; Ai, Xing; Zhang, Zhen-Yu; Ji, Yu-Guo; Luo, Feng-Ji; Chen, Xiao-Qin; Zhang, Ya; Zhu, Li-Wen; Liang, Zheng-Lun; Shen, Xin-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">9882</span>),
    <span class="NLM_cas:pages">2024-2032</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A vaccine for enterovirus 71 (EV71) is needed to address the high burden of disease assocd. with infection.  We assessed the efficacy, safety, immunogenicity, antibody persistence, and immunol. correlates of an inactivated alum-adjuvant EV71 vaccine.We did a randomised, double-blind, placebo-controlled, phase 3 trial.  Healthy children aged 6-35 mo from four centers in China were randomly assigned (1:1) to receive vaccine or alum-adjuvant placebo at day 0 and 28, according to a randomisation list (block size 30) generated by an independent statistician.  Investigators and participants and their guardians were masked to the assignment.  Primary endpoints were EV71-assocd. hand, foot, and mouth disease (HFMD) and EV71-assocd. disease during the surveillance period from day 56 to month 14, analyzed in the per-protocol population.  This study is registered with ClinicalTrials.gov, no. NCT01508247.10 245 participants were enrolled and assigned: 5120 to vaccine vs. 5125 to placebo. 4907 (with three cases of EV71-assocd. HFMD and eight cases of EV71-assocd. disease) vs. 4939 (with 30 cases of EV71-assocd. HFMD and 41 cases of EV71-assocd. disease) were included in the primary efficacy anal.  Vaccine efficacy was 90Â·0% (95% CI 67Â·1-96Â·9) against EV71-assocd. HFMD (p=0Â·0001) and 80Â·4% (95% CI 58Â·2-90Â·8) against EV71-assocd. disease (p<0Â·0001).  Serious adverse events were reported by 62 of 5117 (1Â·2%) participants in the vaccine group vs. 75 of 5123 (1Â·5%) in the placebo group (p=0Â·27).  Adverse events occurred in 3644 (71Â·2%) vs. 3603 (70Â·3%; p=0Â·33).EV71 vaccine provides high efficacy, satisfactory safety, and sustained immunogenicity.China's 12-5 National Major Infectious Disease Program, Beijing Vigoo Biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYdRqUnCjr7LVg90H21EOLACvtfcHk0lgSg00vQDJz9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVGjt7k%253D&md5=90c628e8ded2b29bf0fad5eef24e38b1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2961049-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252961049-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DF.%2BC.%26aulast%3DMeng%26aufirst%3DF.%2BY.%26aulast%3DLi%26aufirst%3DJ.%2BX.%26aulast%3DLi%26aufirst%3DX.%2BL.%26aulast%3DMao%26aufirst%3DQ.%2BY.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BT.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%2BH.%26aulast%3DHu%26aufirst%3DY.%2BM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DL.%2BY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DDong%26aufirst%3DY.%2BY.%26aulast%3DLiang%26aufirst%3DY.%2BC.%26aulast%3DShi%26aufirst%3DN.%2BM.%26aulast%3DGe%26aufirst%3DH.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DAi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DJi%26aufirst%3DY.%2BG.%26aulast%3DLuo%26aufirst%3DF.%2BJ.%26aulast%3DChen%26aufirst%3DX.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%2BW.%26aulast%3DLiang%26aufirst%3DZ.%2BL.%26aulast%3DShen%26aufirst%3DX.%2BL.%26atitle%3DEfficacy%252C%2520safety%252C%2520and%2520immunology%2520of%2520an%2520inactivated%2520alum-adjuvant%2520enterovirus%252071%2520vaccine%2520in%2520children%2520in%2520China%253A%2520a%2520multicentre%252C%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%252C%2520phase%25203%2520trial%26jtitle%3DLancet%26date%3D2013%26volume%3D381%26spage%3D2024%26epage%3D2032%26doi%3D10.1016%2FS0140-6736%2813%2961049-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span> <span> </span><span class="NLM_article-title">2-Year efficacy, immunogenicity, and safety of vigoo enterovirus 71 vaccine in healthy chinese children: a randomized open-label study</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">56</span>â <span class="NLM_lpage">63</span>, <span class="refDoi">Â DOI: 10.1093/infdis/jiw502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1093%2Finfdis%2Fjiw502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28077584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCrtbjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2017&pages=56-63&author=M.+Weiauthor=F.+Mengauthor=S.+Wangauthor=J.+Liauthor=Y.+Zhangauthor=Q.+Maoauthor=Y.+Huauthor=P.+Liuauthor=N.+Shiauthor=H.+Taoauthor=K.+Chuauthor=Y.+Wangauthor=Z.+Liangauthor=X.+Liauthor=F.+Zhu&title=2-Year+efficacy%2C+immunogenicity%2C+and+safety+of+vigoo+enterovirus+71+vaccine+in+healthy+chinese+children%3A+a+randomized+open-label+study&doi=10.1093%2Finfdis%2Fjiw502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">2-year efficacy, immunogenicity, and safety of Vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study</span></div><div class="casAuthors">Wei, Mingwei; Meng, Fanyue; Wang, Shiyuan; Li, Jingxin; Zhang, Yuntao; Mao, Qunying; Hu, Yuemei; Liu, Pei; Shi, Nianmin; Tao, Hong; Chu, Kai; Wang, Yuxiao; Liang, Zhenglun; Li, Xiuling; Zhu, Fengcai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">This study evaluated the 2-yr efficacy, immunogenicity, and safety of the Vigoo enterovirus 71 (EV71) vaccine for up to 2 years.  Overall efficacy was 94.84% (95% confidence interval [CI], 83.53%-98.38%) during the 2-yr follow-up period (P < .0001), and the vaccine efficacy during the second year was 100.00% (95% CI, 84.15%-100.00%) against EV71-assocd. hand-foot-and-mouth disease (HFMD; P < .0001).  Geometric mean titers of neutralizing antibody in participants remained high during the 2-yr follow-up period, and no vaccine-related serious adverse events were recorded.  Two doses of Vigoo EV71 vaccine could provide sustained protection against EV71-assocd. HFMD in healthy Chinese children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk1il39ykPN7Vg90H21EOLACvtfcHk0lgSg00vQDJz9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCrtbjL&md5=577de9bb41d735f4378d5bf98e9863c3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiw502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiw502%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DN.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DF.%26atitle%3D2-Year%2520efficacy%252C%2520immunogenicity%252C%2520and%2520safety%2520of%2520vigoo%2520enterovirus%252071%2520vaccine%2520in%2520healthy%2520chinese%2520children%253A%2520a%2520randomized%2520open-label%2520study%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D215%26spage%3D56%26epage%3D63%26doi%3D10.1093%2Finfdis%2Fjiw502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, S. R.</span></span> <span> </span><span class="NLM_article-title">Antivirals and vaccines for Enterovirus A71</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">65</span> <span class="refDoi">Â DOI: 10.1186/s12929-019-0560-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1186%2Fs12929-019-0560-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=31481071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB3MrkslyntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&author=J.+Y.+Linauthor=Y.+A.+Kungauthor=S.+R.+Shih&title=Antivirals+and+vaccines+for+Enterovirus+A71&doi=10.1186%2Fs12929-019-0560-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antivirals and vaccines for Enterovirus A71</span></div><div class="casAuthors">Lin Jing-Yi; Kung Yu-An; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Enterovirus A71 (EV-A71) is an important emerging virus posing a threat to children under five years old.  EV-A71 infection in infants or young children can cause hand-foot-and-mouth disease, herpangina, or severe neurological complications.  However, there are still no effective antivirals for treatment of these infections.  In this review, we summarize the antiviral compounds developed to date based on various targets of the EV-A71 life cycle.  Moreover, development of a vaccine would be the most effective approach to prevent EV-A71 infection.  Therefore, we also summarize the development and clinical progress of various candidate EV-A71 vaccines, including inactivated whole virus, recombinant VP1 protein, synthetic peptides, viral-like particles, and live attenuated vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNZYm4GTBO6O2mnZh2OgS0fW6udTcc2eYuGKhmPr4j0bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrkslyntA%253D%253D&md5=821da37b6855b1f9de69941b612d5cb8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fs12929-019-0560-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-019-0560-7%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BY.%26aulast%3DKung%26aufirst%3DY.%2BA.%26aulast%3DShih%26aufirst%3DS.%2BR.%26atitle%3DAntivirals%2520and%2520vaccines%2520for%2520Enterovirus%2520A71%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2019%26volume%3D26%26doi%3D10.1186%2Fs12929-019-0560-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahendran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, S.</span></span> <span> </span><span class="NLM_article-title">Recent progress and challenges in drug development to fight hand, foot and mouth disease</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">359</span>â <span class="NLM_lpage">371</span>, <span class="refDoi">Â DOI: 10.1080/17460441.2019.1659241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1080%2F17460441.2019.1659241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=31470744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtbzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=359-371&author=Z.+Q.+Limauthor=Q.+Y.+Ngauthor=J.+W.+Q.+Ngauthor=V.+Mahendranauthor=S.+Alonso&title=Recent+progress+and+challenges+in+drug+development+to+fight+hand%2C+foot+and+mouth+disease&doi=10.1080%2F17460441.2019.1659241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress and challenges in drug development to fight hand, foot and mouth disease</span></div><div class="casAuthors">Lim, Ze Qin; Ng, Qing Yong; Ng, Justin Wei Qing; Mahendran, Vikneswari; Alonso, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-371</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Introduction: Hand, foot and mouth disease (HFMD) is a serious public health concern in the Asia-Pacific region with recurrent cyclical outbreaks.  Enterovirus 71 (EV-A71) and coxsackievirus type A are the main causative agents of HFMD.  While majority of HFMD cases are mild and self-limiting, neurol. complications have been reported for EV-A71 assocd. HFMD.  There is currently no effective treatment against HFMD and monovalent vaccines against EV-A71 are currently limited to the Chinese market.  As of today, HFMD antiviral development has focused on EV-A71 and involves conventional screening of drug libraries.  In recent years, attention has shifted toward identifying druggable host factors to avoid drug resistance and identify drug candidates with broader antiviral activity across EV-A71 genogroups and other HFMD causative agents.  The effective development of HFMD interventions requires us to address the gaps in our understanding of its pathogenesis at the mol. level.  The limited resources devoted to the development of HFMD treatment strategies worldwide also contribute to the slow progress of promising drug and vaccine candidates along the clin. pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8tzKZ33gBHrVg90H21EOLACvtfcHk0lhLIx-5DVII7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtbzF&md5=ee09d83d021c3bd3506fbced272aedbe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F17460441.2019.1659241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2019.1659241%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DZ.%2BQ.%26aulast%3DNg%26aufirst%3DQ.%2BY.%26aulast%3DNg%26aufirst%3DJ.%2BW.%2BQ.%26aulast%3DMahendran%26aufirst%3DV.%26aulast%3DAlonso%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520and%2520challenges%2520in%2520drug%2520development%2520to%2520fight%2520hand%252C%2520foot%2520and%2520mouth%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2020%26volume%3D15%26spage%3D359%26epage%3D371%26doi%3D10.1080%2F17460441.2019.1659241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Enterovirus D68 Antivirals: Past, Present, and Future</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1572</span>â <span class="NLM_lpage">1586</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.0c00120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.0c00120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1ersbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=1572-1586&author=Y.+Huauthor=R.+Musharrafiehauthor=M.+Zhengauthor=J.+Wang&title=Enterovirus+D68+Antivirals%3A+Past%2C+Present%2C+and+Future&doi=10.1021%2Facsinfecdis.0c00120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Enterovirus D68 Antivirals: Past, Present, and Future</span></div><div class="casAuthors">Hu, Yanmei; Musharrafieh, Rami; Zheng, Madeleine; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1572-1586</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Enterovirus D68 (EV-D68) is an RNA virus that causes respiratory illnesses mainly in children.  In severe cases, it can lead to neurol. complications such as acute flaccid myelitis (AFM).  EV-D68 belongs to the enterovirus genera of the Picornaviridae family, which also includes many other significant human pathogens such as poliovirus, enterovirus A71, and rhinovirus.  There are currently no vaccines or antivirals against EV-D68.  In this review, we present the current understanding of the link between EV-D68 and AFM, the mechanism of viral replication, and recent progress in developing EV-D68 antivirals by targeting various viral proteins and host factors that are essential for viral replication.  The future directions of EV-D68 antiviral drug discovery and the criteria for drugs to reach clin. trials are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_c0CXEKHKbVg90H21EOLACvtfcHk0lhLIx-5DVII7A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1ersbk%253D&md5=85baf1cdfee863a4c5c5daae78372c4a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.0c00120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.0c00120%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DEnterovirus%2520D68%2520Antivirals%253A%2520Past%252C%2520Present%252C%2520and%2520Future%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D1572%26epage%3D1586%26doi%3D10.1021%2Facsinfecdis.0c00120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyoo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Schaar, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span> <span> </span><span class="NLM_article-title">Direct-acting antivirals and host-targeting strategies to combat enterovirus infections</span>. <i>Curr. Opin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">8</span>, <span class="refDoi">Â DOI: 10.1016/j.coviro.2017.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.coviro.2017.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28411509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFKqsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1-8&author=L.+Bauerauthor=H.+Lyooauthor=H.+M.+van+der%0ASchaarauthor=J.+R.+Stratingauthor=F.+J.+van+Kuppeveld&title=Direct-acting+antivirals+and+host-targeting+strategies+to+combat+enterovirus+infections&doi=10.1016%2Fj.coviro.2017.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Direct-acting antivirals and host-targeting strategies to combat enterovirus infections</span></div><div class="casAuthors">Bauer, Lisa; Lyoo, Heyrhyoung; van der Schaar, Hilde M.; Strating, Jeroen R. P. M.; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enteroviruses (e.g., poliovirus, enterovirus-A71, coxsackievirus, enterovirus-D68, rhinovirus) include many human pathogens causative of various mild and more severe diseases, esp. in young children.  Unfortunately, antiviral drugs to treat enterovirus infections have not been approved yet.  Over the past decades, several direct-acting inhibitors have been developed, including capsid binders, which block virus entry, and inhibitors of viral enzymes required for genome replication.  Capsid binders and protease inhibitors have been clin. evaluated, but failed due to limited efficacy or toxicity issues.  As an alternative approach, host-targeting inhibitors with potential broad-spectrum activity have been identified.  Furthermore, drug repurposing screens have recently uncovered promising new inhibitors with disparate viral and host targets.  Together, these findings raise hope for the development of (broad-range) anti-enteroviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxT9auTJ_eW7Vg90H21EOLACvtfcHk0ljIkAmjwvYrPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFKqsrc%253D&md5=1f7d35dca32eda896e13b372de4ec255</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2017.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2017.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DLyoo%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BSchaar%26aufirst%3DH.%2BM.%26aulast%3DStrating%26aufirst%3DJ.%2BR.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26atitle%3DDirect-acting%2520antivirals%2520and%2520host-targeting%2520strategies%2520to%2520combat%2520enterovirus%2520infections%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2017%26volume%3D24%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.coviro.2017.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, S.-R.</span></span> <span> </span><span class="NLM_article-title">Enterovirus and Encephalitis</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">261</span>, <span class="refDoi">Â DOI: 10.3389/fmicb.2020.00261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3389%2Ffmicb.2020.00261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32153545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB383hsF2jsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=261&author=B.-S.+Chenauthor=H.-C.+Leeauthor=K.-M.+Leeauthor=Y.-N.+Gongauthor=S.-R.+Shih&title=Enterovirus+and+Encephalitis&doi=10.3389%2Ffmicb.2020.00261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Enterovirus and Encephalitis</span></div><div class="casAuthors">Chen Bo-Shiun; Lee Hou-Chen; Lee Kuo-Ming; Gong Yu-Nong; Shih Shin-Ru; Chen Bo-Shiun; Gong Yu-Nong; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Enterovirus-induced infection of the central nervous system (CNS) results in acute inflammation of the brain (encephalitis) and constitutes a significant global burden to human health.  These viruses are thought to be highly cytolytic, therefore normal brain function could be greatly compromised following enteroviral infection of the CNS.  A further layer of complexity is added by evidence showing that some enteroviruses may establish a persistent infection within the CNS and eventually lead to pathogenesis of certain neurodegenerative disorders.  Interestingly, enterovirus encephalitis is particularly common among young children, suggesting a potential causal link between the development of the neuroimmune system and enteroviral neuroinvasion.  Although the CNS involvement in enterovirus infections is a relatively rare complication, it represents a serious underlying cause of mortality.  Here we review a selection of enteroviruses that infect the CNS and discuss recent advances in the characterization of these enteroviruses with regard to their routes of CNS infection, tropism, virulence, and immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThLNZvSzP0CdyzdcP07UmufW6udTcc2eawlSdo3TRbwLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383hsF2jsA%253D%253D&md5=6eb3e8dcff33ccec6ef514889392c4d9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2020.00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2020.00261%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.-S.%26aulast%3DLee%26aufirst%3DH.-C.%26aulast%3DLee%26aufirst%3DK.-M.%26aulast%3DGong%26aufirst%3DY.-N.%26aulast%3DShih%26aufirst%3DS.-R.%26atitle%3DEnterovirus%2520and%2520Encephalitis%26jtitle%3DFront.%2520Microbiol.%26date%3D2020%26volume%3D11%26spage%3D261%26doi%3D10.3389%2Ffmicb.2020.00261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons-Salort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenfell, B. T.</span></span> <span> </span><span class="NLM_article-title">Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">eabd2400</span> <span class="refDoi">Â DOI: 10.1126/scitranslmed.abd2400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1126%2Fscitranslmed.abd2400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33692131" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2021&author=S.+W.+Parkauthor=M.+Pons-Salortauthor=K.+Messacarauthor=C.+Cookauthor=L.+Meyersauthor=J.+Farrarauthor=B.+T.+Grenfell&title=Epidemiological+dynamics+of+enterovirus+D68+in+the+United+States+and+implications+for+acute+flaccid+myelitis&doi=10.1126%2Fscitranslmed.abd2400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.abd2400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.abd2400%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DPons-Salort%26aufirst%3DM.%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DCook%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DL.%26aulast%3DFarrar%26aufirst%3DJ.%26aulast%3DGrenfell%26aufirst%3DB.%2BT.%26atitle%3DEpidemiological%2520dynamics%2520of%2520enterovirus%2520D68%2520in%2520the%2520United%2520States%2520and%2520implications%2520for%2520acute%2520flaccid%2520myelitis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2021%26volume%3D13%26doi%3D10.1126%2Fscitranslmed.abd2400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pons-Salort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberste, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallansch, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedi, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenfell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassly, N. C.</span></span> <span> </span><span class="NLM_article-title">The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3078</span>â <span class="NLM_lpage">3083</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1721159115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1073%2Fpnas.1721159115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=29507246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1ChtrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=3078-3083&author=M.+Pons-Salortauthor=M.+S.+Obersteauthor=M.+A.+Pallanschauthor=G.+R.+Abediauthor=S.+Takahashiauthor=B.+T.+Grenfellauthor=N.+C.+Grassly&title=The+seasonality+of+nonpolio+enteroviruses+in+the+United+States%3A+Patterns+and+drivers&doi=10.1073%2Fpnas.1721159115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The seasonality of nonpolio enteroviruses in the United States: patterns and drivers</span></div><div class="casAuthors">Pons-Salort, Margarita; Oberste, M. Steven; Pallansch, Mark A.; Abedi, Glen R.; Takahashi, Saki; Grenfell, Bryan T.; Grassly, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3078-3083</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Nonpolio enteroviruses are diverse and common viruses that can circulate year-round but tend to peak in summer.  Although most infections are asymptomatic, they can result in a wide range of neurol. and other diseases.  Many serotypes circulate every year, and different serotypes predominate in different years, but the drivers of their geog. and temporal dynamics are not understood.  We use national enterovirus surveillance data collected by the US Centers for Disease Control and Prevention during 1983-2013, as well as demog. and climatic data for the same period, to study the patterns and drivers of the seasonality of these infections.  We find that the seasonal pattern of enterovirus cases is spatially structured in the United States and similar to that obsd. for historical prevaccination poliomyelitis (1931-1954).  We identify latitudinal gradients for the amplitude and the timing of the peak of cases, meaning that those are more regularly distributed all year-round in the south and have a more pronounced peak that arrives later toward the north.  The peak is estd. to occur between July and Sept. across the United States, and 1 mo earlier than that for historical poliomyelitis.  Using mixed-effects models, we find that climate, but not demog., is likely to drive the seasonal pattern of enterovirus cases and that the dew point temp. alone explains â¼30% of the variation in the intensity of transmission.  Our study contributes to a better understanding of the epidemiol. of enteroviruses, demonstrates important similarities in their circulation dynamics with polioviruses, and identifies potential drivers of their seasonality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFbrTwqQ34bVg90H21EOLACvtfcHk0ljIkAmjwvYrPA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1ChtrzP&md5=946a979916de5e6fee07bf9a395a170a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1721159115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1721159115%26sid%3Dliteratum%253Aachs%26aulast%3DPons-Salort%26aufirst%3DM.%26aulast%3DOberste%26aufirst%3DM.%2BS.%26aulast%3DPallansch%26aufirst%3DM.%2BA.%26aulast%3DAbedi%26aufirst%3DG.%2BR.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DGrenfell%26aufirst%3DB.%2BT.%26aulast%3DGrassly%26aufirst%3DN.%2BC.%26atitle%3DThe%2520seasonality%2520of%2520nonpolio%2520enteroviruses%2520in%2520the%2520United%2520States%253A%2520Patterns%2520and%2520drivers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D3078%26epage%3D3083%26doi%3D10.1073%2Fpnas.1721159115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. F.</span></span> <span> </span><span class="NLM_article-title">Current understanding of human Enterovirus D68</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">490</span>, <span class="refDoi">Â DOI: 10.3390/v11060490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3390%2Fv11060490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVan" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=490&author=J.+Sunauthor=X.+Y.+Huauthor=X.+F.+Yu&title=Current+understanding+of+human+Enterovirus+D68&doi=10.3390%2Fv11060490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Current understanding of human enterovirus D68</span></div><div class="casAuthors">Sun, Jing; Hu, Xiao-Yi; Yu, Xiao-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">490</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Human enterovirus D68 (EV-D68), a member of the species Enterovirus D of the Picornaviridae family, was first isolated in 1962 in the United States.  EV-D68 infection was only infrequently reported until an outbreak occurred in 2014 in the US; since then, it has continued to increase worldwide.  EV-D68 infection leads to severe respiratory illness and has recently been reported to be linked to the development of the neurogenic disease known as acute flaccid myelitis (AFM), mostly in children, seriously endangering public health.  Hitherto, treatment options for EV-D68 infections were limited to supportive care, and as yet there are no approved, specific antiviral drugs or vaccines.  Research on EV-D68 has mainly focused on its epidemiol., and its virol. characteristics and pathogenesis still need to be further explored.  Here, we provide an overview of current research on EV-D68, including the genotypes and genetic characteristics of recent epidemics, the mechanism of infection and virus-host interactions, and its relationship to acute flaccid myelitis (AFM), in order to broaden our understanding of the biol. features of EV-D68 and provide a basis for the development of effective antiviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJUwKWBtbx7Vg90H21EOLACvtfcHk0lg1HITaRsGtRw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVan&md5=1f85392ec96bb95dfabf42e984e52739</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fv11060490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11060490%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%2BY.%26aulast%3DYu%26aufirst%3DX.%2BF.%26atitle%3DCurrent%2520understanding%2520of%2520human%2520Enterovirus%2520D68%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26spage%3D490%26doi%3D10.3390%2Fv11060490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asturias, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Leer-Buter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niesters, H. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abzug, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. R.</span></span> <span> </span><span class="NLM_article-title">Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">e239</span>â <span class="NLM_lpage">e247</span>, <span class="refDoi">Â DOI: 10.1016/S1473-3099(18)30094-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2FS1473-3099%2818%2930094-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=29482893" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=e239-e247&author=K.+Messacarauthor=E.+J.+Asturiasauthor=A.+M.+Hixonauthor=C.+Van+Leer-Buterauthor=H.+G.+M.+Niestersauthor=K.+L.+Tylerauthor=M.+J.+Abzugauthor=S.+R.+Dominguez&title=Enterovirus+D68+and+acute+flaccid+myelitis-evaluating+the+evidence+for+causality&doi=10.1016%2FS1473-3099%2818%2930094-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930094-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930094-X%26sid%3Dliteratum%253Aachs%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DAsturias%26aufirst%3DE.%2BJ.%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DVan%2BLeer-Buter%26aufirst%3DC.%26aulast%3DNiesters%26aufirst%3DH.%2BG.%2BM.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26aulast%3DAbzug%26aufirst%3DM.%2BJ.%26aulast%3DDominguez%26aufirst%3DS.%2BR.%26atitle%3DEnterovirus%2520D68%2520and%2520acute%2520flaccid%2520myelitis-evaluating%2520the%2520evidence%2520for%2520causality%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2018%26volume%3D18%26spage%3De239%26epage%3De247%26doi%3D10.1016%2FS1473-3099%2818%2930094-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. M.</span>; <span class="NLM_string-name">Hixon, A. M.</span>; <span class="NLM_string-name">Oldfield, L. M.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Novotny, M.</span>; <span class="NLM_string-name">Wang, W.</span>; <span class="NLM_string-name">Das, S. R.</span>; <span class="NLM_string-name">Shabman, R. S.</span>; <span class="NLM_string-name">Tyler, K. L.</span>; <span class="NLM_string-name">Scheuermann, R. H.</span></span><span> </span><span class="NLM_article-title">Contemporary circulating Enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells</span> <i>mBio</i><span class="NLM_year">2018</span> <span class="NLM_volume">9</span><span class="refDoi">Â DOI: 10.1128/mBio.01954-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.01954-18" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=D.+M.+Brown&author=A.+M.+Hixon&author=L.+M.+Oldfield&author=Y.+Zhang&author=M.+Novotny&author=W.+Wang&author=S.+R.+Das&author=R.+S.+Shabman&author=K.+L.+Tyler&author=R.+H.+Scheuermann&title=Contemporary+circulating+Enterovirus+D68+strains+have+acquired+the+capacity+for+viral+entry+and+replication+in+human+neuronal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FmBio.01954-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.01954-18%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BM.%26atitle%3DContemporary%2520circulating%2520Enterovirus%2520D68%2520strains%2520have%2520acquired%2520the%2520capacity%2520for%2520viral%2520entry%2520and%2520replication%2520in%2520human%2520neuronal%2520cells%26jtitle%3DmBio%26date%3D2018%26volume%3D9%26doi%3D10.1128%2FmBio.01954-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morens, D. M.</span>; <span class="NLM_string-name">Folkers, G. K.</span>; <span class="NLM_string-name">Fauci, A. S.</span></span> <span> </span><span class="NLM_article-title">Acute flaccid myelitis: something old and something new</span>.  <i>mBio</i> <span class="NLM_year">2019</span>,  <span class="NLM_volume">10</span>, <span class="refDoi">Â DOI: 10.1128/mBio.00521-19</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.00521-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30940708" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+M.+Morens&author=G.+K.+Folkers&author=A.+S.+Fauci&title=Acute+flaccid+myelitis%3A+something+old+and+something+new"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FmBio.00521-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.00521-19%26sid%3Dliteratum%253Aachs%26aulast%3DMorens%26aufirst%3DD.%2BM.%26atitle%3DAcute%2520flaccid%2520myelitis%253A%2520something%2520old%2520and%2520something%2520new%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26doi%3D10.1128%2FmBio.00521-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, C. A.</span></span> <span> </span><span class="NLM_article-title">Acute flaccid myelitis: a clinical review</span>. <i>Semin. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">211</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1055/s-0040-1705123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1055%2Fs-0040-1705123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32143233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB383gsFGrug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=211-218&author=O.+C.+Murphyauthor=C.+A.+Pardo&title=Acute+flaccid+myelitis%3A+a+clinical+review&doi=10.1055%2Fs-0040-1705123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acute Flaccid Myelitis: A Clinical Review</span></div><div class="casAuthors">Murphy Olwen C; Pardo Carlos A</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in neurology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-218</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute flaccid myelitis (AFM) is an emerging disorder primarily affecting children that is characterized by acute flaccid paralysis accompanied by abnormalities of the spinal cord gray matter on magnetic resonance imaging.  In most cases, prodromal fever or respiratory symptoms occur, followed by acute-onset flaccid limb weakness.  Respiratory, axial, bulbar, facial, and extraocular muscles may also be affected.  The clinical manifestations have been described as "polio-like," due to striking similarities to cases of poliomyelitis.  The primary site of injury in AFM is the anterior horn cells of the spinal cord, resulting in a motor neuronopathy.  Seasonal peaks of cases have occurred in the United States every 2 years since 2012.  However, AFM remains a rare disease, which can make it challenging for physicians to recognize and differentiate from other causes of acute flaccid paralysis such as Guillain-Barre syndrome, spinal cord stroke, and transverse myelitis.  Epidemiological evidence suggests that AFM is linked to a viral etiology, with nonpolio enteroviruses (in particular enterovirus D68) demonstrating a plausible association.  The epidemiology, possible etiological factors, clinical features, differential diagnosis, treatment, and outcomes of AFM are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQC5wz-kW0l2w8IxFYvehhofW6udTcc2eaitLQxFsyqX7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383gsFGrug%253D%253D&md5=6caf25d70171c1faa39c4d831c0e2c18</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1055%2Fs-0040-1705123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0040-1705123%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DO.%2BC.%26aulast%3DPardo%26aufirst%3DC.%2BA.%26atitle%3DAcute%2520flaccid%2520myelitis%253A%2520a%2520clinical%2520review%26jtitle%3DSemin.%2520Neurol.%26date%3D2020%26volume%3D40%26spage%3D211%26epage%3D218%26doi%3D10.1055%2Fs-0040-1705123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelzer-Braid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chughtai, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, C. R.</span></span> <span> </span><span class="NLM_article-title">The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation?</span>. <i>Eurosurveillance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">16</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.2807/1560-7917.ES.2018.23.3.17-00310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.2807%2F1560-7917.ES.2018.23.3.17-00310" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=16-24&author=A.+Dydaauthor=S.+Stelzer-Braidauthor=D.+Adamauthor=A.+A.+Chughtaiauthor=C.+R.+MacIntyre&title=The+association+between+acute+flaccid+myelitis+%28AFM%29+and+Enterovirus+D68+%28EV-D68%29+-+what+is+the+evidence+for+causation%3F&doi=10.2807%2F1560-7917.ES.2018.23.3.17-00310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2807%2F1560-7917.ES.2018.23.3.17-00310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2807%252F1560-7917.ES.2018.23.3.17-00310%26sid%3Dliteratum%253Aachs%26aulast%3DDyda%26aufirst%3DA.%26aulast%3DStelzer-Braid%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DD.%26aulast%3DChughtai%26aufirst%3DA.%2BA.%26aulast%3DMacIntyre%26aufirst%3DC.%2BR.%26atitle%3DThe%2520association%2520between%2520acute%2520flaccid%2520myelitis%2520%2528AFM%2529%2520and%2520Enterovirus%2520D68%2520%2528EV-D68%2529%2520-%2520what%2520is%2520the%2520evidence%2520for%2520causation%253F%26jtitle%3DEurosurveillance%26date%3D2018%26volume%3D23%26spage%3D16%26epage%3D24%26doi%3D10.2807%2F1560-7917.ES.2018.23.3.17-00310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span> <span> </span><span class="NLM_article-title">Understanding Enterovirus D68-induced neurologic disease: a basic science review</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">821</span>, <span class="refDoi">Â DOI: 10.3390/v11090821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3390%2Fv11090821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFyns7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=821&author=A.+M.+Hixonauthor=J.+Frostauthor=M.+J.+Rudyauthor=K.+Messacarauthor=P.+Clarkeauthor=K.+L.+Tyler&title=Understanding+Enterovirus+D68-induced+neurologic+disease%3A+a+basic+science+review&doi=10.3390%2Fv11090821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding enterovirus D68-induced neurologic disease: a basic science review</span></div><div class="casAuthors">Hixon, Alison M.; Frost, Joshua; Rudy, Michael J.; Messacar, Kevin; Clarke, Penny; Tyler, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">821</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  In 2014, the United States (US) experienced an unprecedented epidemic of enterovirus D68 (EV-D68)-induced respiratory disease that was temporally assocd. with the emergence of acute flaccid myelitis (AFM), a paralytic disease occurring predominantly in children, that has a striking resemblance to poliomyelitis.  Although a definitive causal link between EV-D68 infection and AFM has not been unequivocally established, rapidly accumulating clin., immunol., and epidemiol. evidence points to EV-D68 as the major causative agent of recent seasonal childhood AFM outbreaks in the US.  This review summarizes evidence, gained from in vivo and in vitro models of EV-D68-induced disease, which demonstrates that contemporary EV-D68 strains isolated during and since the 2014 outbreak differ from historical EV-D68 in several factors influencing neurovirulence, including their genomic sequence, their receptor utilization, their ability to infect neurons, and their neuropathogenicity in mice.  These findings provide biol. plausibility that EV-D68 is a causal agent of AFM and provide important exptl. models for studies of pathogenesis and treatment that are likely to be difficult or impossible in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKGYAUEAzIILVg90H21EOLACvtfcHk0li2_Xk9upQDpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFyns7k%253D&md5=67b6406db8c6d1bda5862556e9273061</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3390%2Fv11090821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11090821%26sid%3Dliteratum%253Aachs%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DFrost%26aufirst%3DJ.%26aulast%3DRudy%26aufirst%3DM.%2BJ.%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DClarke%26aufirst%3DP.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26atitle%3DUnderstanding%2520Enterovirus%2520D68-induced%2520neurologic%2520disease%253A%2520a%2520basic%2520science%2520review%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26spage%3D821%26doi%3D10.3390%2Fv11090821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson-Murphy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bains, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabrocki, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glanternik, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makhani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBiasi, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremoulet, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Haren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abzug, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. R.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">e2118</span>â <span class="NLM_lpage">e2126</span>, <span class="refDoi">Â DOI: 10.1212/WNL.0000000000006670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1212%2FWNL.0000000000006670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30413631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotl2nurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2019&pages=e2118-e2126&author=K.+Messacarauthor=S.+Sillauauthor=S.+E.+Hopkinsauthor=C.+Ottenauthor=M.+Wilson-Murphyauthor=B.+Wongauthor=J.+D.+Santoroauthor=A.+Treisterauthor=H.+K.+Bainsauthor=A.+Torresauthor=L.+Zabrockiauthor=J.+R.+Glanternikauthor=A.+L.+Hurstauthor=J.+A.+Martinauthor=T.+Schreinerauthor=N.+Makhaniauthor=R.+L.+DeBiasiauthor=M.+C.+Kruerauthor=A.+H.+Tremouletauthor=K.+Van+Harenauthor=J.+Desaiauthor=L.+A.+Bensonauthor=M.+P.+Gormanauthor=M.+J.+Abzugauthor=K.+L.+Tylerauthor=S.+R.+Dominguez&title=Safety%2C+tolerability%2C+and+efficacy+of+fluoxetine+as+an+antiviral+for+acute+flaccid+myelitis&doi=10.1212%2FWNL.0000000000006670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis</span></div><div class="casAuthors">Messacar, Kevin; Sillau, Stefan; Hopkins, Sarah E.; Otten, Catherine; Wilson-Murphy, Molly; Wong, Brian; Santoro, Jonathan D.; Treister, Andrew; Bains, Harlori K.; Torres, Alcy; Zabrocki, Luke; Glanternik, Julia R.; Hurst, Amanda L.; Martin, Jan A.; Schreiner, Teri; Makhani, Naila; DeBiasi, Roberta L.; Kruer, Michael C.; Tremoulet, Adriana H.; Van Haren, Keith; Desai, Jay; Benson, Leslie A.; Gorman, Mark P.; Abzug, Mark J.; Tyler, Kenneth L.; Dominguez, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">e2118-e2126</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To det. the safety, tolerability, and efficacy of fluoxetine for proven or presumptive enterovirus (EV) D68-assocd. acute flaccid myelitis (AFM).  Methods: A multicenter cohort study of US patients with AFM in 2015-2016 compared serious adverse events (SAEs), adverse effects, and outcomes between fluoxetine-treated patients and untreated controls.  Fluoxetine was administered at the discretion of treating providers with data gathered retrospectively.  The primary outcome was change in summative limb strength score (SLSS; sum of Medical Research Council strength in all 4 limbs, ranging from 20 [normal strength] to 0 [complete quadriparesis]) between initial examn. and latest follow-up, with increased SLSS reflecting improvement and decreased SLSS reflecting worsened strength.  Results: Fifty-six patients with AFM from 12 centers met study criteria.  Among 30 patients exposed to fluoxetine, no SAEs were reported and adverse effect rates were similar to unexposed patients (47% vs 65%, p = 0.16).  The 28 patients treated with >1 dose of fluoxetine were more likely to have EV-D68 identified (57.1% vs 14.3%, p < 0.001).  Their SLSS was similar at initial examn. (mean SLSS 12.9 vs 14.3, p = 0.31) but lower at nadir (mean SLSS 9.25 vs 12.82, p = 0.02) and latest follow-up (mean SLSS 12.5 vs 16.4, p = 0.005) compared with the 28 patients receiving 1 (n = 2) or no (n = 26) doses.  In propensity-adjusted anal., SLSS from initial examn. to latest follow-up decreased by 0.2 (95% confidence interval [CI] -1.8 to +1.4) in fluoxetine-treated patients and increased by 2.5 (95% CI +0.7 to +4.4) in untreated patients (p = 0.015).  Conclusion: Fluoxetine was well-tolerated.  Fluoxetine was preferentially given to patients with AFM with EV-D68 identified and more severe paralysis at nadir, who ultimately had poorer long-term outcomes.  Classification of evidence: This study provides Class IV evidence that for patients with EV-D68-assocd. AFM, fluoxetine is well-tolerated and not assocd. with improved neurol. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVU-9evGdhCbVg90H21EOLACvtfcHk0li2_Xk9upQDpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotl2nurw%253D&md5=da84cefe43784d5ca8f7cf80eb756597</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000006670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000006670%26sid%3Dliteratum%253Aachs%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DSillau%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DS.%2BE.%26aulast%3DOtten%26aufirst%3DC.%26aulast%3DWilson-Murphy%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DSantoro%26aufirst%3DJ.%2BD.%26aulast%3DTreister%26aufirst%3DA.%26aulast%3DBains%26aufirst%3DH.%2BK.%26aulast%3DTorres%26aufirst%3DA.%26aulast%3DZabrocki%26aufirst%3DL.%26aulast%3DGlanternik%26aufirst%3DJ.%2BR.%26aulast%3DHurst%26aufirst%3DA.%2BL.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSchreiner%26aufirst%3DT.%26aulast%3DMakhani%26aufirst%3DN.%26aulast%3DDeBiasi%26aufirst%3DR.%2BL.%26aulast%3DKruer%26aufirst%3DM.%2BC.%26aulast%3DTremoulet%26aufirst%3DA.%2BH.%26aulast%3DVan%2BHaren%26aufirst%3DK.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DBenson%26aufirst%3DL.%2BA.%26aulast%3DGorman%26aufirst%3DM.%2BP.%26aulast%3DAbzug%26aufirst%3DM.%2BJ.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26aulast%3DDominguez%26aufirst%3DS.%2BR.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520efficacy%2520of%2520fluoxetine%2520as%2520an%2520antiviral%2520for%2520acute%2520flaccid%2520myelitis%26jtitle%3DNeurology%26date%3D2019%26volume%3D92%26spage%3De2118%26epage%3De2126%26doi%3D10.1212%2FWNL.0000000000006670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span> <span> </span><span class="NLM_article-title">Evaluating treatment efficacy in a mouse model of Enterovirus D68-associated paralytic myelitis</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">1245</span>â <span class="NLM_lpage">1253</span>, <span class="refDoi">Â DOI: 10.1093/infdis/jix468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1093%2Finfdis%2Fjix468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28968718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCns77E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2017&pages=1245-1253&author=A.+M.+Hixonauthor=P.+Clarkeauthor=K.+L.+Tyler&title=Evaluating+treatment+efficacy+in+a+mouse+model+of+Enterovirus+D68-associated+paralytic+myelitis&doi=10.1093%2Finfdis%2Fjix468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating treatment efficacy in a mouse model of enterovirus D68-associated paralytic myelitis</span></div><div class="casAuthors">Hixon, Alison M.; Clarke, Penny; Tyler, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1245-1253</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Enterovirus D68 (EV-D68)-assocd. acute flaccid myelitis (AFM) is a devastating neurol. disease for which there are no treatments of proven efficacy.  The unpredictable temporal and geog. distribution of cases and the rarity of the disease make it unlikely that data from randomized controlled trials will be available to guide therapeutic decisions.  Methods: We evaluated the following 3 widely used empirical therapies for the ability to reduce the severity of paralysis in a mouse model of EV-D68 infection: (1) human i.v. Ig (hIVIG), (2) fluoxetine, and (3) dexamethasone.  Neonatal mice were injected i.m. with a human 2014 EV-D68 isolate that reliably induces paralysis in mice due to infection and loss of spinal cord motor neurons.  Mice receiving treatments were evaluated for motor impairment, mortality, and spinal cord viral load.  Results: hIVIG, which contained neutralizing antibodies to EV-D68, reduced paralysis in infected mice and decreased spinal cord viral loads.  Fluoxetine had no effect on motor impairment or viral loads.  Dexamethasone treatment worsened motor impairment, increased mortality, and increased viral loads.  Conclusion: Results in this model of EV-D68-assocd. AFM provide a rational basis for selecting empirical therapy in humans and establish this model as a useful system for evaluating other potential therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9AAZ8yniwrVg90H21EOLACvtfcHk0li2_Xk9upQDpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCns77E&md5=2054e3b6e6db2d57f6d2d6e5dddf3bf5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjix468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjix468%26sid%3Dliteratum%253Aachs%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DClarke%26aufirst%3DP.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26atitle%3DEvaluating%2520treatment%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520Enterovirus%2520D68-associated%2520paralytic%2520myelitis%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D216%26spage%3D1245%26epage%3D1253%26doi%3D10.1093%2Finfdis%2Fjix468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leser, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span> <span> </span><span class="NLM_article-title">A mouse model of paralytic myelitis caused by enterovirus D68</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e1006199</span> <span class="refDoi">Â DOI: 10.1371/journal.ppat.1006199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1371%2Fjournal.ppat.1006199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28231269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCqt7rN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&author=A.+M.+Hixonauthor=G.+Yuauthor=J.+S.+Leserauthor=S.+Yagiauthor=P.+Clarkeauthor=C.+Y.+Chiuauthor=K.+L.+Tyler&title=A+mouse+model+of+paralytic+myelitis+caused+by+enterovirus+D68&doi=10.1371%2Fjournal.ppat.1006199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A mouse model of paralytic myelitis caused by enterovirus D68</span></div><div class="casAuthors">Hixon, Alison M.; Yu, Guixia; Leser, J. Smith; Yagi, Shigeo; Clarke, Penny; Chiu, Charles Y.; Tyler, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1006199/1-e1006199/19</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In 2014, the United States experienced an epidemic of acute flaccid myelitis (AFM) cases in children coincident with a nationwide outbreak of enterovirus D68 (EV-D68) respiratory disease.  Up to half of the 2014 AFM patients had EV-D68 RNA detected by RT-PCR in their respiratory secretions, although EV-D68 was only detected in cerebrospinal fluid (CSF) from one 2014 AFM patient.  Given previously described mol. and epidemiol. assocns. between EV-D68 and AFM, we sought to develop an animal model by screening seven EV-D68 strains for the ability to induce neurol. disease in neonatal mice.  We found that four EV-D68 strains from the 2014 outbreak (out of five tested) produced a paralytic disease in mice resembling human AFM.  The remaining 2014 strain, as well as 1962 prototype EV-D68 strains Fermon and Rhyne, did not produce, or rarely produced, paralysis in mice.  In-depth examn. of the paralysis caused by a representative 2014 strain, MO/14-18947, revealed infectious virus, virion particles, and viral genome in the spinal cords of paralyzed mice.  Paralysis was elicited in mice following i.m., intracerebral, i.p., and intranasal infection, in descending frequency, and was assocd. with infection and loss of motor neurons in the anterior horns of spinal cord segments corresponding to paralyzed limbs.  Virus isolated from spinal cords of infected mice transmitted disease when injected into na.ovrddot.ive mice, fulfilling Koch's postulates in this model.  Finally, we found that EV-D68 immune sera, but not normal mouse sera, protected mice from development of paralysis and death when administered prior to viral challenge.  These studies establish an exptl. model to study EV-D68-induced myelitis and to better understand disease pathogenesis and develop potential therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRh2FIm7qn57Vg90H21EOLACvtfcHk0liDODMML5yeeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCqt7rN&md5=8dcf3e95605c07327d3d2391c19b1e5e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006199%26sid%3Dliteratum%253Aachs%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DLeser%26aufirst%3DJ.%2BS.%26aulast%3DYagi%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DP.%26aulast%3DChiu%26aufirst%3DC.%2BY.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26atitle%3DA%2520mouse%2520model%2520of%2520paralytic%2520myelitis%2520caused%2520by%2520enterovirus%2520D68%26jtitle%3DPLoS%2520Pathog.%26date%3D2017%26volume%3D13%26doi%3D10.1371%2Fjournal.ppat.1006199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wettere, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, E. B.</span></span> <span> </span><span class="NLM_article-title">Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">146</span>â <span class="NLM_lpage">154</span>, <span class="refDoi">Â DOI: 10.1016/j.virol.2018.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.virol.2018.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30390563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKhsbvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2019&pages=146-154&author=B.+L.+Hurstauthor=W.+J.+Evansauthor=D.+F.+Smeeauthor=A.+J.+Van+Wettereauthor=E.+B.+Tarbet&title=Evaluation+of+antiviral+therapies+in+respiratory+and+neurological+disease+models+of+Enterovirus+D68+infection+in+mice&doi=10.1016%2Fj.virol.2018.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice</span></div><div class="casAuthors">Hurst, Brett L.; Evans, W. Joseph; Smee, Donald F.; Van Wettere, Arnaud J.; Tarbet, E. Bart</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is unique among enteroviruses because of the ability to cause severe respiratory disease as well as neurol. disease.  We developed sep. models of respiratory and neurol. disease following EV-D68 infection in AG129 mice that respond to antiviral treatment with guanidine.  In four-week-old mice infected intranasally, EV-D68 replicates to high titers in lung tissue increasing the proinflammatory cytokines MCP-1 and IL-6.  The respiratory infection also produces an acute viremia.  In 10-day-old mice infected i.p., EV-D68 causes a neurol. disease with wt.-loss, paralysis, and mortality.  In our respiratory model, treatment with guanidine provides a two-log redn. in lung virus titers, reduces MCP-1 and IL-6, and prevents histol. lesions in the lungs.  Importantly, viremia is prevented by early treatment with guanidine.  In our neurol. model, guanidine treatment protects mice from wt.-loss, paralysis, and mortality.  These results demonstrate the utility of these models for evaluation of antiviral therapies for EV-D68 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4et8VSBidu7Vg90H21EOLACvtfcHk0liDODMML5yeeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKhsbvN&md5=f09f152f64145da8ab3eed72c93fd304</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2018.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2018.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DB.%2BL.%26aulast%3DEvans%26aufirst%3DW.%2BJ.%26aulast%3DSmee%26aufirst%3DD.%2BF.%26aulast%3DVan%2BWettere%26aufirst%3DA.%2BJ.%26aulast%3DTarbet%26aufirst%3DE.%2BB.%26atitle%3DEvaluation%2520of%2520antiviral%2520therapies%2520in%2520respiratory%2520and%2520neurological%2520disease%2520models%2520of%2520Enterovirus%2520D68%2520infection%2520in%2520mice%26jtitle%3DVirology%26date%3D2019%26volume%3D526%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.virol.2018.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrey, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddharthan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wettere, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinex, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, E. B.</span></span> <span> </span><span class="NLM_article-title">Causation of acute flaccid paralysis by myelitis and myositis in Enterovirus-D68 infected mice deficient in interferon alphabeta/gamma receptor deficient mice</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi">Â DOI: 10.3390/v10010033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3390%2Fv10010033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqu7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=33&author=J.+D.+Morreyauthor=H.+Wangauthor=B.+L.+Hurstauthor=K.+Zukorauthor=V.+Siddharthanauthor=A.+J.+Van+Wettereauthor=D.+G.+Sinexauthor=E.+B.+Tarbet&title=Causation+of+acute+flaccid+paralysis+by+myelitis+and+myositis+in+Enterovirus-D68+infected+mice+deficient+in+interferon+alphabeta%2Fgamma+receptor+deficient+mice&doi=10.3390%2Fv10010033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Causation of acute flaccid paralysis by myelitis and myositis in enterovirus-D68 infected mice deficient in interferon Î±Î²/Î³ receptor deficient mice</span></div><div class="casAuthors">Morrey, John D.; Wang, Hong; Hurst, Brett L.; Zukor, Katherine; Siddharthan, Venkatraman; Van Wettere, Arnaud J.; Sinex, Donal G.; Tarbe, E. Bart</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33/1-33/22</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) caused a large outbreak in the summer and fall of 2014 in the United States.  It causes serious respiratory disease, but causation of assocd. paralysis is controversial, because the virus is not routinely identified in cerebrospinal fluid.  To establish clin. correlates with human disease, we evaluated EV-D68 infection in non-lethal paralysis mouse models.  Ten-day-old mice lacking interferon responses were injected i.p. with the virus.  Paralysis developed in hindlimbs.  After six weeks of paralysis, the motor neurons were depleted due to viral infection.  Hindlimb muscles were also infected and degenerating.  Even at the earliest stage of paralysis, muscles were still infected and were degenerating, in addn. to presence of virus in the spinal cord.  To model natural respiratory infection, five-day-old mice were infected intranasally with EV-D68.  Two of the four infected mice developed forelimb paralysis.  The affected limbs had muscle disease, but no spinal cord infection was detected.  The unique contributions of this study are that EV-D68 causes paralysis in mice, and that causation by muscle disease, with or without spinal cord disease, may help to resolve the controversy that the virus can cause paralysis, even if it cannot be identified in cerebrospinal fluid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDWdgwkwmw-7Vg90H21EOLACvtfcHk0liDODMML5yeeQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqu7vF&md5=17a9f9c85eefe5d1975b3f04e9dc135b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fv10010033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv10010033%26sid%3Dliteratum%253Aachs%26aulast%3DMorrey%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHurst%26aufirst%3DB.%2BL.%26aulast%3DZukor%26aufirst%3DK.%26aulast%3DSiddharthan%26aufirst%3DV.%26aulast%3DVan%2BWettere%26aufirst%3DA.%2BJ.%26aulast%3DSinex%26aufirst%3DD.%2BG.%26aulast%3DTarbet%26aufirst%3DE.%2BB.%26atitle%3DCausation%2520of%2520acute%2520flaccid%2520paralysis%2520by%2520myelitis%2520and%2520myositis%2520in%2520Enterovirus-D68%2520infected%2520mice%2520deficient%2520in%2520interferon%2520alphabeta%252Fgamma%2520receptor%2520deficient%2520mice%26jtitle%3DViruses%26date%3D2018%26volume%3D10%26spage%3D33%26doi%3D10.3390%2Fv10010033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, J. R.</span>; <span class="NLM_string-name">Valentine, M.</span>; <span class="NLM_string-name">Harrison, V.</span>; <span class="NLM_string-name">Fofanov, V. Y.</span>; <span class="NLM_string-name">Gillece, J.</span>; <span class="NLM_string-name">Delisle, J.</span>; <span class="NLM_string-name">Patton, B.</span>; <span class="NLM_string-name">Schupp, J.</span>; <span class="NLM_string-name">Sheridan, K.</span>; <span class="NLM_string-name">Lemmer, D.</span>; <span class="NLM_string-name">Ostdiek, S.</span>; <span class="NLM_string-name">Bains, H. K.</span>; <span class="NLM_string-name">Heim, J.</span>; <span class="NLM_string-name">Sylvester, T.</span>; <span class="NLM_string-name">Prasai, S.</span>; <span class="NLM_string-name">Kretschmer, M.</span>; <span class="NLM_string-name">Fowle, N.</span>; <span class="NLM_string-name">Komatsu, K.</span>; <span class="NLM_string-name">Brady, S.</span>; <span class="NLM_string-name">Robinson, S.</span>; <span class="NLM_string-name">Fitzpatrick, K.</span>; <span class="NLM_string-name">Ostovar, G. A.</span>; <span class="NLM_string-name">Alsop, E.</span>; <span class="NLM_string-name">Hutchins, E.</span>; <span class="NLM_string-name">Jensen, K.</span>; <span class="NLM_string-name">Keim, P.</span>; <span class="NLM_string-name">Engelthaler, D. M.</span></span><span> </span><span class="NLM_article-title">Genomic analyses of acute flaccid myelitis cases among a cluster in Arizona provide further evidence of Enterovirus D68 role</span> <i>mBio</i><span class="NLM_year">2019</span> <span class="NLM_volume">10</span><span class="refDoi">Â DOI: 10.1128/mBio.02262-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.02262-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30670612" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.+R.+Bowers&author=M.+Valentine&author=V.+Harrison&author=V.+Y.+Fofanov&author=J.+Gillece&author=J.+Delisle&author=B.+Patton&author=J.+Schupp&author=K.+Sheridan&author=D.+Lemmer&author=S.+Ostdiek&author=H.+K.+Bains&author=J.+Heim&author=T.+Sylvester&author=S.+Prasai&author=M.+Kretschmer&author=N.+Fowle&author=K.+Komatsu&author=S.+Brady&author=S.+Robinson&author=K.+Fitzpatrick&author=G.+A.+Ostovar&author=E.+Alsop&author=E.+Hutchins&author=K.+Jensen&author=P.+Keim&author=D.+M.+Engelthaler&title=Genomic+analyses+of+acute+flaccid+myelitis+cases+among+a+cluster+in+Arizona+provide+further+evidence+of+Enterovirus+D68+role"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FmBio.02262-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.02262-18%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DJ.%2BR.%26atitle%3DGenomic%2520analyses%2520of%2520acute%2520flaccid%2520myelitis%2520cases%2520among%2520a%2520cluster%2520in%2520Arizona%2520provide%2520further%2520evidence%2520of%2520Enterovirus%2520D68%2520role%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26doi%3D10.1128%2FmBio.02262-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, N.</span>; <span class="NLM_string-name">Ng, T. F. F.</span>; <span class="NLM_string-name">Marine, R. L.</span>; <span class="NLM_string-name">Jain, K.</span>; <span class="NLM_string-name">Ng, J.</span>; <span class="NLM_string-name">Thakkar, R.</span>; <span class="NLM_string-name">Caciula, A.</span>; <span class="NLM_string-name">Price, A.</span>; <span class="NLM_string-name">Garcia, J. A.</span>; <span class="NLM_string-name">Burns, J. C.</span>; <span class="NLM_string-name">Thakur, K. T.</span>; <span class="NLM_string-name">Hetzler, K. L.</span>; <span class="NLM_string-name">Routh, J. A.</span>; <span class="NLM_string-name">Konopka-Anstadt, J. L.</span>; <span class="NLM_string-name">Nix, W. A.</span>; <span class="NLM_string-name">Tokarz, R.</span>; <span class="NLM_string-name">Briese, T.</span>; <span class="NLM_string-name">Oberste, M. S.</span>; <span class="NLM_string-name">Lipkin, W. I.</span></span><span> </span><span class="NLM_article-title">Antibodies to enteroviruses in cerebrospinal fluid of patients with acute flaccid myelitis</span> <i>mBio</i><span class="NLM_year">2019</span> <span class="NLM_volume">10</span><span class="refDoi">Â DOI: 10.1128/mBio.01903-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.01903-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=31409689" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=N.+Mishra&author=T.+F.+F.+Ng&author=R.+L.+Marine&author=K.+Jain&author=J.+Ng&author=R.+Thakkar&author=A.+Caciula&author=A.+Price&author=J.+A.+Garcia&author=J.+C.+Burns&author=K.+T.+Thakur&author=K.+L.+Hetzler&author=J.+A.+Routh&author=J.+L.+Konopka-Anstadt&author=W.+A.+Nix&author=R.+Tokarz&author=T.+Briese&author=M.+S.+Oberste&author=W.+I.+Lipkin&title=Antibodies+to+enteroviruses+in+cerebrospinal+fluid+of+patients+with+acute+flaccid+myelitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FmBio.01903-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.01903-19%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DN.%26atitle%3DAntibodies%2520to%2520enteroviruses%2520in%2520cerebrospinal%2520fluid%2520of%2520patients%2520with%2520acute%2520flaccid%2520myelitis%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26doi%3D10.1128%2FmBio.01903-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tee, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zainol, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, Y. F.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis</span>. <i>Expert Rev. Anti-Infect. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1080/14787210.2021.1851194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1080%2F14787210.2021.1851194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33183118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB3s3ktVyisw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=1-15&author=H.+K.+Teeauthor=M.+I.+Zainolauthor=I.+C.+Samauthor=Y.+F.+Chan&title=Recent+advances+in+the+understanding+of+enterovirus+A71+infection%3A+a+focus+on+neuropathogenesis&doi=10.1080%2F14787210.2021.1851194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis</span></div><div class="casAuthors">Tee Han Kang; Zainol Mohd Izwan; Sam I-Ching; Chan Yoke Fun</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of anti-infective therapy</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction: Hand, foot, and mouth disease caused by enterovirus A71 (EV-A71) is more frequently associated with neurological complications and deaths compared to other enteroviruses.Areas covered: The authors discuss current understanding of the neuropathogenesis of EV-A71 based on various clinical, human, and animal model studies.  The authors discuss the important advancements in virus entry, virus dissemination, and neuroinvasion.  The authors highlight the role of host immune system, host genetic factors, viral quasispecies, and heparan sulfate in EV-A71 neuropathogenesis.Expert opinion: Comparison of EV-A71 with EV-D68 and PV shows similarity in primary target sites and dissemination to the central nervous system.  More research is needed to understand cellular tropisms, persistence of EV-A71, and other possible invasion routes.  EV-A71 infection has varied clinical manifestations which may be attributed to multiple receptors usage.  Future development of antivirals and vaccines should target neurotropic enteroviruses.  Repurposing drug and immunomodulators used in combination could reduce the severity of EV-A71 infection.  Only a few drugs have been tested in clinical trials, and in the absence of antiviral and vaccines (except China), active virus surveillance, good hand hygiene, and physical distancing should be advocated.  A better understanding of EV-A71 neuropathogenesis is critical for antiviral and multivalent vaccines development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOZ2YfmFbyocK3uFsUIZtkfW6udTcc2eZvJTC61ASVnbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s3ktVyisw%253D%253D&md5=6a732bff15e1c4d119daacfd9119dfa3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F14787210.2021.1851194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14787210.2021.1851194%26sid%3Dliteratum%253Aachs%26aulast%3DTee%26aufirst%3DH.%2BK.%26aulast%3DZainol%26aufirst%3DM.%2BI.%26aulast%3DSam%26aufirst%3DI.%2BC.%26aulast%3DChan%26aufirst%3DY.%2BF.%26atitle%3DRecent%2520advances%2520in%2520the%2520understanding%2520of%2520enterovirus%2520A71%2520infection%253A%2520a%2520focus%2520on%2520neuropathogenesis%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2021%26spage%3D1%26epage%3D15%26doi%3D10.1080%2F14787210.2021.1851194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uprety, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, E. H.</span></span> <span> </span><span class="NLM_article-title">Enterovirus infection and acute flaccid myelitis</span>. <i>Curr. Opin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">55</span>â <span class="NLM_lpage">60</span>, <span class="refDoi">Â DOI: 10.1016/j.coviro.2020.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.coviro.2020.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32711392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2isr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=55-60&author=P.+Upretyauthor=E.+H.+Graf&title=Enterovirus+infection+and+acute+flaccid+myelitis&doi=10.1016%2Fj.coviro.2020.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Enterovirus infection and acute flaccid myelitis</span></div><div class="casAuthors">Uprety, Priyanka; Graf, Erin H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-60</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent outbreaks of limb paralysis similar to poliomyelitis, termed acute flaccid myelitis (AFM), have prompted intense investigation into potential etiol.  Peaks of AFM were seen in the United States in 2012, 2014, 2016 and 2018, coincident with peaks in enterovirus transmission, particularly EV-D68.  Similar peaks of AFM and EV-D68 circulation were reported in other parts of the world.  The causal relationship between EV-D68 is still not widely accepted as it is for poliovirus and EV-A71, the latter of which is endemic in the US.  Recent in vitro and mouse model data as well as enhanced-sensitivity diagnostic assays have provided further evidence linking the causal relationship between EV-D68 and AFM.  In addn., an outbreak of EV-A71-assocd. AFM was recently described, highlighting the possibility of an addnl. emerging non-polio enterovirus of public health concern.  As AFM is a devastating disease with poor prognosis in many children, particularly those with EV-D68, recent studies call for increased surveillance, pursuit of novel therapeutics and strategies to prevent transmission before the next outbreak.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoq9izuDAisLVg90H21EOLACvtfcHk0lha8IIIxvQfWQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2isr7F&md5=77a4cc89ee6701f1ef448aa8b6e095c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2020.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2020.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DUprety%26aufirst%3DP.%26aulast%3DGraf%26aufirst%3DE.%2BH.%26atitle%3DEnterovirus%2520infection%2520and%2520acute%2520flaccid%2520myelitis%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2020%26volume%3D40%26spage%3D55%26epage%3D60%26doi%3D10.1016%2Fj.coviro.2020.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martino, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sole, M. J.</span></span> <span> </span><span class="NLM_article-title">Viral infection and the pathogenesis of dilated cardiomyopathy</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">182</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1161/01.RES.74.2.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1161%2F01.RES.74.2.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=8293557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADyaK2c7itlCgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1994&pages=182-188&author=T.+A.+Martinoauthor=P.+Liuauthor=M.+J.+Sole&title=Viral+infection+and+the+pathogenesis+of+dilated+cardiomyopathy&doi=10.1161%2F01.RES.74.2.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Viral infection and the pathogenesis of dilated cardiomyopathy</span></div><div class="casAuthors">Martino T A; Liu P; Sole M J</div><div class="citationInfo"><span class="NLM_cas:title">Circulation research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-8</span>
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    </div><div class="casAbstract">Long-term follow-up studies of patients with suspected viral myocarditis reveal progression to dilated cardiomyopathy (DCM) in a significant number of cases.  Thus, an underlying viral etiology has been hypothesized in the pathogenesis of ongoing heart disease that leads to DCM.  Recent application of molecular biology in clinical diagnosis has strengthened this hypothesis.  By use of probe hybridization and polymerase chain reaction, enteroviral RNA has been detected in the myocardium of patients at all stages of the disease process: myocarditis, chronic heart disease, and DCM.  Experimental murine models of enterovirus-induced heart disease provide a framework for examining the pathogenic mechanisms.  Viral cytotoxicity, immunological responses, viral RNA persistence, and spasm of the coronary microvasculature are all implicated in the ongoing disease process.  Abnormal cardiac function and heart failure are attributed to the pathological changes that occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQob0u4krYlR5SWdIdmEou5fW6udTcc2ean2MJqL5iT9bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7itlCgtw%253D%253D&md5=b1d6f137ef2b26bad42e34bbef5c8c7b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1161%2F01.RES.74.2.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.74.2.182%26sid%3Dliteratum%253Aachs%26aulast%3DMartino%26aufirst%3DT.%2BA.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DSole%26aufirst%3DM.%2BJ.%26atitle%3DViral%2520infection%2520and%2520the%2520pathogenesis%2520of%2520dilated%2520cardiomyopathy%26jtitle%3DCirc.%2520Res.%26date%3D1994%26volume%3D74%26spage%3D182%26epage%3D188%26doi%3D10.1161%2F01.RES.74.2.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunne, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl-Jorgensen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flodstrom-Tullberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyoty, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lernmark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliese, A.</span></span> <span> </span><span class="NLM_article-title">Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">744</span>â <span class="NLM_lpage">753</span>, <span class="refDoi">Â DOI: 10.1007/s00125-019-4811-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1007%2Fs00125-019-4811-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30675626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyrtrrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=744-753&author=J.+L.+Dunneauthor=S.+J.+Richardsonauthor=M.+A.+Atkinsonauthor=M.+E.+Craigauthor=K.+Dahl-Jorgensenauthor=M.+Flodstrom-Tullbergauthor=H.+Hyotyauthor=R.+A.+Inselauthor=A.+Lernmarkauthor=R.+E.+Lloydauthor=N.+G.+Morganauthor=A.+Pugliese&title=Rationale+for+enteroviral+vaccination+and+antiviral+therapies+in+human+type+1+diabetes&doi=10.1007%2Fs00125-019-4811-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes</span></div><div class="casAuthors">Dunne, Jessica L.; Richardson, Sarah J.; Atkinson, Mark A.; Craig, Maria E.; Dahl-Joergensen, Knut; Flodstrom-Tullberg, Malin; Hyoty, Heikki; Insel, Richard A.; Lernmark, Ake; Lloyd, Richard E.; Morgan, Noel G.; Pugliese, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">744-753</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In type 1 diabetes, pancreatic beta cells are destroyed by chronic autoimmune responses.  The disease develops in genetically susceptible individuals, but a role for environmental factors has been postulated.  Viral infections have long been considered as candidates for environmental triggers but, given the lack of evidence for an acute, widespread, cytopathic effect in the pancreas in type 1 diabetes or for a closely related temporal assocn. of diabetes onset with such infections, a role for viruses in type 1 diabetes remains unproven.  Moreover, viruses have rarely been isolated from the pancreas of individuals with type 1 diabetes, mainly (but not solely) due to the inaccessibility of the organ.  Here, we review past and recent literature to evaluate the proposals that chronic, recurrent and, possibly, persistent enteroviral infections occur in pancreatic beta cells in type 1 diabetes.  We also explore whether these infections may be sustained by different virus strains over time and whether multiple viral hits can occur during the natural history of type 1 diabetes.  We emphasize that only a minority of beta cells appear to be infected at any given time and that enteroviruses may become replication defective, which could explain why they have been isolated from the pancreas only rarely.  We argue that enteroviral infection of beta cells largely depends on the host innate and adaptive immune responses, including innate responses mounted by beta cells.  Thus, we propose that viruses could play a role in type 1 diabetes on multiple levels, including in the triggering and chronic stimulation of autoimmunity and in the generation of inflammation and the promotion of beta cell dysfunction and stress, each of which might then contribute to autoimmunity, as part of a vicious circle.  We conclude that studies into the effects of vaccinations and/or antiviral drugs (some of which are currently on-going) is the only means by which the role of viruses in type 1 diabetes can be finally proven or disproven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKWbPvQfYEmLVg90H21EOLACvtfcHk0lgO9SVeXxdKdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyrtrrN&md5=d8fd78d649a86f4756410e1ea9a36bda</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00125-019-4811-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-019-4811-7%26sid%3Dliteratum%253Aachs%26aulast%3DDunne%26aufirst%3DJ.%2BL.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DAtkinson%26aufirst%3DM.%2BA.%26aulast%3DCraig%26aufirst%3DM.%2BE.%26aulast%3DDahl-Jorgensen%26aufirst%3DK.%26aulast%3DFlodstrom-Tullberg%26aufirst%3DM.%26aulast%3DHyoty%26aufirst%3DH.%26aulast%3DInsel%26aufirst%3DR.%2BA.%26aulast%3DLernmark%26aufirst%3DA.%26aulast%3DLloyd%26aufirst%3DR.%2BE.%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26aulast%3DPugliese%26aufirst%3DA.%26atitle%3DRationale%2520for%2520enteroviral%2520vaccination%2520and%2520antiviral%2520therapies%2520in%2520human%2520type%25201%2520diabetes%26jtitle%3DDiabetologia%26date%3D2019%26volume%3D62%26spage%3D744%26epage%3D753%26doi%3D10.1007%2Fs00125-019-4811-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogstad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship (SAR) studies of novel pyrazolopyridine derivatives as inhibitors of enterovirus replication</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1688</span>â <span class="NLM_lpage">1703</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01863</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01863" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Ggtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1688-1703&author=Y.+Xingauthor=J.+Zuoauthor=P.+Krogstadauthor=M.+E.+Jung&title=Synthesis+and+structure-activity+relationship+%28SAR%29+studies+of+novel+pyrazolopyridine+derivatives+as+inhibitors+of+enterovirus+replication&doi=10.1021%2Facs.jmedchem.7b01863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication</span></div><div class="casAuthors">Xing, Yanpeng; Zuo, Jun; Krogstad, Paul; Jung, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1688-1703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyrazolopyridine compds. have been designed and prepd. by a general synthetic route.  Their activities against the replication of poliovirus-1, EV-A71, and CV-B3 enteroviruses were evaluated.  The comprehensive understanding of the structure-activity relationship was obtained by utilizing the variation of four positions, namely, N1, C6, C4, and linker unit.  From the screened analogs, the inhibitors with the highest selectivity indexes at 50% inhibition of viral replication (SI50) were those with iso-Pr at the N1 position and thiophenyl-2-yl unit at C6 position.  Furthermore, the C4 position offered the greatest potential for improvement because many different N-aryl groups had better antiviral activities and compatibilities than the lead compd. JX001 (I).  For example, JX040 (II) with a 2-pyridyl group was the analog with the most potent activity against non-polio enteroviruses, and JX025 (III), possessing a 3-sulfamoylphenyl moiety, had the best activity against polioviruses.  In addn., analog JX037 (IV), possessing a novel pyrazolopyridine heterocycle, was also shown to have good antienteroviral activity, which further enlarges the compd. space for antienteroviral drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYc-19MkthkLVg90H21EOLACvtfcHk0lgO9SVeXxdKdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Ggtrs%253D&md5=ea86d35167fd2059d6d27d7054b205ca</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01863%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DJ.%26aulast%3DKrogstad%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%2520novel%2520pyrazolopyridine%2520derivatives%2520as%2520inhibitors%2520of%2520enterovirus%2520replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1688%26epage%3D1703%26doi%3D10.1021%2Facs.jmedchem.7b01863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulferts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">der Linden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyoo, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mate, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichiere, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelieveld, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omta, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span> <span> </span><span class="NLM_article-title">Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2627</span>â <span class="NLM_lpage">2638</span>, <span class="refDoi">Â DOI: 10.1128/AAC.02182-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FAAC.02182-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=26856848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWrsrjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=2627-2638&author=R.+Ulfertsauthor=S.+M.+de+Boerauthor=L.+der+Lindenauthor=L.+Bauerauthor=H.+R.+Lyooauthor=M.+J.+Mateauthor=J.+Lichiereauthor=B.+Canardauthor=D.+Lelieveldauthor=W.+Omtaauthor=D.+Eganauthor=B.+Coutardauthor=F.+J.+van+Kuppeveld&title=Screening+of+a+library+of+FDA-approved+drugs+identifies+several+enterovirus+replication+inhibitors+that+target+viral+protein+2C&doi=10.1128%2FAAC.02182-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C</span></div><div class="casAuthors">Ulferts, Rachel; deBoer, S. Matthijn; van der Linden, Lonneke; Bauer, Lisa; Lyoo, Hey Rhyoung; Mate, Maria J.; Lichiere, Julie; Canard, Bruno; Lelieveld, Daphne; Omta, Wienand; Egan, David; Coutard, Bruno; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2627-2638</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Enteroviruses (EVs) represent many important pathogens of humans.  Unfortunately, no antiviral compds. currently exist to treat infections with these viruses.  We screened the Prestwick Chem. Library, a library of approved drugs, for inhibitors of coxsackievirus B3, identified pirlindole as a potent novel inhibitor, and confirmed the inhibitory action of dibucaine, zuclopenthixol, fluoxetine, and formoterol.  Upon testing of viruses of several EV species, we found that dibucaine and pirlindole inhibited EV-B and EV-D and that dibucaine also inhibited EV-A, but none of them inhibited EV-C or rhinoviruses (RVs).  In contrast, formoterol inhibited all enteroviruses and rhinoviruses tested.  All compds. acted through the inhibition of genome replication.  Mutations in the coding sequence of the coxsackievirus B3 (CV-B3) 2C protein conferred resistance to dibucaine, pirlindole, and zuclopenthixol but not formoterol, suggesting that 2C is the target for this set of compds.  Importantly, dibucaine bound to CV-B3 protein 2C in vitro, whereas binding to a 2C protein carrying the resistance mutations was reduced, providing an explanation for how resistance is acquired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5y2-PUuIIXbVg90H21EOLACvtfcHk0ljGMpGqmmniSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWrsrjI&md5=053e85cba8625f57c77918322ea53731</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.02182-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02182-15%26sid%3Dliteratum%253Aachs%26aulast%3DUlferts%26aufirst%3DR.%26aulast%3Dde%2BBoer%26aufirst%3DS.%2BM.%26aulast%3Dder%2BLinden%26aufirst%3DL.%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DLyoo%26aufirst%3DH.%2BR.%26aulast%3DMate%26aufirst%3DM.%2BJ.%26aulast%3DLichiere%26aufirst%3DJ.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DLelieveld%26aufirst%3DD.%26aulast%3DOmta%26aufirst%3DW.%26aulast%3DEgan%26aufirst%3DD.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26atitle%3DScreening%2520of%2520a%2520library%2520of%2520FDA-approved%2520drugs%2520identifies%2520several%2520enterovirus%2520replication%2520inhibitors%2520that%2520target%2520viral%2520protein%25202C%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D2627%26epage%3D2638%26doi%3D10.1128%2FAAC.02182-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganaro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonsics, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Kazzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzo Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulferts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hoey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mate, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J. M.</span></span> <span> </span><span class="NLM_article-title">Fluoxetine inhibits enterovirus replication by targeting the viral 2C protein in a stereospecific manner</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1609</span>â <span class="NLM_lpage">1623</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.9b00179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlOmsbrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1609-1623&author=L.+Bauerauthor=R.+Manganaroauthor=B.+Zonsicsauthor=J.+Stratingauthor=P.+El+Kazziauthor=M.+Lorenzo+Lopezauthor=R.+Ulfertsauthor=C.+van+Hoeyauthor=M.+J.+Mateauthor=T.+Langerauthor=B.+Coutardauthor=A.+Brancaleauthor=F.+J.+M.+van+Kuppeveld&title=Fluoxetine+inhibits+enterovirus+replication+by+targeting+the+viral+2C+protein+in+a+stereospecific+manner&doi=10.1021%2Facsinfecdis.9b00179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner</span></div><div class="casAuthors">Bauer, Lisa; Manganaro, Roberto; Zonsics, Birgit; Strating, Jeroen R. P. M.; El Kazzi, Priscila; Lorenzo Lopez, Moira; Ulferts, Rachel; van Hoey, Clara; Mate, Maria J.; Langer, Thierry; Coutard, Bruno; Brancale, Andrea; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1609-1623</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enteroviruses (family Picornaviridae) comprise a large group of human pathogens against which no licensed antiviral therapy exists.  Drug-repurposing screens uncovered the FDA-approved drug fluoxetine as a replication inhibitor of enterovirus B and D species.  Fluoxetine likely targets the nonstructural viral protein 2C, but detailed mode-of-action studies are missing because structural information on 2C of fluoxetine-sensitive enteroviruses is lacking.  We here show that broad-spectrum anti-enteroviral activity of fluoxetine is stereospecific concomitant with binding to recombinant 2C. (S)-Fluoxetine inhibits with a 5-fold lower 50% effective concn. (EC50) than racemic fluoxetine.  Using a homol. model of 2C of the fluoxetine-sensitive enterovirus coxsackievirus B3 (CVB3) based upon a recently elucidated structure of a fluoxetine-insensitive enterovirus, we predicted stable binding of (S)-fluoxetine.  Structure-guided mutations disrupted binding and rendered coxsackievirus B3 (CVB3) resistant to fluoxetine.  The study provides new insights into the anti-enteroviral mode-of-action of fluoxetine.  Importantly, using only (S)-fluoxetine would allow for lower dosing in patients, thereby likely reducing side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdX6ev478njrVg90H21EOLACvtfcHk0ljGMpGqmmniSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlOmsbrK&md5=96cbeaf8723b583919a30f04d86b66aa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00179%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DManganaro%26aufirst%3DR.%26aulast%3DZonsics%26aufirst%3DB.%26aulast%3DStrating%26aufirst%3DJ.%26aulast%3DEl%2BKazzi%26aufirst%3DP.%26aulast%3DLorenzo%2BLopez%26aufirst%3DM.%26aulast%3DUlferts%26aufirst%3DR.%26aulast%3Dvan%2BHoey%26aufirst%3DC.%26aulast%3DMate%26aufirst%3DM.%2BJ.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%2BM.%26atitle%3DFluoxetine%2520inhibits%2520enterovirus%2520replication%2520by%2520targeting%2520the%2520viral%25202C%2520protein%2520in%2520a%2520stereospecific%2520manner%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1609%26epage%3D1623%26doi%3D10.1021%2Facsinfecdis.9b00179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuohy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellampalli, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinoline analogues as potent antivirals against Enterovirus D68 (EV-D68)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4074</span>â <span class="NLM_lpage">4090</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4074-4090&author=R.+Musharrafiehauthor=J.+Zhangauthor=P.+Tuohyauthor=N.+Kitamuraauthor=S.+S.+Bellampalliauthor=Y.+Huauthor=R.+Khannaauthor=J.+Wang&title=Discovery+of+quinoline+analogues+as+potent+antivirals+against+Enterovirus+D68+%28EV-D68%29&doi=10.1021%2Facs.jmedchem.9b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)</span></div><div class="casAuthors">Musharrafieh, Rami; Zhang, Jiantao; Tuohy, Peter; Kitamura, Naoya; Bellampalli, Shreya Sai; Hu, Yanmei; Khanna, Rajesh; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4074-4090</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is an atypical nonpolio enterovirus that mainly infects the respiratory system of humans, leading to moderate-to-severe respiratory diseases.  In rare cases, EV-D68 can spread to the central nervous system and cause paralysis in infected patients, esp. young children and immunocompromised individuals.  There is currently no approved vaccine or antiviral available for the prevention and treatment of EV-D68.  In this study, we aimed to improve the antiviral potency and selectivity of a previously reported EV-D68 inhibitor, dibucaine, through structure-activity relationship studies.  In total, 60 compds. were synthesized and tested against EV-D68 using the viral cytopathic effect assay.  Three compds. 10a, 12a, and 12c were identified to have significantly improved potency (EC50 < 1 Î¼M) and a high selectivity index (>180) compared with dibucaine against five different strains of EV-D68 viruses.  These compds. also showed potent antiviral activity in neuronal cells, such as A172 and SH-SY5Y cells, suggesting they might be further developed for the treatment of both respiratory infection as well as neuronal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpavhbIH0yOdLVg90H21EOLACvtfcHk0ljGMpGqmmniSA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr4%253D&md5=0875f280e936a1c6354d286e54a6b425</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00115%26sid%3Dliteratum%253Aachs%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DTuohy%26aufirst%3DP.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DBellampalli%26aufirst%3DS.%2BS.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DKhanna%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520quinoline%2520analogues%2520as%2520potent%2520antivirals%2520against%2520Enterovirus%2520D68%2520%2528EV-D68%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4074%26epage%3D4090%26doi%3D10.1021%2Facs.jmedchem.9b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Development of broad-spectrum enterovirus antivirals based on quinoline scaffold</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>101</i></span>, <span class="NLM_elocation-id">103981</span> <span class="refDoi">Â DOI: 10.1016/j.bioorg.2020.103981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.bioorg.2020.103981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32559580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1SktbrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2020&author=R.+Musharrafiehauthor=N.+Kitamuraauthor=Y.+Huauthor=J.+Wang&title=Development+of+broad-spectrum+enterovirus+antivirals+based+on+quinoline+scaffold&doi=10.1016%2Fj.bioorg.2020.103981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of broad-spectrum enterovirus antivirals based on quinoline scaffold</span></div><div class="casAuthors">Musharrafieh, Rami; Kitamura, Naoya; Hu, Yanmei; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103981</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-polio enteroviruses such as enterovirus A71 (EV-A71), EV-D68, and coxsackievirus B3 (CVB3) are significant human pathogens with disease manifestations ranging from mild flu-like symptoms to more severe encephalitis, myocarditis, acute flaccid paralysis/myelitis, and even death.  There is currently no effective antivirals to prevent or treat non-polio enterovirus infection.  In this study, we report our progress in developing potent and broad-spectrum antivirals against these non-polio enteroviruses.  Starting from our previously developed lead compds. that had potent antiviral activity against EV-D68, we synthesized 43 analogs and profiled their broad-spectrum antiviral activity against addnl. EV-D68, EV-A71, and CVB3 viruses.  Promising candidates were also selected for mouse microsomal stability test to prioritize lead compds. for future in vivo mouse model studies.  Collectively, this multi-parameter optimization process revealed a promising lead compd. 6aw(I) that showed single-digit to submicromolar EC50 values against two EV-D68 strains (US/KY and US/MO), two EV-A71 strains (Tainan and US/AK), and one CVB3 strain, with a high selectivity index.  Encouragingly, 6aw was stable in mouse microsomes with a half-life of 114.7 min.  Overall, 6aw represents one of the most potent broad-spectrum antiviral against non-polio enteroviruses, rendering it a promising lead candidate for non-polio enteroviruses with translational potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABO-HH714A7Vg90H21EOLACvtfcHk0lgr9abalZAEvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1SktbrE&md5=5f6b75f250087f1a8970353fe6d18670</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103981%26sid%3Dliteratum%253Aachs%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520broad-spectrum%2520enterovirus%2520antivirals%2520based%2520on%2520quinoline%2520scaffold%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D101%26doi%3D10.1016%2Fj.bioorg.2020.103981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoiseaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogstad, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of structurally diverse small-molecule compounds with broad antiviral activity against Enteroviruses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1615</span>â <span class="NLM_lpage">1626</span>, <span class="refDoi">Â DOI: 10.1128/AAC.02646-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FAAC.02646-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2ntbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1615-1626&author=J.+Zuoauthor=S.+Kyeauthor=K.+K.+Quinnauthor=P.+Cooperauthor=R.+Damoiseauxauthor=P.+Krogstad&title=Discovery+of+structurally+diverse+small-molecule+compounds+with+broad+antiviral+activity+against+Enteroviruses&doi=10.1128%2FAAC.02646-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of structurally diverse small-molecule compounds with broad antiviral activity against enteroviruses</span></div><div class="casAuthors">Zuo, Jun; Kye, Steve; Quinn, Kevin K.; Cooper, Paige; Damoiseaux, Robert; Krogstad, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1615-1626</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Antiviral drugs do not currently exist for the treatment of enterovirus infections, which are often severe and potentially life-threatening.  We conducted high-throughput mol. screening and identified a structurally diverse set of compds. that inhibit the replication of coxsackievirus B3, a commonly encountered enterovirus.  These compds. did not interfere with the function of the viral internal ribosome entry site or with the activity of the viral proteases, but they did drastically reduce the synthesis of viral RNA and viral proteins in infected cells.  Sequence anal. of compd.-resistant mutants suggests that the viral 2C protein is targeted by most of these compds.  These compds. demonstrated antiviral activity against a panel of the most commonly encountered enteroviruses and thus represent potential leads for the development of broad-spectrum anti-enteroviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreYBpg81iVG7Vg90H21EOLACvtfcHk0lgr9abalZAEvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2ntbnN&md5=a868a234cbe47a800ff65882e31e96f6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FAAC.02646-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02646-15%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DJ.%26aulast%3DKye%26aufirst%3DS.%26aulast%3DQuinn%26aufirst%3DK.%2BK.%26aulast%3DCooper%26aufirst%3DP.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DKrogstad%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520structurally%2520diverse%2520small-molecule%2520compounds%2520with%2520broad%2520antiviral%2520activity%2520against%2520Enteroviruses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1615%26epage%3D1626%26doi%3D10.1128%2FAAC.02646-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganaro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonsics, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurdiss, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwaagstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donselaar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welter, N. G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kleef, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevilacqua, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassetto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerink, R. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J. M.</span></span> <span> </span><span class="NLM_article-title">Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">e3000904</span> <span class="refDoi">Â DOI: 10.1371/journal.pbio.3000904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1371%2Fjournal.pbio.3000904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33156822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVSqtLvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&author=L.+Bauerauthor=R.+Manganaroauthor=B.+Zonsicsauthor=D.+L.+Hurdissauthor=M.+Zwaagstraauthor=T.+Donselaarauthor=N.+G.+E.+Welterauthor=R.+van+Kleefauthor=M.+L.+Lopezauthor=F.+Bevilacquaauthor=T.+Ramanauthor=S.+Ferlaauthor=M.+Bassettoauthor=J.+Neytsauthor=J.+Stratingauthor=R.+H.+S.+Westerinkauthor=A.+Brancaleauthor=F.+J.+M.+van+Kuppeveld&title=Rational+design+of+highly+potent+broad-spectrum+enterovirus+inhibitors+targeting+the+nonstructural+protein+2C&doi=10.1371%2Fjournal.pbio.3000904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C</span></div><div class="casAuthors">Bauer, Lisa; Manganaro, Roberto; Zonsics, Birgit; Hurdiss, Daniel L.; Zwaagstra, Marleen; Donselaar, Tim; Welter, Naemi G. E.; van Kleef, Regina G. D. M.; Lopez, Moira Lorenzo; Bevilacqua, Federica; Raman, Thamidur; Ferla, Salvatore; Bassetto, Marcella; Neyts, Johan; Strating, Jeroen R. P. M.; Westerink, Remco H. S.; Brancale, Andrea; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e3000904</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">There is a great need for antiviral drugs to treat enterovirus (EV) and rhinovirus (RV) infections, which can be severe and occasionally life-threatening.  The conserved nonstructural protein 2C, which is an AAA+ ATPase, is a promising target for drug development.  Here, we present a structure-activity relationship study of a previously identified compd. that targets the 2C protein of EV-A71 and several EV-B species members, but not poliovirus (PV) (EV-C species).  This compd. is structurally related to the Food and Drug Administration (FDA)-approved drug fluoxetine-which also targets 2C-but has favorable chem. properties.  We identified several compds. with increased antiviral potency and broadened activity.  Four compds. showed broad-spectrum EV and RV activity and inhibited contemporary strains of emerging EVs of public health concern, including EV-A71, coxsackievirus (CV)-A24v, and EV-D68.  Importantly, unlike (S)-fluoxetine, these compds. are no longer neuroactive.  By raising resistant EV-A71, CV-B3, and EV-D68 variants against one of these inhibitors, we identified novel 2C resistance mutations.  Reverse engineering of these mutations revealed a conserved mechanism of resistance development.  Resistant viruses first acquired a mutation in, or adjacent to, the Î±2 helix of 2C.  This mutation disrupted compd. binding and provided drug resistance, but this was at the cost of viral fitness.  Addnl. mutations at distantly localized 2C residues were then acquired to increase resistance and/or to compensate for the loss of fitness.  Using computational methods to identify solvent accessible tunnels near the Î±2 helix in the EV-A71 and PV 2C crystal structures, a conserved binding pocket of the inhibitors is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy0dAstxZbgLVg90H21EOLACvtfcHk0lgr9abalZAEvA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVSqtLvK&md5=f1ba879402ef0001b61cf1e01cd3c768</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.3000904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.3000904%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DManganaro%26aufirst%3DR.%26aulast%3DZonsics%26aufirst%3DB.%26aulast%3DHurdiss%26aufirst%3DD.%2BL.%26aulast%3DZwaagstra%26aufirst%3DM.%26aulast%3DDonselaar%26aufirst%3DT.%26aulast%3DWelter%26aufirst%3DN.%2BG.%2BE.%26aulast%3Dvan%2BKleef%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DM.%2BL.%26aulast%3DBevilacqua%26aufirst%3DF.%26aulast%3DRaman%26aufirst%3DT.%26aulast%3DFerla%26aufirst%3DS.%26aulast%3DBassetto%26aufirst%3DM.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DStrating%26aufirst%3DJ.%26aulast%3DWesterink%26aufirst%3DR.%2BH.%2BS.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%2BM.%26atitle%3DRational%2520design%2520of%2520highly%2520potent%2520broad-spectrum%2520enterovirus%2520inhibitors%2520targeting%2520the%2520nonstructural%2520protein%25202C%26jtitle%3DPLoS%2520Biol.%26date%3D2020%26volume%3D18%26doi%3D10.1371%2Fjournal.pbio.3000904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holm-Hansen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T. K.</span></span> <span> </span><span class="NLM_article-title">Global emergence of enterovirus D68: a systematic review</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">e64</span>â <span class="NLM_lpage">e75</span>, <span class="refDoi">Â DOI: 10.1016/S1473-3099(15)00543-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2FS1473-3099%2815%2900543-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=26929196" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=e64-e75&author=C.+C.+Holm-Hansenauthor=S.+E.+Midgleyauthor=T.+K.+Fischer&title=Global+emergence+of+enterovirus+D68%3A+a+systematic+review&doi=10.1016%2FS1473-3099%2815%2900543-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900543-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900543-5%26sid%3Dliteratum%253Aachs%26aulast%3DHolm-Hansen%26aufirst%3DC.%2BC.%26aulast%3DMidgley%26aufirst%3DS.%2BE.%26aulast%3DFischer%26aufirst%3DT.%2BK.%26atitle%3DGlobal%2520emergence%2520of%2520enterovirus%2520D68%253A%2520a%2520systematic%2520review%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3De64%26epage%3De75%26doi%3D10.1016%2FS1473-3099%2815%2900543-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of the mechanism of action of R523062, a promising antiviral for enterovirus D68</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2260</span>â <span class="NLM_lpage">2270</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.0c00383</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.0c00383" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWnt7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=2260-2270&author=C.+Maauthor=Y.+Huauthor=J.+Zhangauthor=J.+Wang&title=Pharmacological+characterization+of+the+mechanism+of+action+of+R523062%2C+a+promising+antiviral+for+enterovirus+D68&doi=10.1021%2Facsinfecdis.0c00383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68</span></div><div class="casAuthors">Ma, Chunlong; Hu, Yanmei; Zhang, Jiantao; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2260-2270</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is a re-emerging virus that causes moderate to severe respiratory diseases in children.  In severe cases, EV-D68 infection can lead to neurol. complications called acute flaccid myelitis (AFM).  There is currently no antiviral or vaccine available for EV-D68.  The goal of this study is to delineate the mechanism of action of a promising antiviral drug candidate R523062 that was identified through a phenotypic cytopathic effect (CPE)-based high-throughput screening.  R523062 inhibits multiple contemporary EV-D68 strains with single-digit micromolar EC50 values and is less effective against the enterovirus A71 strains.  Resistant mutants identified through serial viral passage expts. were mapped to four viral proteins including VP1-G178S, 2A-V112I, 2C-I227L/Q322R, and 3A-V54A.  The involvements of VP1-G178S, 2A-V112I, and 3A-V54A mutants in drug resistance were ruled out by the drug time-of-addn. expt., protease enzymic assay, and the plaque assay with recombinant virus, resp.  In contrast, recombinant virus encoding the 2C-I227L/Q322R double mutants confers significant drug resistance, which is consistent with the result from serial passage expts.  The thermal shift binding assay showed R523062 binds to the wild-type EV-D68 2C and 2C-Q322R but not 2C-I227L or 2C-I227L/Q322R, confirming 2C as the direct drug target of R523062 and 2C-I227L alone confers drug resistance.  The 2C inhibitor R523062 also showed additive antiviral activity with the viral 2A protease inhibitor telaprevir as well as the viral capsid VP1 inhibitor R856932.  Collectively, this study identified a promising EV-D68 antiviral drug candidate R523062 with a confirmed mechanism of action by targeting the viral 2C protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZhzC8qdFuQ7Vg90H21EOLACvtfcHk0lj7QQY2xPq8tw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWnt7jK&md5=1ceafdc337627131ab3c49153aee685d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.0c00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.0c00383%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520mechanism%2520of%2520action%2520of%2520R523062%252C%2520a%2520promising%2520antiviral%2520for%2520enterovirus%2520D68%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D2260%26epage%3D2270%26doi%3D10.1021%2Facsinfecdis.0c00383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">A novel capsid binding inhibitor displays potent antiviral activity against Enterovirus D68</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1952</span>â <span class="NLM_lpage">1962</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.9b00284</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00284" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslWnu73I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1952-1962&author=C.+Maauthor=Y.+Huauthor=J.+Zhangauthor=R.+Musharrafiehauthor=J.+Wang&title=A+novel+capsid+binding+inhibitor+displays+potent+antiviral+activity+against+Enterovirus+D68&doi=10.1021%2Facsinfecdis.9b00284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68</span></div><div class="casAuthors">Ma, Chunlong; Hu, Yanmei; Zhang, Jiantao; Musharrafieh, Rami; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1952-1962</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is a respiratory viral pathogen that primarily infects children under the age of 8.  Although EV-D68 infection typically leads to moderate to severe respiratory illnesses, recent years have seen increasing cases of EV-D68 triggered neurol. complications such as acute flaccid myelitis (AFM).  There is currently no vaccine or antiviral available for EV-D68; we therefore aimed to develop potent and specific small mol. antivirals against EV-D68.  We report our discovery of a viral capsid inhibitor R856932 (I) that inhibits multiple contemporary EV-D68 strains with single-digit to submicromolar efficacy.  Mechanistic studies have shown that the tetrazole compd. R856932 binds to the hydrophobic pocket of viral capsid protein VP1, thereby preventing viral uncoating and release of viral genome in the infected cells.  The mechanism of action of R856932 was confirmed by time-of-addn., Western blot, RT-qPCR, viral heat inactivation, serial viral passage, and reverse genetics expts.  A single mutation located at VP1, A129V, confers resistance against R856932.  However, a recombination virus encoding VP1-A129V appeared to have compromised fitness of replication compared to the wild-type EV-D68 virus as shown by the competition growth assay.  Overall, the hit compd. identified in this study, R856932, represents a promising starting point with a confirmed mechanism of action that can be further developed into EV-D68 antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtMBV63YPeObVg90H21EOLACvtfcHk0lj7QQY2xPq8tw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslWnu73I&md5=d23f8d3a528caccbfc25c9dca1104902</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00284%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DA%2520novel%2520capsid%2520binding%2520inhibitor%2520displays%2520potent%2520antiviral%2520activity%2520against%2520Enterovirus%2520D68%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1952%26epage%3D1962%26doi%3D10.1021%2Facsinfecdis.9b00284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a soluble fragment of poliovirus 2CATPase</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">e1007304</span> <span class="refDoi">Â DOI: 10.1371/journal.ppat.1007304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1371%2Fjournal.ppat.1007304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30231078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1Ghsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&author=H.+Guanauthor=J.+Tianauthor=C.+Zhangauthor=B.+Qinauthor=S.+Cui&title=Crystal+structure+of+a+soluble+fragment+of+poliovirus+2CATPase&doi=10.1371%2Fjournal.ppat.1007304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a soluble fragment of poliovirus 2CATPase</span></div><div class="casAuthors">Guan, Hongxin; Tian, Juan; Zhang, Chu; Qin, Bo; Cui, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1007304/1-e1007304/24</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Poliovirus (PV) 2CATPase is the most studied 2C protein in the Picornaviridae family.  It is involved in RNA replication, encapsidation and uncoating and many inhibitors have been found that target PV 2CATPase.  Despite numerous investigations to characterize its functions, a high-resoln. structure of PV 2C has not yet been detd.  We report here the crystal structure of a sol. fragment of PV 2CATPase to 2.55Ã, contg. an ATPase domain, a zinc finger and a C-terminal helical domain but missing the N-terminal domain.  The ATPase domain shares the common structural features with EV71 2C and other Superfamily 3 helicases.  The C-terminal cysteine-rich motif folds into a CCCC type zinc finger in which four cysteine ligands and several auxiliary residues assist in zinc binding.  By comparing with the known zinc finger fold groups, we found the zinc finger of 2C proteins belong to a new fold group, which we denote the "Enterovirus 2C-like" group.  The C-terminus of PV 2CATPase forms an amphipathic helix that occupies a hydrophobic pocket located on an adjacent PV 2CATPase in the crystal lattice.  The C-terminus mediated PV 2C-2C interaction promotes self-oligomerization, most likely hexamerization, which is fundamental to the ATPase activity of 2C.  The zinc finger is the most structurally diverse feature in 2C proteins.  Available structural and virol. data suggest that the zinc finger of 2C might confer the specificity of interaction with other proteins.  We built a hexameric ring model of PV 2CATPase and visualized the previously identified functional motifs and drug-resistant sites, thus providing a structure framework for antiviral drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1-3jVzsgtLVg90H21EOLACvtfcHk0lj7QQY2xPq8tw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1Ghsrg%253D&md5=9cb85a7c66db92245e74c1c7aa6cc3f1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1007304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1007304%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520a%2520soluble%2520fragment%2520of%2520poliovirus%25202CATPase%26jtitle%3DPLoS%2520Pathog.%26date%3D2018%26volume%3D14%26doi%3D10.1371%2Fjournal.ppat.1007304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojdyla, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of 2C helicase from enterovirus 71</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e1602573</span> <span class="refDoi">Â DOI: 10.1126/sciadv.1602573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1126%2Fsciadv.1602573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28508043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvVCqtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&author=H.+Guanauthor=J.+Tianauthor=B.+Qinauthor=J.+A.+Wojdylaauthor=B.+Wangauthor=Z.+Zhaoauthor=M.+Wangauthor=S.+Cui&title=Crystal+structure+of+2C+helicase+from+enterovirus+71&doi=10.1126%2Fsciadv.1602573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of 2C helicase from enterovirus 71</span></div><div class="casAuthors">Guan, Hongxin; Tian, Juan; Qin, Bo; Wojdyla, Justyna Aleksandra; Wang, Bei; Zhao, Zhendong; Wang, Meitian; Cui, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Science Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1602573/1-e1602573/9</span>CODEN:
                <span class="NLM_cas:coden">SACDAF</span>;
        ISSN:<span class="NLM_cas:issn">2375-2548</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Enterovirus 71 (EV71) is the major pathogen responsible for outbreaks of hand, foot, and mouth disease.  EV71 nonstructural protein 2C participates in many crit. events throughout the virus life cycle; however, its precise role is not fully understood.  Lack of a high-resoln. structure made it difficult to elucidate 2C activity and prevented inhibitor development.  We report the 2.5 Ã-resoln. crystal structure of the sol. part of EV71 2C, contg. an ATPase (ATPase) domain, a cysteine-rich zinc finger with an unusual fold, and a carboxyl-terminal helical domain.  Unlike other AAA+ ATPases, EV71 2C undergoes a carboxyl terminus-mediated self-oligomerization, which is dependent on a specific interaction between the carboxyl-terminal helix of one monomer and a deep pocket formed between the ATPase and the zinc finger domains of the neighboring monomer.  The carboxyl terminus-mediated self-oligomerization is fundamental to 2C ATPase activity and EV71 replication.  Our findings suggest a strategy for inhibition of enterovirus replication by disruption of the self-oligomerization interface of 2C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo7VMbRjdNQ7Vg90H21EOLACvtfcHk0liVc0ZliCdfDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvVCqtrw%253D&md5=1bbe6b7fa4f6a18e5c3daaff9a270b6e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1602573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1602573%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DWojdyla%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%25202C%2520helicase%2520from%2520enterovirus%252071%26jtitle%3DSci.%2520Adv.%26date%3D2017%26volume%3D3%26doi%3D10.1126%2Fsciadv.1602573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span> <span> </span><span class="NLM_article-title">The Structure, function, and mechanisms of action of Enterovirus non-structural protein 2C</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">615965</span> <span class="refDoi">Â DOI: 10.3389/fmicb.2020.615965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3389%2Ffmicb.2020.615965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33381104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB3svjsl2jtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=S.+H.+Wangauthor=K.+Wangauthor=K.+Zhaoauthor=S.+C.+Huaauthor=J.+Du&title=The+Structure%2C+function%2C+and+mechanisms+of+action+of+Enterovirus+non-structural+protein+2C&doi=10.3389%2Ffmicb.2020.615965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C</span></div><div class="casAuthors">Wang Shao-Hua; Zhao Ke; Du Juan; Wang Kuan; Hua Shu-Cheng; Du Juan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">615965</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Enteroviruses are a group of RNA viruses belonging to the family Picornaviridae.  They include human enterovirus groups A, B, C, and D as well as non-human enteroviruses.  Enterovirus infections can lead to hand, foot, and mouth disease and herpangina, whose clinical manifestations are often mild, although some strains can result in severe neurological complications such as encephalitis, myocarditis, meningitis, and poliomyelitis.  To date, research on enterovirus non-structural proteins has mainly focused on the 2A and 3C proteases and 3D polymerase.  However, another non-structural protein, 2C, is the most highly conserved protein, and plays a vital role in the enterovirus life cycle.  There are relatively few studies on this protein.  Previous studies have demonstrated that enterovirus 2C is involved in virus uncoating, host cell membrane rearrangements, RNA replication, encapsidation, morphogenesis, ATPase, helicase, and chaperoning activities.  Despite ongoing research, little is known about the pathogenesis of enterovirus 2C proteins in viral replication or in the host innate immune system.  In this review, we discuss and summarize the current understanding of the structure, function, and mechanism of the enterovirus 2C proteins, focusing on the key mutations and motifs involved in viral infection, replication, and immune regulation.  We also focus on recent progress in research into the role of 2C proteins in regulating the pattern recognition receptors and type I interferon signaling pathway to facilitate viral replication.  Given these functions and mechanisms, the potential application of the 2C proteins as a target for anti-viral drug development is also discussed.  Future studies will focus on the determination of more crystal structures of enterovirus 2C proteins, which might provide more potential targets for anti-viral drug development against enterovirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoDCmBfl-Q6jDnmmyUf5qOfW6udTcc2eYWAGsr2dL-jLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3svjsl2jtQ%253D%253D&md5=e9e9b352fc23e19891f526046a8f1dc5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2020.615965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2020.615965%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DHua%26aufirst%3DS.%2BC.%26aulast%3DDu%26aufirst%3DJ.%26atitle%3DThe%2520Structure%252C%2520function%252C%2520and%2520mechanisms%2520of%2520action%2520of%2520Enterovirus%2520non-structural%2520protein%25202C%26jtitle%3DFront.%2520Microbiol.%26date%3D2020%26volume%3D11%26doi%3D10.3389%2Ffmicb.2020.615965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volochnyuk, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabukhin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaskon, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmytriv, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grygorenko, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mykhailiuk, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krotko, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pushechnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A. A.</span></span> <span> </span><span class="NLM_article-title">Approach to the library of fused pyridine-4-carboxylic acids by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">510</span>â <span class="NLM_lpage">517</span>, <span class="refDoi">Â DOI: 10.1021/cc100040q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc100040q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVOisrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=510-517&author=D.+M.+Volochnyukauthor=S.+V.+Ryabukhinauthor=A.+S.+Plaskonauthor=Y.+V.+Dmytrivauthor=O.+O.+Grygorenkoauthor=P.+K.+Mykhailiukauthor=D.+G.+Krotkoauthor=A.+Pushechnikovauthor=A.+A.+Tolmachev&title=Approach+to+the+library+of+fused+pyridine-4-carboxylic+acids+by+Combes-type+reaction+of+acyl+pyruvates+and+electron-rich+amino+heterocycles&doi=10.1021%2Fcc100040q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Approach to the library of fused pyridine-4-carboxylic acids by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles</span></div><div class="casAuthors">Volochnyuk, Dmitriy M.; Ryabukhin, Sergey V.; Plaskon, Andrey S.; Dmytriv, Yuri V.; Grygorenko, Oleksandr O.; Mykhailiuk, Pavel K.; Krotko, Dmitriy G.; Pushechnikov, Alexei; Tolmachev, Andrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">510-517</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A library of fused pyridine-4-carboxylic acids (including pyrazolo[3,4-b]pyridines, isoxazolo[5,4-b]pyridines, furo[2,3-b]pyridines, thieno[2,3-b]pyridines, and pyrido[2,3-d]pyrimidines) was generated by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles followed by hydrolysis of the ester.  The library members were also demonstrated to undergo the std. combinatorial transformations including amide coupling and esterification, as well as less common heterocyclizations to 1,2,4-triazoles and 1,2,4-oxadiazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJgt2hTXsbyrVg90H21EOLACvtfcHk0liVc0ZliCdfDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVOisrw%253D&md5=7d593f0d469e366a9b7931e3677b7962</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fcc100040q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc100040q%26sid%3Dliteratum%253Aachs%26aulast%3DVolochnyuk%26aufirst%3DD.%2BM.%26aulast%3DRyabukhin%26aufirst%3DS.%2BV.%26aulast%3DPlaskon%26aufirst%3DA.%2BS.%26aulast%3DDmytriv%26aufirst%3DY.%2BV.%26aulast%3DGrygorenko%26aufirst%3DO.%2BO.%26aulast%3DMykhailiuk%26aufirst%3DP.%2BK.%26aulast%3DKrotko%26aufirst%3DD.%2BG.%26aulast%3DPushechnikov%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DA.%2BA.%26atitle%3DApproach%2520to%2520the%2520library%2520of%2520fused%2520pyridine-4-carboxylic%2520acids%2520by%2520Combes-type%2520reaction%2520of%2520acyl%2520pyruvates%2520and%2520electron-rich%2520amino%2520heterocycles%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2010%26volume%3D12%26spage%3D510%26epage%3D517%26doi%3D10.1021%2Fcc100040q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span>; <span class="NLM_string-name">Ma, C.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Diesing, J. M.</span>; <span class="NLM_string-name">Marty, M. T.</span>; <span class="NLM_string-name">Wang, J.</span></span><span> </span><span class="NLM_article-title">Validating enterovirus D68-2A(pro) as an antiviral drug target and the discovery of telaprevir as a potent D68-2A(pro) inhibitor</span> <i>J. Virol.</i><span class="NLM_year">2019</span> <span class="NLM_volume">93</span><span class="refDoi">Â DOI: 10.1128/JVI.02221-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FJVI.02221-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30674624" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=R.+Musharrafieh&author=C.+Ma&author=J.+Zhang&author=Y.+Hu&author=J.+M.+Diesing&author=M.+T.+Marty&author=J.+Wang&title=Validating+enterovirus+D68-2A%28pro%29+as+an+antiviral+drug+target+and+the+discovery+of+telaprevir+as+a+potent+D68-2A%28pro%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FJVI.02221-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FJVI.02221-18%26sid%3Dliteratum%253Aachs%26aulast%3DMusharrafieh%26aufirst%3DR.%26atitle%3DValidating%2520enterovirus%2520D68-2A%2528pro%2529%2520as%2520an%2520antiviral%2520drug%2520target%2520and%2520the%2520discovery%2520of%2520telaprevir%2520as%2520a%2520potent%2520D68-2A%2528pro%2529%2520inhibitor%26jtitle%3DJ.%2520Virol.%26date%3D2019%26volume%3D93%26doi%3D10.1128%2FJVI.02221-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">317</span>â <span class="NLM_lpage">330</span>, <span class="refDoi">Â DOI: 10.1080/22221751.2021.1888660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1080%2F22221751.2021.1888660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33560940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3MXltlegtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2021&pages=317-330&author=Y.+Huauthor=X.+Mengauthor=F.+Zhangauthor=Y.+Xiangauthor=J.+Wang&title=The+in+vitro+antiviral+activity+of+lactoferrin+against+common+human+coronaviruses+and+SARS-CoV-2+is+mediated+by+targeting+the+heparan+sulfate+co-receptor&doi=10.1080%2F22221751.2021.1888660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor</span></div><div class="casAuthors">Hu, Yanmei; Meng, Xiangzhi; Zhang, Fushun; Xiang, Yan; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Microbes & Infections</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">EMIMC4</span>;
        ISSN:<span class="NLM_cas:issn">2222-1751</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that lacks effective therapeutic interventions.  SARS-CoV-2 infects ACE2-expressing cells and gains cell entry through either direct plasma membrane fusion or endocytosis.  Recent studies have shown that in addn. to ACE2, heparan sulfate proteoglycans (HSPGs) also play an important role in SARS-CoV-2 cell attachment by serving as an attachment factor.  Binding of viral spike protein to HSPGs leads to the enrichment of local concn. for the subsequent specific binding with ACE2.  We therefore hypothesize that blocking the interactions between viral spike protein and the HSPGs will lead to inhibition of viral replication.  In this study, we report our findings of the broad-spectrum antiviral activity and the mechanism of action of lactoferrin (LF) against multiple common human coronaviruses as well as SARS-CoV-2.  Our study has shown that LF has broad-spectrum antiviral activity against SARS-CoV-2, HCoV-OC43, HCoV-NL63, and HCoV-229E in cell culture, and bovine lactoferrin (BLF) is more potent than human lactoferrin.  Mechanistic studies revealed that BLF binds to HSPGs, thereby blocking viral attachment to the host cell.  The antiviral activity of BLF can be antagonized by the HSPG mimetic heparin.  Combination therapy expt. showed that the antiviral activity of LF is synergistic with remdesivir in cell culture.  Mol. modeling suggests that the N-terminal pos. charged region in BLF (residues 17-41) confers the binding to HSPGs.  Overall, LF appears to be a promising drug candidate for COVID-19 that warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KJMYvpJE-LVg90H21EOLACvtfcHk0lhQEFV7pj2XWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXltlegtrg%253D&md5=a5c5c402b46462fe9a0cc836f5b90d9d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F22221751.2021.1888660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2021.1888660%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DThe%2520in%2520vitro%2520antiviral%2520activity%2520of%2520lactoferrin%2520against%2520common%2520human%2520coronaviruses%2520and%2520SARS-CoV-2%2520is%2520mediated%2520by%2520targeting%2520the%2520heparan%2520sulfate%2520co-receptor%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2021%26volume%3D10%26spage%3D317%26epage%3D330%26doi%3D10.1080%2F22221751.2021.1888660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">586</span>â <span class="NLM_lpage">597</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.0c00761</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.0c00761" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3MXlt1ShtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2021&pages=586-597&author=Y.+Huauthor=C.+Maauthor=T.+Szetoauthor=B.+Hurstauthor=B.+Tarbetauthor=J.+Wang&title=Boceprevir%2C+calpain+inhibitors+II+and+XII%2C+and+GC-376+have+broad-spectrum+antiviral+activity+against+coronaviruses&doi=10.1021%2Facsinfecdis.0c00761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses</span></div><div class="casAuthors">Hu, Yanmei; Ma, Chunlong; Szeto, Tommy; Hurst, Brett; Tarbet, Bart; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-597</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As the COVID-19 pandemic continues to unfold, the morbidity and mortality are increasing daily.  Effective treatment for SARS-CoV-2 is urgently needed.  We recently discovered 4 SARS-CoV-2 main protease (Mpro) inhibitors including boceprevir, calpain inhibitors II and XII, and GC-376 with potent antiviral activity against infectious SARS-CoV-2 in cell culture.  In this study, we further characterized the mechanism of action of these 4 compds. using the SARS-CoV-2 pseudovirus neutralization assay.  GC-376 and calpain inhibitors II and XII have a dual mechanism of action by inhibiting both viral Mpro and host cathepsin L in Vero cells.  To rule out the cell-type dependent effect, the antiviral activity of these 4 compds. against SARS-CoV-2 was also confirmed in type 2 transmembrane serine protease-expressing Caco-2 cells using the viral yield redn. assay.  In addn., we found that these 4 compds. have broad-spectrum antiviral activity in inhibiting not only SARS-CoV-2 but also SARS-CoV, and MERS-CoV, as well as human coronaviruses (CoVs) 229E, OC43, and NL63.  The mechanism of action is through targeting the viral Mpro, which was supported by the thermal shift-binding assay and enzymic fluorescence resonance energy transfer assay.  We further showed that these 4 compds. have additive antiviral effect when combined with remdesivir.  Altogether, these results suggest that boceprevir, calpain inhibitors II and XII, and GC-376 might be promising starting points for further development against existing human coronaviruses as well as future emerging CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRHKMIw3urjrVg90H21EOLACvtfcHk0lhQEFV7pj2XWw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXlt1ShtLw%253D&md5=9fbd5c46edbba079726dd936696ac745</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.0c00761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.0c00761%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DSzeto%26aufirst%3DT.%26aulast%3DHurst%26aufirst%3DB.%26aulast%3DTarbet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DBoceprevir%252C%2520calpain%2520inhibitors%2520II%2520and%2520XII%252C%2520and%2520GC-376%2520have%2520broad-spectrum%2520antiviral%2520activity%2520against%2520coronaviruses%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2021%26volume%3D7%26spage%3D586%26epage%3D597%26doi%3D10.1021%2Facsinfecdis.0c00761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>118</i></span>, <span class="NLM_elocation-id">e2024420118</span> <span class="refDoi">Â DOI: 10.1073/pnas.2024420118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1073%2Fpnas.2024420118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33568498" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2021&author=C.+Maauthor=J.+Wang&title=Dipyridamole%2C+chloroquine%2C+montelukast+sodium%2C+candesartan%2C+oxytetracycline%2C+and+atazanavir+are+not+SARS-CoV-2+main+protease+inhibitors&doi=10.1073%2Fpnas.2024420118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2024420118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2024420118%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDipyridamole%252C%2520chloroquine%252C%2520montelukast%2520sodium%252C%2520candesartan%252C%2520oxytetracycline%252C%2520and%2520atazanavir%2520are%2520not%2520SARS-CoV-2%2520main%2520protease%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2021%26volume%3D118%26doi%3D10.1073%2Fpnas.2024420118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sacco, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolocouris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">eabe0751</span> <span class="refDoi">Â DOI: 10.1126/sciadv.abe0751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1126%2Fsciadv.abe0751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33158912" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&author=M.+D.+Saccoauthor=C.+Maauthor=P.+Lagariasauthor=A.+Gaoauthor=J.+A.+Townsendauthor=X.+Mengauthor=P.+Dubeauthor=X.+Zhangauthor=Y.+Huauthor=N.+Kitamuraauthor=B.+Hurstauthor=B.+Tarbetauthor=M.+T.+Martyauthor=A.+Kolocourisauthor=Y.+Xiangauthor=Y.+Chenauthor=J.+Wang&title=Structure+and+inhibition+of+the+SARS-CoV-2+main+protease+reveal+strategy+for+developing+dual+inhibitors+against+M%28pro%29+and+cathepsin+L&doi=10.1126%2Fsciadv.abe0751"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.abe0751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.abe0751%26sid%3Dliteratum%253Aachs%26aulast%3DSacco%26aufirst%3DM.%2BD.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLagarias%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DTownsend%26aufirst%3DJ.%2BA.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DDube%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DHurst%26aufirst%3DB.%26aulast%3DTarbet%26aufirst%3DB.%26aulast%3DMarty%26aufirst%3DM.%2BT.%26aulast%3DKolocouris%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DStructure%2520and%2520inhibition%2520of%2520the%2520SARS-CoV-2%2520main%2520protease%2520reveal%2520strategy%2520for%2520developing%2520dual%2520inhibitors%2520against%2520M%2528pro%2529%2520and%2520cathepsin%2520L%26jtitle%3DSci.%2520Adv.%26date%3D2020%26volume%3D6%26doi%3D10.1126%2Fsciadv.abe0751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">113</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.antiviral.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28778830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yltrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2017&pages=103-113&author=Y.+Huauthor=J.+Zhangauthor=R.+G.+Musharrafiehauthor=C.+Maauthor=R.+Hauauthor=J.+Wang&title=Discovery+of+dapivirine%2C+a+nonnucleoside+HIV-1+reverse+transcriptase+inhibitor%2C+as+a+broad-spectrum+antiviral+against+both+influenza+A+and+B+viruses&doi=10.1016%2Fj.antiviral.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses</span></div><div class="casAuthors">Hu, Yanmei; Zhang, Jiantao; Musharrafieh, Rami Ghassan; Ma, Chunlong; Hau, Raymond; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The emergence of multidrug-resistant influenza viruses poses a persistent threat to public health.  The current prophylaxis and therapeutic interventions for influenza virus infection have limited efficacy due to the continuous antigenic drift and antigenic shift of influenza viruses.  As part of our ongoing effort to develop the next generation of influenza antivirals with broad-spectrum antiviral activity and a high genetic barrier to drug resistance, in this study we report the discovery of dapivirine, an FDA-approved HIV nonnucleoside reverse transcriptase inhibitor, as a broad-spectrum antiviral against multiple strains of influenza A and B viruses with low micromolar efficacy.  Mechanistic studies revealed that dapivirine inhibits the nuclear entry of viral ribonucleoproteins at the early stage of viral replication.  As a result, viral RNA and protein synthesis were inhibited.  Furthermore, dapivirine has a high in vitro genetic barrier to drug resistance, and its antiviral activity is synergistic with oseltamivir carboxylate.  In summary, the in vitro antiviral results of dapivirine suggest it is a promising candidate for the development of the next generation of dual influenza and HIV antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrja8AYHlAdj7Vg90H21EOLACvtfcHk0liicaHDkgFv-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yltrvF&md5=d5f0838b6c1127a6e13266cd6834bad8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMusharrafieh%26aufirst%3DR.%2BG.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHau%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520dapivirine%252C%2520a%2520nonnucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitor%252C%2520as%2520a%2520broad-spectrum%2520antiviral%2520against%2520both%2520influenza%2520A%2520and%2520B%2520viruses%26jtitle%3DAntiviral%2520Res.%26date%3D2017%26volume%3D145%26spage%3D103%26epage%3D113%26doi%3D10.1016%2Fj.antiviral.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekosz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, R. A.</span></span> <span> </span><span class="NLM_article-title">Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1391</span>â <span class="NLM_lpage">1399</span>, <span class="refDoi">Â DOI: 10.1128/JVI.76.3.1391-1399.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FJVI.76.3.1391-1399.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=11773413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFCqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2002&pages=1391-1399&author=M.+Takedaauthor=A.+Pekoszauthor=K.+Shuckauthor=L.+H.+Pintoauthor=R.+A.+Lamb&title=Influenza+a+virus+M2+ion+channel+activity+is+essential+for+efficient+replication+in+tissue+culture&doi=10.1128%2FJVI.76.3.1391-1399.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Influenza A virus M2 ion channel activity is essential for efficient replication in tissue culture</span></div><div class="casAuthors">Takeda, Makoto; Pekosz, Andrew; Shuck, Kevin; Pinto, Lawrence H.; Lamb, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1391-1399</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The amantadine-sensitive ion channel activity of influenza A virus M2 protein was discovered through understanding the two steps in the virus life cycle that are inhibited by the antiviral drug amantadine: virus uncoating in endosomes and M2 protein-mediated equilibration of the intralumenal pH of the trans Golgi network.  Recently it was reported that influenza virus can undergo multiple cycles of replication without M2 ion channel activity.  An M2 protein contg. a deletion in the transmembrane (TM) domain (M2-del29-31) has no detectable ion channel activity, yet a mutant virus was obtained contg. this deletion.  Watanabe and colleagues reported that the M2-del29-31 virus replicated as efficiently as wild-type (wt) virus.  The authors have investigated the effect of amantadine on the growth of four influenza viruses: A/WSN/33; N31S-M2WSN, a mutant in which an asparagine residue at position 31 in the M2 TM domain was replaced with a serine residue; MUd/WSN, which possesses seven RNA segments from WSN plus the RNA segment 7 derived from A/Udorn/72; and A/Udorn/72.  N31S-M2WSN was amantadine sensitive, whereas A/WSN/33 was amantadine resistant, indicating that the M2 residue N31 is the sole determinant of resistance of A/WSN/33 to amantadine.  The growth of influenza viruses inhibited by amantadine was compared to the growth of an M2-del29-31 virus.  The authors found that the M2-del29-31 virus was debilitated in growth to an extent similar to that of influenza virus grown in the presence of amantadine.  Furthermore, in a test of biol. fitness, it was found that wt virus almost completely outgrew M2-del29-31 virus in 4 days after cocultivation of a 100:1 ratio of M2-del29-31 virus to wt virus, resp.  It is concluded that the M2 ion channel protein, which is conserved in all known strains of influenza virus, evolved its function because it contributes to the efficient replication of the virus in a single cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq831U_z_ksu7Vg90H21EOLACvtfcHk0liicaHDkgFv-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFCqsg%253D%253D&md5=920f5cad01fde5442b20d8fafc3e4934</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FJVI.76.3.1391-1399.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.76.3.1391-1399.2002%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DPekosz%26aufirst%3DA.%26aulast%3DShuck%26aufirst%3DK.%26aulast%3DPinto%26aufirst%3DL.%2BH.%26aulast%3DLamb%26aufirst%3DR.%2BA.%26atitle%3DInfluenza%2520a%2520virus%2520M2%2520ion%2520channel%2520activity%2520is%2520essential%2520for%2520efficient%2520replication%2520in%2520tissue%2520culture%26jtitle%3DJ.%2520Virol.%26date%3D2002%26volume%3D76%26spage%3D1391%26epage%3D1399%26doi%3D10.1128%2FJVI.76.3.1391-1399.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0014.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structurally diverse enterovirus 2C inhibitors. The hit compound <b>7a</b> identified from our high-throughput screening served as a starting point for the lead optimization in this study.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Synthesis of pyrazolopyridine analogues. (A) Synthesis of 1<i>H</i>-pyrazolo[3,4,-<i>b</i>]pyridine-4-carboxylic acid. (B) Representative synthesis of pyrazolopyridines with either tertiary amine (<b>7g</b>), secondary, or primary amine (<b>7k</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of SAR studies of pyrazolopyridine. Substitutions led to compounds with a low selectivity index (SI) are labeled in red. Potent leads have each of the shown substituents R<sub>1</sub>, R<sub>3</sub>, R<sub>4</sub>, and R<sub>6</sub>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Antiviral activity of compounds <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> against EV-D68 US/MO/14-18947 in plaque assay. The plaque areas were quantified in Image J, and EC<sub>50</sub> values were determined through curve fittings in Graphpad Prism 8 using log (concentration of inhibitors) vs percentage of plaque area with variable slopes. The results are the mean Â± standard deviation of two repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Antiviral activity of compounds <b>7d</b>, <b>7h</b>, <b>10a</b>, and <b>19</b> against EV-D68 US/MO/14-18947 in neuronal cell line SH-SY5Y using immunofluorescence assay. The immunofluorescence signals were quantified in Image J, and EC<sub>50</sub> values were determined through curve fittings in Graphpad Prism 8 using log (concentration of inhibitors) vs percentage of positive control with variable slopes. The results are the mean Â± standard deviation of two repeats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Mechanism of action of the broad-spectrum antiviral <b>7d</b>. (A) Drug sensitivity of <b>7d</b> against different strains of recombinant EV-D68 viruses in plaque assay. (B) Thermal shift binding assay of <b>7d</b> against purified EV-D68 2C protein and the mutants selected from viral passage experiments. (C) Thermal shift binding assay of <b>7d</b> against EV-D68 2C, EV-A71 2C, and CVB3 2C. (D) Melting temperature <i>T</i><sub>m</sub> and thermal shift Î<i>T</i><sub>m</sub> of EV-D68 2C, EV-A71 2C, and CVB3 2C in the presence of different concentrations of <b>7d</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/medium/jm1c00758_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (A) Competition growth assay of rD183V/D323G with the rWT EV-D68 virus. Electropherogram traces of 2C protein coding region were exported from Chromas Lite 2.6, and residues 183 and 323 from viruses at each passage were shown on the left side. Codon GAT is for Asp, condon GTT is for Val, and codon GGT is for Gly. The percentages of the mutant and WT virus populations at both positions were determined by measuring the height of the nucleotide peaks in the sequencing trace and shown on the right side. (B) Stability of recombinant virus rD183V/D323G propagated in cell culture. The recombinant virus rD183V/D323G was propagated in RD cells sequentially for four passages, and 2C protein coding regions from the viruses collected from passages 2, 3, and 4 (P2, P3, P4) were sequenced. Electropherogram traces at residues 183 and 323 from viruses at each passage were shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/acs.jmedchem.1c00758/20210616/images/large/jm1c00758_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00758&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i92">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40087" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40087" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baggen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibaut, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J. M.</span></span> <span> </span><span class="NLM_article-title">The life cycle of non-polio enteroviruses and how to target it</span>. <i>Nat. Rev. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">368</span>â <span class="NLM_lpage">381</span>, <span class="refDoi">Â DOI: 10.1038/s41579-018-0005-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1038%2Fs41579-018-0005-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=29626210" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXosVCgtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2018&pages=368-381&author=J.+Baggenauthor=H.+J.+Thibautauthor=J.+Stratingauthor=F.+J.+M.+van+Kuppeveld&title=The+life+cycle+of+non-polio+enteroviruses+and+how+to+target+it&doi=10.1038%2Fs41579-018-0005-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The life cycle of non-polio enteroviruses and how to target it</span></div><div class="casAuthors">Baggen, Jim; Jan Thibaut, Hendrik; Strating, Jeroen R. P. M.; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">368-381</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  The genus Enterovirus (EV) of the family Picornaviridae includes poliovirus, coxsackieviruses, echoviruses, numbered enteroviruses and rhinoviruses.  These diverse viruses cause a variety of diseases, including non-specific febrile illness, hand-foot-and-mouth disease, neonatal sepsis-like disease, encephalitis, paralysis and respiratory diseases.  In recent years, several non-polio enteroviruses (NPEVs) have emerged as serious public health concerns.  These include EV-A71, which has caused epidemics of hand-foot-and-mouth disease in Southeast Asia, and EV-D68, which recently caused a large outbreak of severe lower respiratory tract disease in North America.  Infections with these viruses are assocd. with severe neurol. complications.  For decades, most research has focused on poliovirus, but in recent years, our knowledge of NPEVs has increased considerably.  In this Review, we summarize recent insights from enterovirus research with a special emphasis on NPEVs.  We discuss virion structures, host-receptor interactions, viral uncoating and the recent discovery of a universal enterovirus host factor that is involved in viral genome release.  Moreover, we briefly explain the mechanisms of viral genome replication, virion assembly and virion release, and describe potential targets for antiviral therapy.  We reflect on how these recent discoveries may help the development of antiviral therapies and vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj0u0CSm-oNLVg90H21EOLACvtfcHk0lh916jBQpDq2w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXosVCgtLs%253D&md5=b085070903d06c30ba4f444175952921</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41579-018-0005-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41579-018-0005-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaggen%26aufirst%3DJ.%26aulast%3DThibaut%26aufirst%3DH.%2BJ.%26aulast%3DStrating%26aufirst%3DJ.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%2BM.%26atitle%3DThe%2520life%2520cycle%2520of%2520non-polio%2520enteroviruses%2520and%2520how%2520to%2520target%2520it%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2018%26volume%3D16%26spage%3D368%26epage%3D381%26doi%3D10.1038%2Fs41579-018-0005-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span> <span> </span><span class="NLM_article-title">EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">7</span>, <span class="refDoi">Â DOI: 10.1038/emi.2016.73</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1038%2Femi.2016.73" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2016&pages=1-7&author=Q.+Maoauthor=Y.+Wangauthor=L.+Bianauthor=M.+Xuauthor=Z.+Liang&title=EV-A71+vaccine+licensure%3A+a+first+step+for+multivalent+enterovirus+vaccine+to+control+HFMD+and+other+severe+diseases&doi=10.1038%2Femi.2016.73"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Femi.2016.73&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femi.2016.73%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBian%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DLiang%26aufirst%3DZ.%26atitle%3DEV-A71%2520vaccine%2520licensure%253A%2520a%2520first%2520step%2520for%2520multivalent%2520enterovirus%2520vaccine%2520to%2520control%2520HFMD%2520and%2520other%2520severe%2520diseases%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2016%26volume%3D5%26spage%3D1%26epage%3D7%26doi%3D10.1038%2Femi.2016.73" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, Y. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X. L.</span></span> <span> </span><span class="NLM_article-title">Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>381</i></span>,  <span class="NLM_fpage">2024</span>â <span class="NLM_lpage">2032</span>, <span class="refDoi">Â DOI: 10.1016/S0140-6736(13)61049-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2FS0140-6736%2813%2961049-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=23726161" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosVGjt7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=381&publication_year=2013&pages=2024-2032&author=F.+C.+Zhuauthor=F.+Y.+Mengauthor=J.+X.+Liauthor=X.+L.+Liauthor=Q.+Y.+Maoauthor=H.+Taoauthor=Y.+T.+Zhangauthor=X.+Yaoauthor=K.+Chuauthor=Q.+H.+Chenauthor=Y.+M.+Huauthor=X.+Wuauthor=P.+Liuauthor=L.+Y.+Zhuauthor=F.+Gaoauthor=H.+Jinauthor=Y.+J.+Chenauthor=Y.+Y.+Dongauthor=Y.+C.+Liangauthor=N.+M.+Shiauthor=H.+M.+Geauthor=L.+Liuauthor=S.+G.+Chenauthor=X.+Aiauthor=Z.+Y.+Zhangauthor=Y.+G.+Jiauthor=F.+J.+Luoauthor=X.+Q.+Chenauthor=Y.+Zhangauthor=L.+W.+Zhuauthor=Z.+L.+Liangauthor=X.+L.+Shen&title=Efficacy%2C+safety%2C+and+immunology+of+an+inactivated+alum-adjuvant+enterovirus+71+vaccine+in+children+in+China%3A+a+multicentre%2C+randomised%2C+double-blind%2C+placebo-controlled%2C+phase+3+trial&doi=10.1016%2FS0140-6736%2813%2961049-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial</span></div><div class="casAuthors">Zhu, Feng-Cai; Meng, Fan-Yue; Li, Jing-Xin; Li, Xiu-Ling; Mao, Qun-Ying; Tao, Hong; Zhang, Yun-Tao; Yao, Xin; Chu, Kai; Chen, Qing-Hua; Hu, Yue-Mei; Wu, Xing; Liu, Pei; Zhu, Lin-Yang; Gao, Fan; Jin, Hui; Chen, Yi-Juan; Dong, Yu-Ying; Liang, Yong-Chun; Shi, Nian-Min; Ge, Heng-Ming; Liu, Lin; Chen, Sheng-Gen; Ai, Xing; Zhang, Zhen-Yu; Ji, Yu-Guo; Luo, Feng-Ji; Chen, Xiao-Qin; Zhang, Ya; Zhu, Li-Wen; Liang, Zheng-Lun; Shen, Xin-Liang</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">381</span>
        (<span class="NLM_cas:issue">9882</span>),
    <span class="NLM_cas:pages">2024-2032</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A vaccine for enterovirus 71 (EV71) is needed to address the high burden of disease assocd. with infection.  We assessed the efficacy, safety, immunogenicity, antibody persistence, and immunol. correlates of an inactivated alum-adjuvant EV71 vaccine.We did a randomised, double-blind, placebo-controlled, phase 3 trial.  Healthy children aged 6-35 mo from four centers in China were randomly assigned (1:1) to receive vaccine or alum-adjuvant placebo at day 0 and 28, according to a randomisation list (block size 30) generated by an independent statistician.  Investigators and participants and their guardians were masked to the assignment.  Primary endpoints were EV71-assocd. hand, foot, and mouth disease (HFMD) and EV71-assocd. disease during the surveillance period from day 56 to month 14, analyzed in the per-protocol population.  This study is registered with ClinicalTrials.gov, no. NCT01508247.10 245 participants were enrolled and assigned: 5120 to vaccine vs. 5125 to placebo. 4907 (with three cases of EV71-assocd. HFMD and eight cases of EV71-assocd. disease) vs. 4939 (with 30 cases of EV71-assocd. HFMD and 41 cases of EV71-assocd. disease) were included in the primary efficacy anal.  Vaccine efficacy was 90Â·0% (95% CI 67Â·1-96Â·9) against EV71-assocd. HFMD (p=0Â·0001) and 80Â·4% (95% CI 58Â·2-90Â·8) against EV71-assocd. disease (p<0Â·0001).  Serious adverse events were reported by 62 of 5117 (1Â·2%) participants in the vaccine group vs. 75 of 5123 (1Â·5%) in the placebo group (p=0Â·27).  Adverse events occurred in 3644 (71Â·2%) vs. 3603 (70Â·3%; p=0Â·33).EV71 vaccine provides high efficacy, satisfactory safety, and sustained immunogenicity.China's 12-5 National Major Infectious Disease Program, Beijing Vigoo Biol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYdRqUnCjr7LVg90H21EOLACvtfcHk0ljHGOkdwEaMDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosVGjt7k%253D&md5=90c628e8ded2b29bf0fad5eef24e38b1</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2813%2961049-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252813%252961049-1%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DF.%2BC.%26aulast%3DMeng%26aufirst%3DF.%2BY.%26aulast%3DLi%26aufirst%3DJ.%2BX.%26aulast%3DLi%26aufirst%3DX.%2BL.%26aulast%3DMao%26aufirst%3DQ.%2BY.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%2BT.%26aulast%3DYao%26aufirst%3DX.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DQ.%2BH.%26aulast%3DHu%26aufirst%3DY.%2BM.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DZhu%26aufirst%3DL.%2BY.%26aulast%3DGao%26aufirst%3DF.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DY.%2BJ.%26aulast%3DDong%26aufirst%3DY.%2BY.%26aulast%3DLiang%26aufirst%3DY.%2BC.%26aulast%3DShi%26aufirst%3DN.%2BM.%26aulast%3DGe%26aufirst%3DH.%2BM.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DS.%2BG.%26aulast%3DAi%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DZ.%2BY.%26aulast%3DJi%26aufirst%3DY.%2BG.%26aulast%3DLuo%26aufirst%3DF.%2BJ.%26aulast%3DChen%26aufirst%3DX.%2BQ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DL.%2BW.%26aulast%3DLiang%26aufirst%3DZ.%2BL.%26aulast%3DShen%26aufirst%3DX.%2BL.%26atitle%3DEfficacy%252C%2520safety%252C%2520and%2520immunology%2520of%2520an%2520inactivated%2520alum-adjuvant%2520enterovirus%252071%2520vaccine%2520in%2520children%2520in%2520China%253A%2520a%2520multicentre%252C%2520randomised%252C%2520double-blind%252C%2520placebo-controlled%252C%2520phase%25203%2520trial%26jtitle%3DLancet%26date%3D2013%26volume%3D381%26spage%3D2024%26epage%3D2032%26doi%3D10.1016%2FS0140-6736%2813%2961049-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, F.</span></span> <span> </span><span class="NLM_article-title">2-Year efficacy, immunogenicity, and safety of vigoo enterovirus 71 vaccine in healthy chinese children: a randomized open-label study</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>215</i></span>,  <span class="NLM_fpage">56</span>â <span class="NLM_lpage">63</span>, <span class="refDoi">Â DOI: 10.1093/infdis/jiw502</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1093%2Finfdis%2Fjiw502" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28077584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFCrtbjL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=215&publication_year=2017&pages=56-63&author=M.+Weiauthor=F.+Mengauthor=S.+Wangauthor=J.+Liauthor=Y.+Zhangauthor=Q.+Maoauthor=Y.+Huauthor=P.+Liuauthor=N.+Shiauthor=H.+Taoauthor=K.+Chuauthor=Y.+Wangauthor=Z.+Liangauthor=X.+Liauthor=F.+Zhu&title=2-Year+efficacy%2C+immunogenicity%2C+and+safety+of+vigoo+enterovirus+71+vaccine+in+healthy+chinese+children%3A+a+randomized+open-label+study&doi=10.1093%2Finfdis%2Fjiw502"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">2-year efficacy, immunogenicity, and safety of Vigoo enterovirus 71 vaccine in healthy Chinese children: a randomized open-label study</span></div><div class="casAuthors">Wei, Mingwei; Meng, Fanyue; Wang, Shiyuan; Li, Jingxin; Zhang, Yuntao; Mao, Qunying; Hu, Yuemei; Liu, Pei; Shi, Nianmin; Tao, Hong; Chu, Kai; Wang, Yuxiao; Liang, Zhenglun; Li, Xiuling; Zhu, Fengcai</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">215</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">56-63</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">This study evaluated the 2-yr efficacy, immunogenicity, and safety of the Vigoo enterovirus 71 (EV71) vaccine for up to 2 years.  Overall efficacy was 94.84% (95% confidence interval [CI], 83.53%-98.38%) during the 2-yr follow-up period (P < .0001), and the vaccine efficacy during the second year was 100.00% (95% CI, 84.15%-100.00%) against EV71-assocd. hand-foot-and-mouth disease (HFMD; P < .0001).  Geometric mean titers of neutralizing antibody in participants remained high during the 2-yr follow-up period, and no vaccine-related serious adverse events were recorded.  Two doses of Vigoo EV71 vaccine could provide sustained protection against EV71-assocd. HFMD in healthy Chinese children.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk1il39ykPN7Vg90H21EOLACvtfcHk0ljHGOkdwEaMDQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFCrtbjL&md5=577de9bb41d735f4378d5bf98e9863c3</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjiw502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjiw502%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DShi%26aufirst%3DN.%26aulast%3DTao%26aufirst%3DH.%26aulast%3DChu%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLiang%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DF.%26atitle%3D2-Year%2520efficacy%252C%2520immunogenicity%252C%2520and%2520safety%2520of%2520vigoo%2520enterovirus%252071%2520vaccine%2520in%2520healthy%2520chinese%2520children%253A%2520a%2520randomized%2520open-label%2520study%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D215%26spage%3D56%26epage%3D63%26doi%3D10.1093%2Finfdis%2Fjiw502" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kung, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, S. R.</span></span> <span> </span><span class="NLM_article-title">Antivirals and vaccines for Enterovirus A71</span>. <i>J. Biomed. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>, <span class="NLM_elocation-id">65</span> <span class="refDoi">Â DOI: 10.1186/s12929-019-0560-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1186%2Fs12929-019-0560-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=31481071" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB3MrkslyntA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&author=J.+Y.+Linauthor=Y.+A.+Kungauthor=S.+R.+Shih&title=Antivirals+and+vaccines+for+Enterovirus+A71&doi=10.1186%2Fs12929-019-0560-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Antivirals and vaccines for Enterovirus A71</span></div><div class="casAuthors">Lin Jing-Yi; Kung Yu-An; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru</div><div class="citationInfo"><span class="NLM_cas:title">Journal of biomedical science</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">65</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Enterovirus A71 (EV-A71) is an important emerging virus posing a threat to children under five years old.  EV-A71 infection in infants or young children can cause hand-foot-and-mouth disease, herpangina, or severe neurological complications.  However, there are still no effective antivirals for treatment of these infections.  In this review, we summarize the antiviral compounds developed to date based on various targets of the EV-A71 life cycle.  Moreover, development of a vaccine would be the most effective approach to prevent EV-A71 infection.  Therefore, we also summarize the development and clinical progress of various candidate EV-A71 vaccines, including inactivated whole virus, recombinant VP1 protein, synthetic peptides, viral-like particles, and live attenuated vaccines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSNZYm4GTBO6O2mnZh2OgS0fW6udTcc2ebC4TC29E2pdrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MrkslyntA%253D%253D&md5=821da37b6855b1f9de69941b612d5cb8</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fs12929-019-0560-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12929-019-0560-7%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DJ.%2BY.%26aulast%3DKung%26aufirst%3DY.%2BA.%26aulast%3DShih%26aufirst%3DS.%2BR.%26atitle%3DAntivirals%2520and%2520vaccines%2520for%2520Enterovirus%2520A71%26jtitle%3DJ.%2520Biomed.%2520Sci.%26date%3D2019%26volume%3D26%26doi%3D10.1186%2Fs12929-019-0560-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lim, Z. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, Q. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J. W. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahendran, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, S.</span></span> <span> </span><span class="NLM_article-title">Recent progress and challenges in drug development to fight hand, foot and mouth disease</span>. <i>Expert Opin. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">359</span>â <span class="NLM_lpage">371</span>, <span class="refDoi">Â DOI: 10.1080/17460441.2019.1659241</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1080%2F17460441.2019.1659241" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=31470744" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtbzF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2020&pages=359-371&author=Z.+Q.+Limauthor=Q.+Y.+Ngauthor=J.+W.+Q.+Ngauthor=V.+Mahendranauthor=S.+Alonso&title=Recent+progress+and+challenges+in+drug+development+to+fight+hand%2C+foot+and+mouth+disease&doi=10.1080%2F17460441.2019.1659241"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress and challenges in drug development to fight hand, foot and mouth disease</span></div><div class="casAuthors">Lim, Ze Qin; Ng, Qing Yong; Ng, Justin Wei Qing; Mahendran, Vikneswari; Alonso, Sylvie</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Discovery</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">359-371</span>CODEN:
                <span class="NLM_cas:coden">EODDBX</span>;
        ISSN:<span class="NLM_cas:issn">1746-0441</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">A review.  Introduction: Hand, foot and mouth disease (HFMD) is a serious public health concern in the Asia-Pacific region with recurrent cyclical outbreaks.  Enterovirus 71 (EV-A71) and coxsackievirus type A are the main causative agents of HFMD.  While majority of HFMD cases are mild and self-limiting, neurol. complications have been reported for EV-A71 assocd. HFMD.  There is currently no effective treatment against HFMD and monovalent vaccines against EV-A71 are currently limited to the Chinese market.  As of today, HFMD antiviral development has focused on EV-A71 and involves conventional screening of drug libraries.  In recent years, attention has shifted toward identifying druggable host factors to avoid drug resistance and identify drug candidates with broader antiviral activity across EV-A71 genogroups and other HFMD causative agents.  The effective development of HFMD interventions requires us to address the gaps in our understanding of its pathogenesis at the mol. level.  The limited resources devoted to the development of HFMD treatment strategies worldwide also contribute to the slow progress of promising drug and vaccine candidates along the clin. pipeline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8tzKZ33gBHrVg90H21EOLACvtfcHk0lhqoVDQiRKJLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ygtbzF&md5=ee09d83d021c3bd3506fbced272aedbe</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1080%2F17460441.2019.1659241&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17460441.2019.1659241%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DZ.%2BQ.%26aulast%3DNg%26aufirst%3DQ.%2BY.%26aulast%3DNg%26aufirst%3DJ.%2BW.%2BQ.%26aulast%3DMahendran%26aufirst%3DV.%26aulast%3DAlonso%26aufirst%3DS.%26atitle%3DRecent%2520progress%2520and%2520challenges%2520in%2520drug%2520development%2520to%2520fight%2520hand%252C%2520foot%2520and%2520mouth%2520disease%26jtitle%3DExpert%2520Opin.%2520Drug%2520Discovery%26date%3D2020%26volume%3D15%26spage%3D359%26epage%3D371%26doi%3D10.1080%2F17460441.2019.1659241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Enterovirus D68 Antivirals: Past, Present, and Future</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1572</span>â <span class="NLM_lpage">1586</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.0c00120</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.0c00120" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXot1ersbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=1572-1586&author=Y.+Huauthor=R.+Musharrafiehauthor=M.+Zhengauthor=J.+Wang&title=Enterovirus+D68+Antivirals%3A+Past%2C+Present%2C+and+Future&doi=10.1021%2Facsinfecdis.0c00120"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Enterovirus D68 Antivirals: Past, Present, and Future</span></div><div class="casAuthors">Hu, Yanmei; Musharrafieh, Rami; Zheng, Madeleine; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1572-1586</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Enterovirus D68 (EV-D68) is an RNA virus that causes respiratory illnesses mainly in children.  In severe cases, it can lead to neurol. complications such as acute flaccid myelitis (AFM).  EV-D68 belongs to the enterovirus genera of the Picornaviridae family, which also includes many other significant human pathogens such as poliovirus, enterovirus A71, and rhinovirus.  There are currently no vaccines or antivirals against EV-D68.  In this review, we present the current understanding of the link between EV-D68 and AFM, the mechanism of viral replication, and recent progress in developing EV-D68 antivirals by targeting various viral proteins and host factors that are essential for viral replication.  The future directions of EV-D68 antiviral drug discovery and the criteria for drugs to reach clin. trials are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrj_c0CXEKHKbVg90H21EOLACvtfcHk0lhqoVDQiRKJLw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXot1ersbk%253D&md5=85baf1cdfee863a4c5c5daae78372c4a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.0c00120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.0c00120%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DZheng%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DEnterovirus%2520D68%2520Antivirals%253A%2520Past%252C%2520Present%252C%2520and%2520Future%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D1572%26epage%3D1586%26doi%3D10.1021%2Facsinfecdis.0c00120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyoo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Schaar, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span> <span> </span><span class="NLM_article-title">Direct-acting antivirals and host-targeting strategies to combat enterovirus infections</span>. <i>Curr. Opin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">8</span>, <span class="refDoi">Â DOI: 10.1016/j.coviro.2017.03.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.coviro.2017.03.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28411509" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlsFKqsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2017&pages=1-8&author=L.+Bauerauthor=H.+Lyooauthor=H.+M.+van+der%0ASchaarauthor=J.+R.+Stratingauthor=F.+J.+van+Kuppeveld&title=Direct-acting+antivirals+and+host-targeting+strategies+to+combat+enterovirus+infections&doi=10.1016%2Fj.coviro.2017.03.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Direct-acting antivirals and host-targeting strategies to combat enterovirus infections</span></div><div class="casAuthors">Bauer, Lisa; Lyoo, Heyrhyoung; van der Schaar, Hilde M.; Strating, Jeroen R. P. M.; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-8</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enteroviruses (e.g., poliovirus, enterovirus-A71, coxsackievirus, enterovirus-D68, rhinovirus) include many human pathogens causative of various mild and more severe diseases, esp. in young children.  Unfortunately, antiviral drugs to treat enterovirus infections have not been approved yet.  Over the past decades, several direct-acting inhibitors have been developed, including capsid binders, which block virus entry, and inhibitors of viral enzymes required for genome replication.  Capsid binders and protease inhibitors have been clin. evaluated, but failed due to limited efficacy or toxicity issues.  As an alternative approach, host-targeting inhibitors with potential broad-spectrum activity have been identified.  Furthermore, drug repurposing screens have recently uncovered promising new inhibitors with disparate viral and host targets.  Together, these findings raise hope for the development of (broad-range) anti-enteroviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxT9auTJ_eW7Vg90H21EOLACvtfcHk0lhv-5cWL1tPCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlsFKqsrc%253D&md5=1f7d35dca32eda896e13b372de4ec255</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2017.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2017.03.009%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DLyoo%26aufirst%3DH.%26aulast%3Dvan%2Bder%2BSchaar%26aufirst%3DH.%2BM.%26aulast%3DStrating%26aufirst%3DJ.%2BR.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26atitle%3DDirect-acting%2520antivirals%2520and%2520host-targeting%2520strategies%2520to%2520combat%2520enterovirus%2520infections%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2017%26volume%3D24%26spage%3D1%26epage%3D8%26doi%3D10.1016%2Fj.coviro.2017.03.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.-N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, S.-R.</span></span> <span> </span><span class="NLM_article-title">Enterovirus and Encephalitis</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">261</span>, <span class="refDoi">Â DOI: 10.3389/fmicb.2020.00261</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3389%2Ffmicb.2020.00261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32153545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB383hsF2jsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=261&author=B.-S.+Chenauthor=H.-C.+Leeauthor=K.-M.+Leeauthor=Y.-N.+Gongauthor=S.-R.+Shih&title=Enterovirus+and+Encephalitis&doi=10.3389%2Ffmicb.2020.00261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Enterovirus and Encephalitis</span></div><div class="casAuthors">Chen Bo-Shiun; Lee Hou-Chen; Lee Kuo-Ming; Gong Yu-Nong; Shih Shin-Ru; Chen Bo-Shiun; Gong Yu-Nong; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru; Shih Shin-Ru</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Enterovirus-induced infection of the central nervous system (CNS) results in acute inflammation of the brain (encephalitis) and constitutes a significant global burden to human health.  These viruses are thought to be highly cytolytic, therefore normal brain function could be greatly compromised following enteroviral infection of the CNS.  A further layer of complexity is added by evidence showing that some enteroviruses may establish a persistent infection within the CNS and eventually lead to pathogenesis of certain neurodegenerative disorders.  Interestingly, enterovirus encephalitis is particularly common among young children, suggesting a potential causal link between the development of the neuroimmune system and enteroviral neuroinvasion.  Although the CNS involvement in enterovirus infections is a relatively rare complication, it represents a serious underlying cause of mortality.  Here we review a selection of enteroviruses that infect the CNS and discuss recent advances in the characterization of these enteroviruses with regard to their routes of CNS infection, tropism, virulence, and immune responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcThLNZvSzP0CdyzdcP07UmufW6udTcc2eaMGvEW4nTX4rntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383hsF2jsA%253D%253D&md5=6eb3e8dcff33ccec6ef514889392c4d9</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2020.00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2020.00261%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DB.-S.%26aulast%3DLee%26aufirst%3DH.-C.%26aulast%3DLee%26aufirst%3DK.-M.%26aulast%3DGong%26aufirst%3DY.-N.%26aulast%3DShih%26aufirst%3DS.-R.%26atitle%3DEnterovirus%2520and%2520Encephalitis%26jtitle%3DFront.%2520Microbiol.%26date%3D2020%26volume%3D11%26spage%3D261%26doi%3D10.3389%2Ffmicb.2020.00261" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pons-Salort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenfell, B. T.</span></span> <span> </span><span class="NLM_article-title">Epidemiological dynamics of enterovirus D68 in the United States and implications for acute flaccid myelitis</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">eabd2400</span> <span class="refDoi">Â DOI: 10.1126/scitranslmed.abd2400</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1126%2Fscitranslmed.abd2400" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33692131" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2021&author=S.+W.+Parkauthor=M.+Pons-Salortauthor=K.+Messacarauthor=C.+Cookauthor=L.+Meyersauthor=J.+Farrarauthor=B.+T.+Grenfell&title=Epidemiological+dynamics+of+enterovirus+D68+in+the+United+States+and+implications+for+acute+flaccid+myelitis&doi=10.1126%2Fscitranslmed.abd2400"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.abd2400&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.abd2400%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BW.%26aulast%3DPons-Salort%26aufirst%3DM.%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DCook%26aufirst%3DC.%26aulast%3DMeyers%26aufirst%3DL.%26aulast%3DFarrar%26aufirst%3DJ.%26aulast%3DGrenfell%26aufirst%3DB.%2BT.%26atitle%3DEpidemiological%2520dynamics%2520of%2520enterovirus%2520D68%2520in%2520the%2520United%2520States%2520and%2520implications%2520for%2520acute%2520flaccid%2520myelitis%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2021%26volume%3D13%26doi%3D10.1126%2Fscitranslmed.abd2400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pons-Salort, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberste, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pallansch, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abedi, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenfell, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grassly, N. C.</span></span> <span> </span><span class="NLM_article-title">The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">3078</span>â <span class="NLM_lpage">3083</span>, <span class="refDoi">Â DOI: 10.1073/pnas.1721159115</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1073%2Fpnas.1721159115" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=29507246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1ChtrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2018&pages=3078-3083&author=M.+Pons-Salortauthor=M.+S.+Obersteauthor=M.+A.+Pallanschauthor=G.+R.+Abediauthor=S.+Takahashiauthor=B.+T.+Grenfellauthor=N.+C.+Grassly&title=The+seasonality+of+nonpolio+enteroviruses+in+the+United+States%3A+Patterns+and+drivers&doi=10.1073%2Fpnas.1721159115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The seasonality of nonpolio enteroviruses in the United States: patterns and drivers</span></div><div class="casAuthors">Pons-Salort, Margarita; Oberste, M. Steven; Pallansch, Mark A.; Abedi, Glen R.; Takahashi, Saki; Grenfell, Bryan T.; Grassly, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3078-3083</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Nonpolio enteroviruses are diverse and common viruses that can circulate year-round but tend to peak in summer.  Although most infections are asymptomatic, they can result in a wide range of neurol. and other diseases.  Many serotypes circulate every year, and different serotypes predominate in different years, but the drivers of their geog. and temporal dynamics are not understood.  We use national enterovirus surveillance data collected by the US Centers for Disease Control and Prevention during 1983-2013, as well as demog. and climatic data for the same period, to study the patterns and drivers of the seasonality of these infections.  We find that the seasonal pattern of enterovirus cases is spatially structured in the United States and similar to that obsd. for historical prevaccination poliomyelitis (1931-1954).  We identify latitudinal gradients for the amplitude and the timing of the peak of cases, meaning that those are more regularly distributed all year-round in the south and have a more pronounced peak that arrives later toward the north.  The peak is estd. to occur between July and Sept. across the United States, and 1 mo earlier than that for historical poliomyelitis.  Using mixed-effects models, we find that climate, but not demog., is likely to drive the seasonal pattern of enterovirus cases and that the dew point temp. alone explains â¼30% of the variation in the intensity of transmission.  Our study contributes to a better understanding of the epidemiol. of enteroviruses, demonstrates important similarities in their circulation dynamics with polioviruses, and identifies potential drivers of their seasonality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFbrTwqQ34bVg90H21EOLACvtfcHk0lhv-5cWL1tPCA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1ChtrzP&md5=946a979916de5e6fee07bf9a395a170a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1721159115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1721159115%26sid%3Dliteratum%253Aachs%26aulast%3DPons-Salort%26aufirst%3DM.%26aulast%3DOberste%26aufirst%3DM.%2BS.%26aulast%3DPallansch%26aufirst%3DM.%2BA.%26aulast%3DAbedi%26aufirst%3DG.%2BR.%26aulast%3DTakahashi%26aufirst%3DS.%26aulast%3DGrenfell%26aufirst%3DB.%2BT.%26aulast%3DGrassly%26aufirst%3DN.%2BC.%26atitle%3DThe%2520seasonality%2520of%2520nonpolio%2520enteroviruses%2520in%2520the%2520United%2520States%253A%2520Patterns%2520and%2520drivers%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2018%26volume%3D115%26spage%3D3078%26epage%3D3083%26doi%3D10.1073%2Fpnas.1721159115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X. F.</span></span> <span> </span><span class="NLM_article-title">Current understanding of human Enterovirus D68</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">490</span>, <span class="refDoi">Â DOI: 10.3390/v11060490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3390%2Fv11060490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXksVan" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=490&author=J.+Sunauthor=X.+Y.+Huauthor=X.+F.+Yu&title=Current+understanding+of+human+Enterovirus+D68&doi=10.3390%2Fv11060490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Current understanding of human enterovirus D68</span></div><div class="casAuthors">Sun, Jing; Hu, Xiao-Yi; Yu, Xiao-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">490</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Human enterovirus D68 (EV-D68), a member of the species Enterovirus D of the Picornaviridae family, was first isolated in 1962 in the United States.  EV-D68 infection was only infrequently reported until an outbreak occurred in 2014 in the US; since then, it has continued to increase worldwide.  EV-D68 infection leads to severe respiratory illness and has recently been reported to be linked to the development of the neurogenic disease known as acute flaccid myelitis (AFM), mostly in children, seriously endangering public health.  Hitherto, treatment options for EV-D68 infections were limited to supportive care, and as yet there are no approved, specific antiviral drugs or vaccines.  Research on EV-D68 has mainly focused on its epidemiol., and its virol. characteristics and pathogenesis still need to be further explored.  Here, we provide an overview of current research on EV-D68, including the genotypes and genetic characteristics of recent epidemics, the mechanism of infection and virus-host interactions, and its relationship to acute flaccid myelitis (AFM), in order to broaden our understanding of the biol. features of EV-D68 and provide a basis for the development of effective antiviral agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqJUwKWBtbx7Vg90H21EOLACvtfcHk0lg9UlUW_BX0BQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXksVan&md5=1f85392ec96bb95dfabf42e984e52739</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3390%2Fv11060490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11060490%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DX.%2BY.%26aulast%3DYu%26aufirst%3DX.%2BF.%26atitle%3DCurrent%2520understanding%2520of%2520human%2520Enterovirus%2520D68%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26spage%3D490%26doi%3D10.3390%2Fv11060490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asturias, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Leer-Buter, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niesters, H. G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abzug, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. R.</span></span> <span> </span><span class="NLM_article-title">Enterovirus D68 and acute flaccid myelitis-evaluating the evidence for causality</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">e239</span>â <span class="NLM_lpage">e247</span>, <span class="refDoi">Â DOI: 10.1016/S1473-3099(18)30094-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2FS1473-3099%2818%2930094-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=29482893" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2018&pages=e239-e247&author=K.+Messacarauthor=E.+J.+Asturiasauthor=A.+M.+Hixonauthor=C.+Van+Leer-Buterauthor=H.+G.+M.+Niestersauthor=K.+L.+Tylerauthor=M.+J.+Abzugauthor=S.+R.+Dominguez&title=Enterovirus+D68+and+acute+flaccid+myelitis-evaluating+the+evidence+for+causality&doi=10.1016%2FS1473-3099%2818%2930094-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2818%2930094-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252818%252930094-X%26sid%3Dliteratum%253Aachs%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DAsturias%26aufirst%3DE.%2BJ.%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DVan%2BLeer-Buter%26aufirst%3DC.%26aulast%3DNiesters%26aufirst%3DH.%2BG.%2BM.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26aulast%3DAbzug%26aufirst%3DM.%2BJ.%26aulast%3DDominguez%26aufirst%3DS.%2BR.%26atitle%3DEnterovirus%2520D68%2520and%2520acute%2520flaccid%2520myelitis-evaluating%2520the%2520evidence%2520for%2520causality%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2018%26volume%3D18%26spage%3De239%26epage%3De247%26doi%3D10.1016%2FS1473-3099%2818%2930094-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brown, D. M.</span>; <span class="NLM_string-name">Hixon, A. M.</span>; <span class="NLM_string-name">Oldfield, L. M.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Novotny, M.</span>; <span class="NLM_string-name">Wang, W.</span>; <span class="NLM_string-name">Das, S. R.</span>; <span class="NLM_string-name">Shabman, R. S.</span>; <span class="NLM_string-name">Tyler, K. L.</span>; <span class="NLM_string-name">Scheuermann, R. H.</span></span><span> </span><span class="NLM_article-title">Contemporary circulating Enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells</span> <i>mBio</i><span class="NLM_year">2018</span> <span class="NLM_volume">9</span><span class="refDoi">Â DOI: 10.1128/mBio.01954-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.01954-18" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=D.+M.+Brown&author=A.+M.+Hixon&author=L.+M.+Oldfield&author=Y.+Zhang&author=M.+Novotny&author=W.+Wang&author=S.+R.+Das&author=R.+S.+Shabman&author=K.+L.+Tyler&author=R.+H.+Scheuermann&title=Contemporary+circulating+Enterovirus+D68+strains+have+acquired+the+capacity+for+viral+entry+and+replication+in+human+neuronal+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1128%2FmBio.01954-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.01954-18%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DD.%2BM.%26atitle%3DContemporary%2520circulating%2520Enterovirus%2520D68%2520strains%2520have%2520acquired%2520the%2520capacity%2520for%2520viral%2520entry%2520and%2520replication%2520in%2520human%2520neuronal%2520cells%26jtitle%3DmBio%26date%3D2018%26volume%3D9%26doi%3D10.1128%2FmBio.01954-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morens, D. M.</span>; <span class="NLM_string-name">Folkers, G. K.</span>; <span class="NLM_string-name">Fauci, A. S.</span></span> <span> </span><span class="NLM_article-title">Acute flaccid myelitis: something old and something new</span>.  <i>mBio</i> <span class="NLM_year">2019</span>,  <span class="NLM_volume">10</span>, <span class="refDoi">Â DOI: 10.1128/mBio.00521-19</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.00521-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30940708" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=D.+M.+Morens&author=G.+K.+Folkers&author=A.+S.+Fauci&title=Acute+flaccid+myelitis%3A+something+old+and+something+new"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1128%2FmBio.00521-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.00521-19%26sid%3Dliteratum%253Aachs%26aulast%3DMorens%26aufirst%3DD.%2BM.%26atitle%3DAcute%2520flaccid%2520myelitis%253A%2520something%2520old%2520and%2520something%2520new%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26doi%3D10.1128%2FmBio.00521-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, O. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardo, C. A.</span></span> <span> </span><span class="NLM_article-title">Acute flaccid myelitis: a clinical review</span>. <i>Semin. Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">211</span>â <span class="NLM_lpage">218</span>, <span class="refDoi">Â DOI: 10.1055/s-0040-1705123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1055%2Fs-0040-1705123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32143233" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB383gsFGrug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=211-218&author=O.+C.+Murphyauthor=C.+A.+Pardo&title=Acute+flaccid+myelitis%3A+a+clinical+review&doi=10.1055%2Fs-0040-1705123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Acute Flaccid Myelitis: A Clinical Review</span></div><div class="casAuthors">Murphy Olwen C; Pardo Carlos A</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in neurology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">211-218</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Acute flaccid myelitis (AFM) is an emerging disorder primarily affecting children that is characterized by acute flaccid paralysis accompanied by abnormalities of the spinal cord gray matter on magnetic resonance imaging.  In most cases, prodromal fever or respiratory symptoms occur, followed by acute-onset flaccid limb weakness.  Respiratory, axial, bulbar, facial, and extraocular muscles may also be affected.  The clinical manifestations have been described as "polio-like," due to striking similarities to cases of poliomyelitis.  The primary site of injury in AFM is the anterior horn cells of the spinal cord, resulting in a motor neuronopathy.  Seasonal peaks of cases have occurred in the United States every 2 years since 2012.  However, AFM remains a rare disease, which can make it challenging for physicians to recognize and differentiate from other causes of acute flaccid paralysis such as Guillain-Barre syndrome, spinal cord stroke, and transverse myelitis.  Epidemiological evidence suggests that AFM is linked to a viral etiology, with nonpolio enteroviruses (in particular enterovirus D68) demonstrating a plausible association.  The epidemiology, possible etiological factors, clinical features, differential diagnosis, treatment, and outcomes of AFM are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQC5wz-kW0l2w8IxFYvehhofW6udTcc2ebmkSIfdm4TKbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383gsFGrug%253D%253D&md5=6caf25d70171c1faa39c4d831c0e2c18</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1055%2Fs-0040-1705123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0040-1705123%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DO.%2BC.%26aulast%3DPardo%26aufirst%3DC.%2BA.%26atitle%3DAcute%2520flaccid%2520myelitis%253A%2520a%2520clinical%2520review%26jtitle%3DSemin.%2520Neurol.%26date%3D2020%26volume%3D40%26spage%3D211%26epage%3D218%26doi%3D10.1055%2Fs-0040-1705123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stelzer-Braid, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chughtai, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacIntyre, C. R.</span></span> <span> </span><span class="NLM_article-title">The association between acute flaccid myelitis (AFM) and Enterovirus D68 (EV-D68) - what is the evidence for causation?</span>. <i>Eurosurveillance</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">16</span>â <span class="NLM_lpage">24</span>, <span class="refDoi">Â DOI: 10.2807/1560-7917.ES.2018.23.3.17-00310</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.2807%2F1560-7917.ES.2018.23.3.17-00310" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=16-24&author=A.+Dydaauthor=S.+Stelzer-Braidauthor=D.+Adamauthor=A.+A.+Chughtaiauthor=C.+R.+MacIntyre&title=The+association+between+acute+flaccid+myelitis+%28AFM%29+and+Enterovirus+D68+%28EV-D68%29+-+what+is+the+evidence+for+causation%3F&doi=10.2807%2F1560-7917.ES.2018.23.3.17-00310"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.2807%2F1560-7917.ES.2018.23.3.17-00310&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2807%252F1560-7917.ES.2018.23.3.17-00310%26sid%3Dliteratum%253Aachs%26aulast%3DDyda%26aufirst%3DA.%26aulast%3DStelzer-Braid%26aufirst%3DS.%26aulast%3DAdam%26aufirst%3DD.%26aulast%3DChughtai%26aufirst%3DA.%2BA.%26aulast%3DMacIntyre%26aufirst%3DC.%2BR.%26atitle%3DThe%2520association%2520between%2520acute%2520flaccid%2520myelitis%2520%2528AFM%2529%2520and%2520Enterovirus%2520D68%2520%2528EV-D68%2529%2520-%2520what%2520is%2520the%2520evidence%2520for%2520causation%253F%26jtitle%3DEurosurveillance%26date%3D2018%26volume%3D23%26spage%3D16%26epage%3D24%26doi%3D10.2807%2F1560-7917.ES.2018.23.3.17-00310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frost, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rudy, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span> <span> </span><span class="NLM_article-title">Understanding Enterovirus D68-induced neurologic disease: a basic science review</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">821</span>, <span class="refDoi">Â DOI: 10.3390/v11090821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3390%2Fv11090821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXmsFyns7k%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2019&pages=821&author=A.+M.+Hixonauthor=J.+Frostauthor=M.+J.+Rudyauthor=K.+Messacarauthor=P.+Clarkeauthor=K.+L.+Tyler&title=Understanding+Enterovirus+D68-induced+neurologic+disease%3A+a+basic+science+review&doi=10.3390%2Fv11090821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding enterovirus D68-induced neurologic disease: a basic science review</span></div><div class="casAuthors">Hixon, Alison M.; Frost, Joshua; Rudy, Michael J.; Messacar, Kevin; Clarke, Penny; Tyler, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">821</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  In 2014, the United States (US) experienced an unprecedented epidemic of enterovirus D68 (EV-D68)-induced respiratory disease that was temporally assocd. with the emergence of acute flaccid myelitis (AFM), a paralytic disease occurring predominantly in children, that has a striking resemblance to poliomyelitis.  Although a definitive causal link between EV-D68 infection and AFM has not been unequivocally established, rapidly accumulating clin., immunol., and epidemiol. evidence points to EV-D68 as the major causative agent of recent seasonal childhood AFM outbreaks in the US.  This review summarizes evidence, gained from in vivo and in vitro models of EV-D68-induced disease, which demonstrates that contemporary EV-D68 strains isolated during and since the 2014 outbreak differ from historical EV-D68 in several factors influencing neurovirulence, including their genomic sequence, their receptor utilization, their ability to infect neurons, and their neuropathogenicity in mice.  These findings provide biol. plausibility that EV-D68 is a causal agent of AFM and provide important exptl. models for studies of pathogenesis and treatment that are likely to be difficult or impossible in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKGYAUEAzIILVg90H21EOLACvtfcHk0lheepk5mlAOZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXmsFyns7k%253D&md5=67b6406db8c6d1bda5862556e9273061</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.3390%2Fv11090821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv11090821%26sid%3Dliteratum%253Aachs%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DFrost%26aufirst%3DJ.%26aulast%3DRudy%26aufirst%3DM.%2BJ.%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DClarke%26aufirst%3DP.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26atitle%3DUnderstanding%2520Enterovirus%2520D68-induced%2520neurologic%2520disease%253A%2520a%2520basic%2520science%2520review%26jtitle%3DViruses%26date%3D2019%26volume%3D11%26spage%3D821%26doi%3D10.3390%2Fv11090821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Messacar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sillau, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otten, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson-Murphy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santoro, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treister, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bains, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zabrocki, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glanternik, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makhani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBiasi, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruer, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tremoulet, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Haren, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benson, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gorman, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abzug, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, S. R.</span></span> <span> </span><span class="NLM_article-title">Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">e2118</span>â <span class="NLM_lpage">e2126</span>, <span class="refDoi">Â DOI: 10.1212/WNL.0000000000006670</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1212%2FWNL.0000000000006670" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30413631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXotl2nurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2019&pages=e2118-e2126&author=K.+Messacarauthor=S.+Sillauauthor=S.+E.+Hopkinsauthor=C.+Ottenauthor=M.+Wilson-Murphyauthor=B.+Wongauthor=J.+D.+Santoroauthor=A.+Treisterauthor=H.+K.+Bainsauthor=A.+Torresauthor=L.+Zabrockiauthor=J.+R.+Glanternikauthor=A.+L.+Hurstauthor=J.+A.+Martinauthor=T.+Schreinerauthor=N.+Makhaniauthor=R.+L.+DeBiasiauthor=M.+C.+Kruerauthor=A.+H.+Tremouletauthor=K.+Van+Harenauthor=J.+Desaiauthor=L.+A.+Bensonauthor=M.+P.+Gormanauthor=M.+J.+Abzugauthor=K.+L.+Tylerauthor=S.+R.+Dominguez&title=Safety%2C+tolerability%2C+and+efficacy+of+fluoxetine+as+an+antiviral+for+acute+flaccid+myelitis&doi=10.1212%2FWNL.0000000000006670"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety, tolerability, and efficacy of fluoxetine as an antiviral for acute flaccid myelitis</span></div><div class="casAuthors">Messacar, Kevin; Sillau, Stefan; Hopkins, Sarah E.; Otten, Catherine; Wilson-Murphy, Molly; Wong, Brian; Santoro, Jonathan D.; Treister, Andrew; Bains, Harlori K.; Torres, Alcy; Zabrocki, Luke; Glanternik, Julia R.; Hurst, Amanda L.; Martin, Jan A.; Schreiner, Teri; Makhani, Naila; DeBiasi, Roberta L.; Kruer, Michael C.; Tremoulet, Adriana H.; Van Haren, Keith; Desai, Jay; Benson, Leslie A.; Gorman, Mark P.; Abzug, Mark J.; Tyler, Kenneth L.; Dominguez, Samuel R.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">e2118-e2126</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To det. the safety, tolerability, and efficacy of fluoxetine for proven or presumptive enterovirus (EV) D68-assocd. acute flaccid myelitis (AFM).  Methods: A multicenter cohort study of US patients with AFM in 2015-2016 compared serious adverse events (SAEs), adverse effects, and outcomes between fluoxetine-treated patients and untreated controls.  Fluoxetine was administered at the discretion of treating providers with data gathered retrospectively.  The primary outcome was change in summative limb strength score (SLSS; sum of Medical Research Council strength in all 4 limbs, ranging from 20 [normal strength] to 0 [complete quadriparesis]) between initial examn. and latest follow-up, with increased SLSS reflecting improvement and decreased SLSS reflecting worsened strength.  Results: Fifty-six patients with AFM from 12 centers met study criteria.  Among 30 patients exposed to fluoxetine, no SAEs were reported and adverse effect rates were similar to unexposed patients (47% vs 65%, p = 0.16).  The 28 patients treated with >1 dose of fluoxetine were more likely to have EV-D68 identified (57.1% vs 14.3%, p < 0.001).  Their SLSS was similar at initial examn. (mean SLSS 12.9 vs 14.3, p = 0.31) but lower at nadir (mean SLSS 9.25 vs 12.82, p = 0.02) and latest follow-up (mean SLSS 12.5 vs 16.4, p = 0.005) compared with the 28 patients receiving 1 (n = 2) or no (n = 26) doses.  In propensity-adjusted anal., SLSS from initial examn. to latest follow-up decreased by 0.2 (95% confidence interval [CI] -1.8 to +1.4) in fluoxetine-treated patients and increased by 2.5 (95% CI +0.7 to +4.4) in untreated patients (p = 0.015).  Conclusion: Fluoxetine was well-tolerated.  Fluoxetine was preferentially given to patients with AFM with EV-D68 identified and more severe paralysis at nadir, who ultimately had poorer long-term outcomes.  Classification of evidence: This study provides Class IV evidence that for patients with EV-D68-assocd. AFM, fluoxetine is well-tolerated and not assocd. with improved neurol. outcomes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVU-9evGdhCbVg90H21EOLACvtfcHk0lheepk5mlAOZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXotl2nurw%253D&md5=da84cefe43784d5ca8f7cf80eb756597</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000006670&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000006670%26sid%3Dliteratum%253Aachs%26aulast%3DMessacar%26aufirst%3DK.%26aulast%3DSillau%26aufirst%3DS.%26aulast%3DHopkins%26aufirst%3DS.%2BE.%26aulast%3DOtten%26aufirst%3DC.%26aulast%3DWilson-Murphy%26aufirst%3DM.%26aulast%3DWong%26aufirst%3DB.%26aulast%3DSantoro%26aufirst%3DJ.%2BD.%26aulast%3DTreister%26aufirst%3DA.%26aulast%3DBains%26aufirst%3DH.%2BK.%26aulast%3DTorres%26aufirst%3DA.%26aulast%3DZabrocki%26aufirst%3DL.%26aulast%3DGlanternik%26aufirst%3DJ.%2BR.%26aulast%3DHurst%26aufirst%3DA.%2BL.%26aulast%3DMartin%26aufirst%3DJ.%2BA.%26aulast%3DSchreiner%26aufirst%3DT.%26aulast%3DMakhani%26aufirst%3DN.%26aulast%3DDeBiasi%26aufirst%3DR.%2BL.%26aulast%3DKruer%26aufirst%3DM.%2BC.%26aulast%3DTremoulet%26aufirst%3DA.%2BH.%26aulast%3DVan%2BHaren%26aufirst%3DK.%26aulast%3DDesai%26aufirst%3DJ.%26aulast%3DBenson%26aufirst%3DL.%2BA.%26aulast%3DGorman%26aufirst%3DM.%2BP.%26aulast%3DAbzug%26aufirst%3DM.%2BJ.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26aulast%3DDominguez%26aufirst%3DS.%2BR.%26atitle%3DSafety%252C%2520tolerability%252C%2520and%2520efficacy%2520of%2520fluoxetine%2520as%2520an%2520antiviral%2520for%2520acute%2520flaccid%2520myelitis%26jtitle%3DNeurology%26date%3D2019%26volume%3D92%26spage%3De2118%26epage%3De2126%26doi%3D10.1212%2FWNL.0000000000006670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span> <span> </span><span class="NLM_article-title">Evaluating treatment efficacy in a mouse model of Enterovirus D68-associated paralytic myelitis</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>216</i></span>,  <span class="NLM_fpage">1245</span>â <span class="NLM_lpage">1253</span>, <span class="refDoi">Â DOI: 10.1093/infdis/jix468</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1093%2Finfdis%2Fjix468" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28968718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVCns77E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=216&publication_year=2017&pages=1245-1253&author=A.+M.+Hixonauthor=P.+Clarkeauthor=K.+L.+Tyler&title=Evaluating+treatment+efficacy+in+a+mouse+model+of+Enterovirus+D68-associated+paralytic+myelitis&doi=10.1093%2Finfdis%2Fjix468"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluating treatment efficacy in a mouse model of enterovirus D68-associated paralytic myelitis</span></div><div class="casAuthors">Hixon, Alison M.; Clarke, Penny; Tyler, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">216</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1245-1253</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">1537-6613</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Enterovirus D68 (EV-D68)-assocd. acute flaccid myelitis (AFM) is a devastating neurol. disease for which there are no treatments of proven efficacy.  The unpredictable temporal and geog. distribution of cases and the rarity of the disease make it unlikely that data from randomized controlled trials will be available to guide therapeutic decisions.  Methods: We evaluated the following 3 widely used empirical therapies for the ability to reduce the severity of paralysis in a mouse model of EV-D68 infection: (1) human i.v. Ig (hIVIG), (2) fluoxetine, and (3) dexamethasone.  Neonatal mice were injected i.m. with a human 2014 EV-D68 isolate that reliably induces paralysis in mice due to infection and loss of spinal cord motor neurons.  Mice receiving treatments were evaluated for motor impairment, mortality, and spinal cord viral load.  Results: hIVIG, which contained neutralizing antibodies to EV-D68, reduced paralysis in infected mice and decreased spinal cord viral loads.  Fluoxetine had no effect on motor impairment or viral loads.  Dexamethasone treatment worsened motor impairment, increased mortality, and increased viral loads.  Conclusion: Results in this model of EV-D68-assocd. AFM provide a rational basis for selecting empirical therapy in humans and establish this model as a useful system for evaluating other potential therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra9AAZ8yniwrVg90H21EOLACvtfcHk0lheepk5mlAOZA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVCns77E&md5=2054e3b6e6db2d57f6d2d6e5dddf3bf5</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2Fjix468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252Fjix468%26sid%3Dliteratum%253Aachs%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DClarke%26aufirst%3DP.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26atitle%3DEvaluating%2520treatment%2520efficacy%2520in%2520a%2520mouse%2520model%2520of%2520Enterovirus%2520D68-associated%2520paralytic%2520myelitis%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2017%26volume%3D216%26spage%3D1245%26epage%3D1253%26doi%3D10.1093%2Finfdis%2Fjix468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hixon, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leser, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clarke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, K. L.</span></span> <span> </span><span class="NLM_article-title">A mouse model of paralytic myelitis caused by enterovirus D68</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e1006199</span> <span class="refDoi">Â DOI: 10.1371/journal.ppat.1006199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1371%2Fjournal.ppat.1006199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28231269" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVCqt7rN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&author=A.+M.+Hixonauthor=G.+Yuauthor=J.+S.+Leserauthor=S.+Yagiauthor=P.+Clarkeauthor=C.+Y.+Chiuauthor=K.+L.+Tyler&title=A+mouse+model+of+paralytic+myelitis+caused+by+enterovirus+D68&doi=10.1371%2Fjournal.ppat.1006199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">A mouse model of paralytic myelitis caused by enterovirus D68</span></div><div class="casAuthors">Hixon, Alison M.; Yu, Guixia; Leser, J. Smith; Yagi, Shigeo; Clarke, Penny; Chiu, Charles Y.; Tyler, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">e1006199/1-e1006199/19</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">In 2014, the United States experienced an epidemic of acute flaccid myelitis (AFM) cases in children coincident with a nationwide outbreak of enterovirus D68 (EV-D68) respiratory disease.  Up to half of the 2014 AFM patients had EV-D68 RNA detected by RT-PCR in their respiratory secretions, although EV-D68 was only detected in cerebrospinal fluid (CSF) from one 2014 AFM patient.  Given previously described mol. and epidemiol. assocns. between EV-D68 and AFM, we sought to develop an animal model by screening seven EV-D68 strains for the ability to induce neurol. disease in neonatal mice.  We found that four EV-D68 strains from the 2014 outbreak (out of five tested) produced a paralytic disease in mice resembling human AFM.  The remaining 2014 strain, as well as 1962 prototype EV-D68 strains Fermon and Rhyne, did not produce, or rarely produced, paralysis in mice.  In-depth examn. of the paralysis caused by a representative 2014 strain, MO/14-18947, revealed infectious virus, virion particles, and viral genome in the spinal cords of paralyzed mice.  Paralysis was elicited in mice following i.m., intracerebral, i.p., and intranasal infection, in descending frequency, and was assocd. with infection and loss of motor neurons in the anterior horns of spinal cord segments corresponding to paralyzed limbs.  Virus isolated from spinal cords of infected mice transmitted disease when injected into na.ovrddot.ive mice, fulfilling Koch's postulates in this model.  Finally, we found that EV-D68 immune sera, but not normal mouse sera, protected mice from development of paralysis and death when administered prior to viral challenge.  These studies establish an exptl. model to study EV-D68-induced myelitis and to better understand disease pathogenesis and develop potential therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRh2FIm7qn57Vg90H21EOLACvtfcHk0lgaRtTMm76HdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVCqt7rN&md5=8dcf3e95605c07327d3d2391c19b1e5e</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1006199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1006199%26sid%3Dliteratum%253Aachs%26aulast%3DHixon%26aufirst%3DA.%2BM.%26aulast%3DYu%26aufirst%3DG.%26aulast%3DLeser%26aufirst%3DJ.%2BS.%26aulast%3DYagi%26aufirst%3DS.%26aulast%3DClarke%26aufirst%3DP.%26aulast%3DChiu%26aufirst%3DC.%2BY.%26aulast%3DTyler%26aufirst%3DK.%2BL.%26atitle%3DA%2520mouse%2520model%2520of%2520paralytic%2520myelitis%2520caused%2520by%2520enterovirus%2520D68%26jtitle%3DPLoS%2520Pathog.%26date%3D2017%26volume%3D13%26doi%3D10.1371%2Fjournal.ppat.1006199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smee, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wettere, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, E. B.</span></span> <span> </span><span class="NLM_article-title">Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>526</i></span>,  <span class="NLM_fpage">146</span>â <span class="NLM_lpage">154</span>, <span class="refDoi">Â DOI: 10.1016/j.virol.2018.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.virol.2018.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30390563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVKhsbvN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=526&publication_year=2019&pages=146-154&author=B.+L.+Hurstauthor=W.+J.+Evansauthor=D.+F.+Smeeauthor=A.+J.+Van+Wettereauthor=E.+B.+Tarbet&title=Evaluation+of+antiviral+therapies+in+respiratory+and+neurological+disease+models+of+Enterovirus+D68+infection+in+mice&doi=10.1016%2Fj.virol.2018.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of antiviral therapies in respiratory and neurological disease models of Enterovirus D68 infection in mice</span></div><div class="casAuthors">Hurst, Brett L.; Evans, W. Joseph; Smee, Donald F.; Van Wettere, Arnaud J.; Tarbet, E. Bart</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">526</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is unique among enteroviruses because of the ability to cause severe respiratory disease as well as neurol. disease.  We developed sep. models of respiratory and neurol. disease following EV-D68 infection in AG129 mice that respond to antiviral treatment with guanidine.  In four-week-old mice infected intranasally, EV-D68 replicates to high titers in lung tissue increasing the proinflammatory cytokines MCP-1 and IL-6.  The respiratory infection also produces an acute viremia.  In 10-day-old mice infected i.p., EV-D68 causes a neurol. disease with wt.-loss, paralysis, and mortality.  In our respiratory model, treatment with guanidine provides a two-log redn. in lung virus titers, reduces MCP-1 and IL-6, and prevents histol. lesions in the lungs.  Importantly, viremia is prevented by early treatment with guanidine.  In our neurol. model, guanidine treatment protects mice from wt.-loss, paralysis, and mortality.  These results demonstrate the utility of these models for evaluation of antiviral therapies for EV-D68 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4et8VSBidu7Vg90H21EOLACvtfcHk0lgaRtTMm76HdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVKhsbvN&md5=f09f152f64145da8ab3eed72c93fd304</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2018.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2018.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DHurst%26aufirst%3DB.%2BL.%26aulast%3DEvans%26aufirst%3DW.%2BJ.%26aulast%3DSmee%26aufirst%3DD.%2BF.%26aulast%3DVan%2BWettere%26aufirst%3DA.%2BJ.%26aulast%3DTarbet%26aufirst%3DE.%2BB.%26atitle%3DEvaluation%2520of%2520antiviral%2520therapies%2520in%2520respiratory%2520and%2520neurological%2520disease%2520models%2520of%2520Enterovirus%2520D68%2520infection%2520in%2520mice%26jtitle%3DVirology%26date%3D2019%26volume%3D526%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.virol.2018.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morrey, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukor, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siddharthan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Wettere, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinex, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, E. B.</span></span> <span> </span><span class="NLM_article-title">Causation of acute flaccid paralysis by myelitis and myositis in Enterovirus-D68 infected mice deficient in interferon alphabeta/gamma receptor deficient mice</span>. <i>Viruses</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">33</span>, <span class="refDoi">Â DOI: 10.3390/v10010033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3390%2Fv10010033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitFyqu7vF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=33&author=J.+D.+Morreyauthor=H.+Wangauthor=B.+L.+Hurstauthor=K.+Zukorauthor=V.+Siddharthanauthor=A.+J.+Van+Wettereauthor=D.+G.+Sinexauthor=E.+B.+Tarbet&title=Causation+of+acute+flaccid+paralysis+by+myelitis+and+myositis+in+Enterovirus-D68+infected+mice+deficient+in+interferon+alphabeta%2Fgamma+receptor+deficient+mice&doi=10.3390%2Fv10010033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Causation of acute flaccid paralysis by myelitis and myositis in enterovirus-D68 infected mice deficient in interferon Î±Î²/Î³ receptor deficient mice</span></div><div class="casAuthors">Morrey, John D.; Wang, Hong; Hurst, Brett L.; Zukor, Katherine; Siddharthan, Venkatraman; Van Wettere, Arnaud J.; Sinex, Donal G.; Tarbe, E. Bart</div><div class="citationInfo"><span class="NLM_cas:title">Viruses</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">33/1-33/22</span>CODEN:
                <span class="NLM_cas:coden">VIRUBR</span>;
        ISSN:<span class="NLM_cas:issn">1999-4915</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) caused a large outbreak in the summer and fall of 2014 in the United States.  It causes serious respiratory disease, but causation of assocd. paralysis is controversial, because the virus is not routinely identified in cerebrospinal fluid.  To establish clin. correlates with human disease, we evaluated EV-D68 infection in non-lethal paralysis mouse models.  Ten-day-old mice lacking interferon responses were injected i.p. with the virus.  Paralysis developed in hindlimbs.  After six weeks of paralysis, the motor neurons were depleted due to viral infection.  Hindlimb muscles were also infected and degenerating.  Even at the earliest stage of paralysis, muscles were still infected and were degenerating, in addn. to presence of virus in the spinal cord.  To model natural respiratory infection, five-day-old mice were infected intranasally with EV-D68.  Two of the four infected mice developed forelimb paralysis.  The affected limbs had muscle disease, but no spinal cord infection was detected.  The unique contributions of this study are that EV-D68 causes paralysis in mice, and that causation by muscle disease, with or without spinal cord disease, may help to resolve the controversy that the virus can cause paralysis, even if it cannot be identified in cerebrospinal fluid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDWdgwkwmw-7Vg90H21EOLACvtfcHk0lgaRtTMm76HdQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitFyqu7vF&md5=17a9f9c85eefe5d1975b3f04e9dc135b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.3390%2Fv10010033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fv10010033%26sid%3Dliteratum%253Aachs%26aulast%3DMorrey%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DHurst%26aufirst%3DB.%2BL.%26aulast%3DZukor%26aufirst%3DK.%26aulast%3DSiddharthan%26aufirst%3DV.%26aulast%3DVan%2BWettere%26aufirst%3DA.%2BJ.%26aulast%3DSinex%26aufirst%3DD.%2BG.%26aulast%3DTarbet%26aufirst%3DE.%2BB.%26atitle%3DCausation%2520of%2520acute%2520flaccid%2520paralysis%2520by%2520myelitis%2520and%2520myositis%2520in%2520Enterovirus-D68%2520infected%2520mice%2520deficient%2520in%2520interferon%2520alphabeta%252Fgamma%2520receptor%2520deficient%2520mice%26jtitle%3DViruses%26date%3D2018%26volume%3D10%26spage%3D33%26doi%3D10.3390%2Fv10010033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bowers, J. R.</span>; <span class="NLM_string-name">Valentine, M.</span>; <span class="NLM_string-name">Harrison, V.</span>; <span class="NLM_string-name">Fofanov, V. Y.</span>; <span class="NLM_string-name">Gillece, J.</span>; <span class="NLM_string-name">Delisle, J.</span>; <span class="NLM_string-name">Patton, B.</span>; <span class="NLM_string-name">Schupp, J.</span>; <span class="NLM_string-name">Sheridan, K.</span>; <span class="NLM_string-name">Lemmer, D.</span>; <span class="NLM_string-name">Ostdiek, S.</span>; <span class="NLM_string-name">Bains, H. K.</span>; <span class="NLM_string-name">Heim, J.</span>; <span class="NLM_string-name">Sylvester, T.</span>; <span class="NLM_string-name">Prasai, S.</span>; <span class="NLM_string-name">Kretschmer, M.</span>; <span class="NLM_string-name">Fowle, N.</span>; <span class="NLM_string-name">Komatsu, K.</span>; <span class="NLM_string-name">Brady, S.</span>; <span class="NLM_string-name">Robinson, S.</span>; <span class="NLM_string-name">Fitzpatrick, K.</span>; <span class="NLM_string-name">Ostovar, G. A.</span>; <span class="NLM_string-name">Alsop, E.</span>; <span class="NLM_string-name">Hutchins, E.</span>; <span class="NLM_string-name">Jensen, K.</span>; <span class="NLM_string-name">Keim, P.</span>; <span class="NLM_string-name">Engelthaler, D. M.</span></span><span> </span><span class="NLM_article-title">Genomic analyses of acute flaccid myelitis cases among a cluster in Arizona provide further evidence of Enterovirus D68 role</span> <i>mBio</i><span class="NLM_year">2019</span> <span class="NLM_volume">10</span><span class="refDoi">Â DOI: 10.1128/mBio.02262-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.02262-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30670612" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=J.+R.+Bowers&author=M.+Valentine&author=V.+Harrison&author=V.+Y.+Fofanov&author=J.+Gillece&author=J.+Delisle&author=B.+Patton&author=J.+Schupp&author=K.+Sheridan&author=D.+Lemmer&author=S.+Ostdiek&author=H.+K.+Bains&author=J.+Heim&author=T.+Sylvester&author=S.+Prasai&author=M.+Kretschmer&author=N.+Fowle&author=K.+Komatsu&author=S.+Brady&author=S.+Robinson&author=K.+Fitzpatrick&author=G.+A.+Ostovar&author=E.+Alsop&author=E.+Hutchins&author=K.+Jensen&author=P.+Keim&author=D.+M.+Engelthaler&title=Genomic+analyses+of+acute+flaccid+myelitis+cases+among+a+cluster+in+Arizona+provide+further+evidence+of+Enterovirus+D68+role"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1128%2FmBio.02262-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.02262-18%26sid%3Dliteratum%253Aachs%26aulast%3DBowers%26aufirst%3DJ.%2BR.%26atitle%3DGenomic%2520analyses%2520of%2520acute%2520flaccid%2520myelitis%2520cases%2520among%2520a%2520cluster%2520in%2520Arizona%2520provide%2520further%2520evidence%2520of%2520Enterovirus%2520D68%2520role%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26doi%3D10.1128%2FmBio.02262-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mishra, N.</span>; <span class="NLM_string-name">Ng, T. F. F.</span>; <span class="NLM_string-name">Marine, R. L.</span>; <span class="NLM_string-name">Jain, K.</span>; <span class="NLM_string-name">Ng, J.</span>; <span class="NLM_string-name">Thakkar, R.</span>; <span class="NLM_string-name">Caciula, A.</span>; <span class="NLM_string-name">Price, A.</span>; <span class="NLM_string-name">Garcia, J. A.</span>; <span class="NLM_string-name">Burns, J. C.</span>; <span class="NLM_string-name">Thakur, K. T.</span>; <span class="NLM_string-name">Hetzler, K. L.</span>; <span class="NLM_string-name">Routh, J. A.</span>; <span class="NLM_string-name">Konopka-Anstadt, J. L.</span>; <span class="NLM_string-name">Nix, W. A.</span>; <span class="NLM_string-name">Tokarz, R.</span>; <span class="NLM_string-name">Briese, T.</span>; <span class="NLM_string-name">Oberste, M. S.</span>; <span class="NLM_string-name">Lipkin, W. I.</span></span><span> </span><span class="NLM_article-title">Antibodies to enteroviruses in cerebrospinal fluid of patients with acute flaccid myelitis</span> <i>mBio</i><span class="NLM_year">2019</span> <span class="NLM_volume">10</span><span class="refDoi">Â DOI: 10.1128/mBio.01903-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FmBio.01903-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=31409689" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=N.+Mishra&author=T.+F.+F.+Ng&author=R.+L.+Marine&author=K.+Jain&author=J.+Ng&author=R.+Thakkar&author=A.+Caciula&author=A.+Price&author=J.+A.+Garcia&author=J.+C.+Burns&author=K.+T.+Thakur&author=K.+L.+Hetzler&author=J.+A.+Routh&author=J.+L.+Konopka-Anstadt&author=W.+A.+Nix&author=R.+Tokarz&author=T.+Briese&author=M.+S.+Oberste&author=W.+I.+Lipkin&title=Antibodies+to+enteroviruses+in+cerebrospinal+fluid+of+patients+with+acute+flaccid+myelitis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1128%2FmBio.01903-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FmBio.01903-19%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DN.%26atitle%3DAntibodies%2520to%2520enteroviruses%2520in%2520cerebrospinal%2520fluid%2520of%2520patients%2520with%2520acute%2520flaccid%2520myelitis%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26doi%3D10.1128%2FmBio.01903-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tee, H. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zainol, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sam, I. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, Y. F.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis</span>. <i>Expert Rev. Anti-Infect. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">1</span>â <span class="NLM_lpage">15</span>, <span class="refDoi">Â DOI: 10.1080/14787210.2021.1851194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1080%2F14787210.2021.1851194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33183118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB3s3ktVyisw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=1-15&author=H.+K.+Teeauthor=M.+I.+Zainolauthor=I.+C.+Samauthor=Y.+F.+Chan&title=Recent+advances+in+the+understanding+of+enterovirus+A71+infection%3A+a+focus+on+neuropathogenesis&doi=10.1080%2F14787210.2021.1851194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis</span></div><div class="casAuthors">Tee Han Kang; Zainol Mohd Izwan; Sam I-Ching; Chan Yoke Fun</div><div class="citationInfo"><span class="NLM_cas:title">Expert review of anti-infective therapy</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Introduction: Hand, foot, and mouth disease caused by enterovirus A71 (EV-A71) is more frequently associated with neurological complications and deaths compared to other enteroviruses.Areas covered: The authors discuss current understanding of the neuropathogenesis of EV-A71 based on various clinical, human, and animal model studies.  The authors discuss the important advancements in virus entry, virus dissemination, and neuroinvasion.  The authors highlight the role of host immune system, host genetic factors, viral quasispecies, and heparan sulfate in EV-A71 neuropathogenesis.Expert opinion: Comparison of EV-A71 with EV-D68 and PV shows similarity in primary target sites and dissemination to the central nervous system.  More research is needed to understand cellular tropisms, persistence of EV-A71, and other possible invasion routes.  EV-A71 infection has varied clinical manifestations which may be attributed to multiple receptors usage.  Future development of antivirals and vaccines should target neurotropic enteroviruses.  Repurposing drug and immunomodulators used in combination could reduce the severity of EV-A71 infection.  Only a few drugs have been tested in clinical trials, and in the absence of antiviral and vaccines (except China), active virus surveillance, good hand hygiene, and physical distancing should be advocated.  A better understanding of EV-A71 neuropathogenesis is critical for antiviral and multivalent vaccines development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSOZ2YfmFbyocK3uFsUIZtkfW6udTcc2eajor9EgSlAFLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3s3ktVyisw%253D%253D&md5=6a732bff15e1c4d119daacfd9119dfa3</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1080%2F14787210.2021.1851194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14787210.2021.1851194%26sid%3Dliteratum%253Aachs%26aulast%3DTee%26aufirst%3DH.%2BK.%26aulast%3DZainol%26aufirst%3DM.%2BI.%26aulast%3DSam%26aufirst%3DI.%2BC.%26aulast%3DChan%26aufirst%3DY.%2BF.%26atitle%3DRecent%2520advances%2520in%2520the%2520understanding%2520of%2520enterovirus%2520A71%2520infection%253A%2520a%2520focus%2520on%2520neuropathogenesis%26jtitle%3DExpert%2520Rev.%2520Anti-Infect.%2520Ther.%26date%3D2021%26spage%3D1%26epage%3D15%26doi%3D10.1080%2F14787210.2021.1851194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Uprety, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graf, E. H.</span></span> <span> </span><span class="NLM_article-title">Enterovirus infection and acute flaccid myelitis</span>. <i>Curr. Opin. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">55</span>â <span class="NLM_lpage">60</span>, <span class="refDoi">Â DOI: 10.1016/j.coviro.2020.06.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.coviro.2020.06.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32711392" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtl2isr7F" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2020&pages=55-60&author=P.+Upretyauthor=E.+H.+Graf&title=Enterovirus+infection+and+acute+flaccid+myelitis&doi=10.1016%2Fj.coviro.2020.06.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Enterovirus infection and acute flaccid myelitis</span></div><div class="casAuthors">Uprety, Priyanka; Graf, Erin H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Virology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">55-60</span>CODEN:
                <span class="NLM_cas:coden">COVUAF</span>;
        ISSN:<span class="NLM_cas:issn">1879-6257</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Recent outbreaks of limb paralysis similar to poliomyelitis, termed acute flaccid myelitis (AFM), have prompted intense investigation into potential etiol.  Peaks of AFM were seen in the United States in 2012, 2014, 2016 and 2018, coincident with peaks in enterovirus transmission, particularly EV-D68.  Similar peaks of AFM and EV-D68 circulation were reported in other parts of the world.  The causal relationship between EV-D68 is still not widely accepted as it is for poliovirus and EV-A71, the latter of which is endemic in the US.  Recent in vitro and mouse model data as well as enhanced-sensitivity diagnostic assays have provided further evidence linking the causal relationship between EV-D68 and AFM.  In addn., an outbreak of EV-A71-assocd. AFM was recently described, highlighting the possibility of an addnl. emerging non-polio enterovirus of public health concern.  As AFM is a devastating disease with poor prognosis in many children, particularly those with EV-D68, recent studies call for increased surveillance, pursuit of novel therapeutics and strategies to prevent transmission before the next outbreak.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoq9izuDAisLVg90H21EOLACvtfcHk0lj-zKwxU5e-OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtl2isr7F&md5=77a4cc89ee6701f1ef448aa8b6e095c2</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.coviro.2020.06.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coviro.2020.06.006%26sid%3Dliteratum%253Aachs%26aulast%3DUprety%26aufirst%3DP.%26aulast%3DGraf%26aufirst%3DE.%2BH.%26atitle%3DEnterovirus%2520infection%2520and%2520acute%2520flaccid%2520myelitis%26jtitle%3DCurr.%2520Opin.%2520Virol.%26date%3D2020%26volume%3D40%26spage%3D55%26epage%3D60%26doi%3D10.1016%2Fj.coviro.2020.06.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martino, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sole, M. J.</span></span> <span> </span><span class="NLM_article-title">Viral infection and the pathogenesis of dilated cardiomyopathy</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">182</span>â <span class="NLM_lpage">188</span>, <span class="refDoi">Â DOI: 10.1161/01.RES.74.2.182</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1161%2F01.RES.74.2.182" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=8293557" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADyaK2c7itlCgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1994&pages=182-188&author=T.+A.+Martinoauthor=P.+Liuauthor=M.+J.+Sole&title=Viral+infection+and+the+pathogenesis+of+dilated+cardiomyopathy&doi=10.1161%2F01.RES.74.2.182"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Viral infection and the pathogenesis of dilated cardiomyopathy</span></div><div class="casAuthors">Martino T A; Liu P; Sole M J</div><div class="citationInfo"><span class="NLM_cas:title">Circulation research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">182-8</span>
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    </div><div class="casAbstract">Long-term follow-up studies of patients with suspected viral myocarditis reveal progression to dilated cardiomyopathy (DCM) in a significant number of cases.  Thus, an underlying viral etiology has been hypothesized in the pathogenesis of ongoing heart disease that leads to DCM.  Recent application of molecular biology in clinical diagnosis has strengthened this hypothesis.  By use of probe hybridization and polymerase chain reaction, enteroviral RNA has been detected in the myocardium of patients at all stages of the disease process: myocarditis, chronic heart disease, and DCM.  Experimental murine models of enterovirus-induced heart disease provide a framework for examining the pathogenic mechanisms.  Viral cytotoxicity, immunological responses, viral RNA persistence, and spasm of the coronary microvasculature are all implicated in the ongoing disease process.  Abnormal cardiac function and heart failure are attributed to the pathological changes that occur.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQob0u4krYlR5SWdIdmEou5fW6udTcc2eb1WoT-bbFJArntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c7itlCgtw%253D%253D&md5=b1d6f137ef2b26bad42e34bbef5c8c7b</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1161%2F01.RES.74.2.182&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.74.2.182%26sid%3Dliteratum%253Aachs%26aulast%3DMartino%26aufirst%3DT.%2BA.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DSole%26aufirst%3DM.%2BJ.%26atitle%3DViral%2520infection%2520and%2520the%2520pathogenesis%2520of%2520dilated%2520cardiomyopathy%26jtitle%3DCirc.%2520Res.%26date%3D1994%26volume%3D74%26spage%3D182%26epage%3D188%26doi%3D10.1161%2F01.RES.74.2.182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dunne, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richardson, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkinson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahl-Jorgensen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flodstrom-Tullberg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyoty, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lernmark, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lloyd, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pugliese, A.</span></span> <span> </span><span class="NLM_article-title">Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">744</span>â <span class="NLM_lpage">753</span>, <span class="refDoi">Â DOI: 10.1007/s00125-019-4811-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1007%2Fs00125-019-4811-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30675626" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVyrtrrN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=744-753&author=J.+L.+Dunneauthor=S.+J.+Richardsonauthor=M.+A.+Atkinsonauthor=M.+E.+Craigauthor=K.+Dahl-Jorgensenauthor=M.+Flodstrom-Tullbergauthor=H.+Hyotyauthor=R.+A.+Inselauthor=A.+Lernmarkauthor=R.+E.+Lloydauthor=N.+G.+Morganauthor=A.+Pugliese&title=Rationale+for+enteroviral+vaccination+and+antiviral+therapies+in+human+type+1+diabetes&doi=10.1007%2Fs00125-019-4811-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes</span></div><div class="casAuthors">Dunne, Jessica L.; Richardson, Sarah J.; Atkinson, Mark A.; Craig, Maria E.; Dahl-Joergensen, Knut; Flodstrom-Tullberg, Malin; Hyoty, Heikki; Insel, Richard A.; Lernmark, Ake; Lloyd, Richard E.; Morgan, Noel G.; Pugliese, Alberto</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">744-753</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  In type 1 diabetes, pancreatic beta cells are destroyed by chronic autoimmune responses.  The disease develops in genetically susceptible individuals, but a role for environmental factors has been postulated.  Viral infections have long been considered as candidates for environmental triggers but, given the lack of evidence for an acute, widespread, cytopathic effect in the pancreas in type 1 diabetes or for a closely related temporal assocn. of diabetes onset with such infections, a role for viruses in type 1 diabetes remains unproven.  Moreover, viruses have rarely been isolated from the pancreas of individuals with type 1 diabetes, mainly (but not solely) due to the inaccessibility of the organ.  Here, we review past and recent literature to evaluate the proposals that chronic, recurrent and, possibly, persistent enteroviral infections occur in pancreatic beta cells in type 1 diabetes.  We also explore whether these infections may be sustained by different virus strains over time and whether multiple viral hits can occur during the natural history of type 1 diabetes.  We emphasize that only a minority of beta cells appear to be infected at any given time and that enteroviruses may become replication defective, which could explain why they have been isolated from the pancreas only rarely.  We argue that enteroviral infection of beta cells largely depends on the host innate and adaptive immune responses, including innate responses mounted by beta cells.  Thus, we propose that viruses could play a role in type 1 diabetes on multiple levels, including in the triggering and chronic stimulation of autoimmunity and in the generation of inflammation and the promotion of beta cell dysfunction and stress, each of which might then contribute to autoimmunity, as part of a vicious circle.  We conclude that studies into the effects of vaccinations and/or antiviral drugs (some of which are currently on-going) is the only means by which the role of viruses in type 1 diabetes can be finally proven or disproven.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKWbPvQfYEmLVg90H21EOLACvtfcHk0lj-zKwxU5e-OQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVyrtrrN&md5=d8fd78d649a86f4756410e1ea9a36bda</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1007%2Fs00125-019-4811-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-019-4811-7%26sid%3Dliteratum%253Aachs%26aulast%3DDunne%26aufirst%3DJ.%2BL.%26aulast%3DRichardson%26aufirst%3DS.%2BJ.%26aulast%3DAtkinson%26aufirst%3DM.%2BA.%26aulast%3DCraig%26aufirst%3DM.%2BE.%26aulast%3DDahl-Jorgensen%26aufirst%3DK.%26aulast%3DFlodstrom-Tullberg%26aufirst%3DM.%26aulast%3DHyoty%26aufirst%3DH.%26aulast%3DInsel%26aufirst%3DR.%2BA.%26aulast%3DLernmark%26aufirst%3DA.%26aulast%3DLloyd%26aufirst%3DR.%2BE.%26aulast%3DMorgan%26aufirst%3DN.%2BG.%26aulast%3DPugliese%26aufirst%3DA.%26atitle%3DRationale%2520for%2520enteroviral%2520vaccination%2520and%2520antiviral%2520therapies%2520in%2520human%2520type%25201%2520diabetes%26jtitle%3DDiabetologia%26date%3D2019%26volume%3D62%26spage%3D744%26epage%3D753%26doi%3D10.1007%2Fs00125-019-4811-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xing, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogstad, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationship (SAR) studies of novel pyrazolopyridine derivatives as inhibitors of enterovirus replication</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">1688</span>â <span class="NLM_lpage">1703</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.7b01863</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01863" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1Ggtrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=1688-1703&author=Y.+Xingauthor=J.+Zuoauthor=P.+Krogstadauthor=M.+E.+Jung&title=Synthesis+and+structure-activity+relationship+%28SAR%29+studies+of+novel+pyrazolopyridine+derivatives+as+inhibitors+of+enterovirus+replication&doi=10.1021%2Facs.jmedchem.7b01863"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationship (SAR) Studies of Novel Pyrazolopyridine Derivatives as Inhibitors of Enterovirus Replication</span></div><div class="casAuthors">Xing, Yanpeng; Zuo, Jun; Krogstad, Paul; Jung, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1688-1703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel pyrazolopyridine compds. have been designed and prepd. by a general synthetic route.  Their activities against the replication of poliovirus-1, EV-A71, and CV-B3 enteroviruses were evaluated.  The comprehensive understanding of the structure-activity relationship was obtained by utilizing the variation of four positions, namely, N1, C6, C4, and linker unit.  From the screened analogs, the inhibitors with the highest selectivity indexes at 50% inhibition of viral replication (SI50) were those with iso-Pr at the N1 position and thiophenyl-2-yl unit at C6 position.  Furthermore, the C4 position offered the greatest potential for improvement because many different N-aryl groups had better antiviral activities and compatibilities than the lead compd. JX001 (I).  For example, JX040 (II) with a 2-pyridyl group was the analog with the most potent activity against non-polio enteroviruses, and JX025 (III), possessing a 3-sulfamoylphenyl moiety, had the best activity against polioviruses.  In addn., analog JX037 (IV), possessing a novel pyrazolopyridine heterocycle, was also shown to have good antienteroviral activity, which further enlarges the compd. space for antienteroviral drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYc-19MkthkLVg90H21EOLACvtfcHk0lhCFY9K_B6NDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1Ggtrs%253D&md5=ea86d35167fd2059d6d27d7054b205ca</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01863%26sid%3Dliteratum%253Aachs%26aulast%3DXing%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DJ.%26aulast%3DKrogstad%26aufirst%3DP.%26aulast%3DJung%26aufirst%3DM.%2BE.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%2520novel%2520pyrazolopyridine%2520derivatives%2520as%2520inhibitors%2520of%2520enterovirus%2520replication%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D1688%26epage%3D1703%26doi%3D10.1021%2Facs.jmedchem.7b01863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ulferts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">der Linden, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyoo, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mate, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lichiere, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lelieveld, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omta, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J.</span></span> <span> </span><span class="NLM_article-title">Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2627</span>â <span class="NLM_lpage">2638</span>, <span class="refDoi">Â DOI: 10.1128/AAC.02182-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FAAC.02182-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=26856848" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslWrsrjI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=2627-2638&author=R.+Ulfertsauthor=S.+M.+de+Boerauthor=L.+der+Lindenauthor=L.+Bauerauthor=H.+R.+Lyooauthor=M.+J.+Mateauthor=J.+Lichiereauthor=B.+Canardauthor=D.+Lelieveldauthor=W.+Omtaauthor=D.+Eganauthor=B.+Coutardauthor=F.+J.+van+Kuppeveld&title=Screening+of+a+library+of+FDA-approved+drugs+identifies+several+enterovirus+replication+inhibitors+that+target+viral+protein+2C&doi=10.1128%2FAAC.02182-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Screening of a library of FDA-approved drugs identifies several enterovirus replication inhibitors that target viral protein 2C</span></div><div class="casAuthors">Ulferts, Rachel; deBoer, S. Matthijn; van der Linden, Lonneke; Bauer, Lisa; Lyoo, Hey Rhyoung; Mate, Maria J.; Lichiere, Julie; Canard, Bruno; Lelieveld, Daphne; Omta, Wienand; Egan, David; Coutard, Bruno; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">2627-2638</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Enteroviruses (EVs) represent many important pathogens of humans.  Unfortunately, no antiviral compds. currently exist to treat infections with these viruses.  We screened the Prestwick Chem. Library, a library of approved drugs, for inhibitors of coxsackievirus B3, identified pirlindole as a potent novel inhibitor, and confirmed the inhibitory action of dibucaine, zuclopenthixol, fluoxetine, and formoterol.  Upon testing of viruses of several EV species, we found that dibucaine and pirlindole inhibited EV-B and EV-D and that dibucaine also inhibited EV-A, but none of them inhibited EV-C or rhinoviruses (RVs).  In contrast, formoterol inhibited all enteroviruses and rhinoviruses tested.  All compds. acted through the inhibition of genome replication.  Mutations in the coding sequence of the coxsackievirus B3 (CV-B3) 2C protein conferred resistance to dibucaine, pirlindole, and zuclopenthixol but not formoterol, suggesting that 2C is the target for this set of compds.  Importantly, dibucaine bound to CV-B3 protein 2C in vitro, whereas binding to a 2C protein carrying the resistance mutations was reduced, providing an explanation for how resistance is acquired.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5y2-PUuIIXbVg90H21EOLACvtfcHk0lhCFY9K_B6NDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslWrsrjI&md5=053e85cba8625f57c77918322ea53731</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2FAAC.02182-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02182-15%26sid%3Dliteratum%253Aachs%26aulast%3DUlferts%26aufirst%3DR.%26aulast%3Dde%2BBoer%26aufirst%3DS.%2BM.%26aulast%3Dder%2BLinden%26aufirst%3DL.%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DLyoo%26aufirst%3DH.%2BR.%26aulast%3DMate%26aufirst%3DM.%2BJ.%26aulast%3DLichiere%26aufirst%3DJ.%26aulast%3DCanard%26aufirst%3DB.%26aulast%3DLelieveld%26aufirst%3DD.%26aulast%3DOmta%26aufirst%3DW.%26aulast%3DEgan%26aufirst%3DD.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%26atitle%3DScreening%2520of%2520a%2520library%2520of%2520FDA-approved%2520drugs%2520identifies%2520several%2520enterovirus%2520replication%2520inhibitors%2520that%2520target%2520viral%2520protein%25202C%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D2627%26epage%3D2638%26doi%3D10.1128%2FAAC.02182-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganaro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonsics, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El Kazzi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzo Lopez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ulferts, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Hoey, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mate, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langer, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutard, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J. M.</span></span> <span> </span><span class="NLM_article-title">Fluoxetine inhibits enterovirus replication by targeting the viral 2C protein in a stereospecific manner</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1609</span>â <span class="NLM_lpage">1623</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.9b00179</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00179" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlOmsbrK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1609-1623&author=L.+Bauerauthor=R.+Manganaroauthor=B.+Zonsicsauthor=J.+Stratingauthor=P.+El+Kazziauthor=M.+Lorenzo+Lopezauthor=R.+Ulfertsauthor=C.+van+Hoeyauthor=M.+J.+Mateauthor=T.+Langerauthor=B.+Coutardauthor=A.+Brancaleauthor=F.+J.+M.+van+Kuppeveld&title=Fluoxetine+inhibits+enterovirus+replication+by+targeting+the+viral+2C+protein+in+a+stereospecific+manner&doi=10.1021%2Facsinfecdis.9b00179"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Fluoxetine Inhibits Enterovirus Replication by Targeting the Viral 2C Protein in a Stereospecific Manner</span></div><div class="casAuthors">Bauer, Lisa; Manganaro, Roberto; Zonsics, Birgit; Strating, Jeroen R. P. M.; El Kazzi, Priscila; Lorenzo Lopez, Moira; Ulferts, Rachel; van Hoey, Clara; Mate, Maria J.; Langer, Thierry; Coutard, Bruno; Brancale, Andrea; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1609-1623</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enteroviruses (family Picornaviridae) comprise a large group of human pathogens against which no licensed antiviral therapy exists.  Drug-repurposing screens uncovered the FDA-approved drug fluoxetine as a replication inhibitor of enterovirus B and D species.  Fluoxetine likely targets the nonstructural viral protein 2C, but detailed mode-of-action studies are missing because structural information on 2C of fluoxetine-sensitive enteroviruses is lacking.  We here show that broad-spectrum anti-enteroviral activity of fluoxetine is stereospecific concomitant with binding to recombinant 2C. (S)-Fluoxetine inhibits with a 5-fold lower 50% effective concn. (EC50) than racemic fluoxetine.  Using a homol. model of 2C of the fluoxetine-sensitive enterovirus coxsackievirus B3 (CVB3) based upon a recently elucidated structure of a fluoxetine-insensitive enterovirus, we predicted stable binding of (S)-fluoxetine.  Structure-guided mutations disrupted binding and rendered coxsackievirus B3 (CVB3) resistant to fluoxetine.  The study provides new insights into the anti-enteroviral mode-of-action of fluoxetine.  Importantly, using only (S)-fluoxetine would allow for lower dosing in patients, thereby likely reducing side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdX6ev478njrVg90H21EOLACvtfcHk0lhCFY9K_B6NDA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlOmsbrK&md5=96cbeaf8723b583919a30f04d86b66aa</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00179&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00179%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DManganaro%26aufirst%3DR.%26aulast%3DZonsics%26aufirst%3DB.%26aulast%3DStrating%26aufirst%3DJ.%26aulast%3DEl%2BKazzi%26aufirst%3DP.%26aulast%3DLorenzo%2BLopez%26aufirst%3DM.%26aulast%3DUlferts%26aufirst%3DR.%26aulast%3Dvan%2BHoey%26aufirst%3DC.%26aulast%3DMate%26aufirst%3DM.%2BJ.%26aulast%3DLanger%26aufirst%3DT.%26aulast%3DCoutard%26aufirst%3DB.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%2BM.%26atitle%3DFluoxetine%2520inhibits%2520enterovirus%2520replication%2520by%2520targeting%2520the%2520viral%25202C%2520protein%2520in%2520a%2520stereospecific%2520manner%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1609%26epage%3D1623%26doi%3D10.1021%2Facsinfecdis.9b00179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuohy, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellampalli, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khanna, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinoline analogues as potent antivirals against Enterovirus D68 (EV-D68)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4074</span>â <span class="NLM_lpage">4090</span>, <span class="refDoi">Â DOI: 10.1021/acs.jmedchem.9b00115</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00115" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4074-4090&author=R.+Musharrafiehauthor=J.+Zhangauthor=P.+Tuohyauthor=N.+Kitamuraauthor=S.+S.+Bellampalliauthor=Y.+Huauthor=R.+Khannaauthor=J.+Wang&title=Discovery+of+quinoline+analogues+as+potent+antivirals+against+Enterovirus+D68+%28EV-D68%29&doi=10.1021%2Facs.jmedchem.9b00115"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)</span></div><div class="casAuthors">Musharrafieh, Rami; Zhang, Jiantao; Tuohy, Peter; Kitamura, Naoya; Bellampalli, Shreya Sai; Hu, Yanmei; Khanna, Rajesh; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4074-4090</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is an atypical nonpolio enterovirus that mainly infects the respiratory system of humans, leading to moderate-to-severe respiratory diseases.  In rare cases, EV-D68 can spread to the central nervous system and cause paralysis in infected patients, esp. young children and immunocompromised individuals.  There is currently no approved vaccine or antiviral available for the prevention and treatment of EV-D68.  In this study, we aimed to improve the antiviral potency and selectivity of a previously reported EV-D68 inhibitor, dibucaine, through structure-activity relationship studies.  In total, 60 compds. were synthesized and tested against EV-D68 using the viral cytopathic effect assay.  Three compds. 10a, 12a, and 12c were identified to have significantly improved potency (EC50 < 1 Î¼M) and a high selectivity index (>180) compared with dibucaine against five different strains of EV-D68 viruses.  These compds. also showed potent antiviral activity in neuronal cells, such as A172 and SH-SY5Y cells, suggesting they might be further developed for the treatment of both respiratory infection as well as neuronal infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpavhbIH0yOdLVg90H21EOLACvtfcHk0lgslOdexuN6Wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmtVCjtr4%253D&md5=0875f280e936a1c6354d286e54a6b425</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00115%26sid%3Dliteratum%253Aachs%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DTuohy%26aufirst%3DP.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DBellampalli%26aufirst%3DS.%2BS.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DKhanna%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520quinoline%2520analogues%2520as%2520potent%2520antivirals%2520against%2520Enterovirus%2520D68%2520%2528EV-D68%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4074%26epage%3D4090%26doi%3D10.1021%2Facs.jmedchem.9b00115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Development of broad-spectrum enterovirus antivirals based on quinoline scaffold</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>101</i></span>, <span class="NLM_elocation-id">103981</span> <span class="refDoi">Â DOI: 10.1016/j.bioorg.2020.103981</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.bioorg.2020.103981" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=32559580" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXht1SktbrE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2020&author=R.+Musharrafiehauthor=N.+Kitamuraauthor=Y.+Huauthor=J.+Wang&title=Development+of+broad-spectrum+enterovirus+antivirals+based+on+quinoline+scaffold&doi=10.1016%2Fj.bioorg.2020.103981"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Development of broad-spectrum enterovirus antivirals based on quinoline scaffold</span></div><div class="casAuthors">Musharrafieh, Rami; Kitamura, Naoya; Hu, Yanmei; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103981</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Non-polio enteroviruses such as enterovirus A71 (EV-A71), EV-D68, and coxsackievirus B3 (CVB3) are significant human pathogens with disease manifestations ranging from mild flu-like symptoms to more severe encephalitis, myocarditis, acute flaccid paralysis/myelitis, and even death.  There is currently no effective antivirals to prevent or treat non-polio enterovirus infection.  In this study, we report our progress in developing potent and broad-spectrum antivirals against these non-polio enteroviruses.  Starting from our previously developed lead compds. that had potent antiviral activity against EV-D68, we synthesized 43 analogs and profiled their broad-spectrum antiviral activity against addnl. EV-D68, EV-A71, and CVB3 viruses.  Promising candidates were also selected for mouse microsomal stability test to prioritize lead compds. for future in vivo mouse model studies.  Collectively, this multi-parameter optimization process revealed a promising lead compd. 6aw(I) that showed single-digit to submicromolar EC50 values against two EV-D68 strains (US/KY and US/MO), two EV-A71 strains (Tainan and US/AK), and one CVB3 strain, with a high selectivity index.  Encouragingly, 6aw was stable in mouse microsomes with a half-life of 114.7 min.  Overall, 6aw represents one of the most potent broad-spectrum antiviral against non-polio enteroviruses, rendering it a promising lead candidate for non-polio enteroviruses with translational potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrABO-HH714A7Vg90H21EOLACvtfcHk0lgslOdexuN6Wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXht1SktbrE&md5=5f6b75f250087f1a8970353fe6d18670</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103981&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103981%26sid%3Dliteratum%253Aachs%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDevelopment%2520of%2520broad-spectrum%2520enterovirus%2520antivirals%2520based%2520on%2520quinoline%2520scaffold%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D101%26doi%3D10.1016%2Fj.bioorg.2020.103981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kye, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinn, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Damoiseaux, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krogstad, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of structurally diverse small-molecule compounds with broad antiviral activity against Enteroviruses</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">1615</span>â <span class="NLM_lpage">1626</span>, <span class="refDoi">Â DOI: 10.1128/AAC.02646-15</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FAAC.02646-15" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2ntbnN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=1615-1626&author=J.+Zuoauthor=S.+Kyeauthor=K.+K.+Quinnauthor=P.+Cooperauthor=R.+Damoiseauxauthor=P.+Krogstad&title=Discovery+of+structurally+diverse+small-molecule+compounds+with+broad+antiviral+activity+against+Enteroviruses&doi=10.1128%2FAAC.02646-15"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of structurally diverse small-molecule compounds with broad antiviral activity against enteroviruses</span></div><div class="casAuthors">Zuo, Jun; Kye, Steve; Quinn, Kevin K.; Cooper, Paige; Damoiseaux, Robert; Krogstad, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1615-1626</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Antiviral drugs do not currently exist for the treatment of enterovirus infections, which are often severe and potentially life-threatening.  We conducted high-throughput mol. screening and identified a structurally diverse set of compds. that inhibit the replication of coxsackievirus B3, a commonly encountered enterovirus.  These compds. did not interfere with the function of the viral internal ribosome entry site or with the activity of the viral proteases, but they did drastically reduce the synthesis of viral RNA and viral proteins in infected cells.  Sequence anal. of compd.-resistant mutants suggests that the viral 2C protein is targeted by most of these compds.  These compds. demonstrated antiviral activity against a panel of the most commonly encountered enteroviruses and thus represent potential leads for the development of broad-spectrum anti-enteroviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreYBpg81iVG7Vg90H21EOLACvtfcHk0lgslOdexuN6Wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2ntbnN&md5=a868a234cbe47a800ff65882e31e96f6</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1128%2FAAC.02646-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02646-15%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DJ.%26aulast%3DKye%26aufirst%3DS.%26aulast%3DQuinn%26aufirst%3DK.%2BK.%26aulast%3DCooper%26aufirst%3DP.%26aulast%3DDamoiseaux%26aufirst%3DR.%26aulast%3DKrogstad%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520structurally%2520diverse%2520small-molecule%2520compounds%2520with%2520broad%2520antiviral%2520activity%2520against%2520Enteroviruses%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D1615%26epage%3D1626%26doi%3D10.1128%2FAAC.02646-15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganaro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zonsics, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurdiss, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwaagstra, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donselaar, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Welter, N. G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kleef, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bevilacqua, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bassetto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neyts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strating, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Westerink, R. H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kuppeveld, F. J. M.</span></span> <span> </span><span class="NLM_article-title">Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C</span>. <i>PLoS Biol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>18</i></span>, <span class="NLM_elocation-id">e3000904</span> <span class="refDoi">Â DOI: 10.1371/journal.pbio.3000904</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1371%2Fjournal.pbio.3000904" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33156822" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisVSqtLvK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2020&author=L.+Bauerauthor=R.+Manganaroauthor=B.+Zonsicsauthor=D.+L.+Hurdissauthor=M.+Zwaagstraauthor=T.+Donselaarauthor=N.+G.+E.+Welterauthor=R.+van+Kleefauthor=M.+L.+Lopezauthor=F.+Bevilacquaauthor=T.+Ramanauthor=S.+Ferlaauthor=M.+Bassettoauthor=J.+Neytsauthor=J.+Stratingauthor=R.+H.+S.+Westerinkauthor=A.+Brancaleauthor=F.+J.+M.+van+Kuppeveld&title=Rational+design+of+highly+potent+broad-spectrum+enterovirus+inhibitors+targeting+the+nonstructural+protein+2C&doi=10.1371%2Fjournal.pbio.3000904"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Rational design of highly potent broad-spectrum enterovirus inhibitors targeting the nonstructural protein 2C</span></div><div class="casAuthors">Bauer, Lisa; Manganaro, Roberto; Zonsics, Birgit; Hurdiss, Daniel L.; Zwaagstra, Marleen; Donselaar, Tim; Welter, Naemi G. E.; van Kleef, Regina G. D. M.; Lopez, Moira Lorenzo; Bevilacqua, Federica; Raman, Thamidur; Ferla, Salvatore; Bassetto, Marcella; Neyts, Johan; Strating, Jeroen R. P. M.; Westerink, Remco H. S.; Brancale, Andrea; van Kuppeveld, Frank J. M.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Biology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e3000904</span>CODEN:
                <span class="NLM_cas:coden">PBLIBG</span>;
        ISSN:<span class="NLM_cas:issn">1545-7885</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">There is a great need for antiviral drugs to treat enterovirus (EV) and rhinovirus (RV) infections, which can be severe and occasionally life-threatening.  The conserved nonstructural protein 2C, which is an AAA+ ATPase, is a promising target for drug development.  Here, we present a structure-activity relationship study of a previously identified compd. that targets the 2C protein of EV-A71 and several EV-B species members, but not poliovirus (PV) (EV-C species).  This compd. is structurally related to the Food and Drug Administration (FDA)-approved drug fluoxetine-which also targets 2C-but has favorable chem. properties.  We identified several compds. with increased antiviral potency and broadened activity.  Four compds. showed broad-spectrum EV and RV activity and inhibited contemporary strains of emerging EVs of public health concern, including EV-A71, coxsackievirus (CV)-A24v, and EV-D68.  Importantly, unlike (S)-fluoxetine, these compds. are no longer neuroactive.  By raising resistant EV-A71, CV-B3, and EV-D68 variants against one of these inhibitors, we identified novel 2C resistance mutations.  Reverse engineering of these mutations revealed a conserved mechanism of resistance development.  Resistant viruses first acquired a mutation in, or adjacent to, the Î±2 helix of 2C.  This mutation disrupted compd. binding and provided drug resistance, but this was at the cost of viral fitness.  Addnl. mutations at distantly localized 2C residues were then acquired to increase resistance and/or to compensate for the loss of fitness.  Using computational methods to identify solvent accessible tunnels near the Î±2 helix in the EV-A71 and PV 2C crystal structures, a conserved binding pocket of the inhibitors is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy0dAstxZbgLVg90H21EOLACvtfcHk0lhL9NNqNECidQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisVSqtLvK&md5=f1ba879402ef0001b61cf1e01cd3c768</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pbio.3000904&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pbio.3000904%26sid%3Dliteratum%253Aachs%26aulast%3DBauer%26aufirst%3DL.%26aulast%3DManganaro%26aufirst%3DR.%26aulast%3DZonsics%26aufirst%3DB.%26aulast%3DHurdiss%26aufirst%3DD.%2BL.%26aulast%3DZwaagstra%26aufirst%3DM.%26aulast%3DDonselaar%26aufirst%3DT.%26aulast%3DWelter%26aufirst%3DN.%2BG.%2BE.%26aulast%3Dvan%2BKleef%26aufirst%3DR.%26aulast%3DLopez%26aufirst%3DM.%2BL.%26aulast%3DBevilacqua%26aufirst%3DF.%26aulast%3DRaman%26aufirst%3DT.%26aulast%3DFerla%26aufirst%3DS.%26aulast%3DBassetto%26aufirst%3DM.%26aulast%3DNeyts%26aufirst%3DJ.%26aulast%3DStrating%26aufirst%3DJ.%26aulast%3DWesterink%26aufirst%3DR.%2BH.%2BS.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3Dvan%2BKuppeveld%26aufirst%3DF.%2BJ.%2BM.%26atitle%3DRational%2520design%2520of%2520highly%2520potent%2520broad-spectrum%2520enterovirus%2520inhibitors%2520targeting%2520the%2520nonstructural%2520protein%25202C%26jtitle%3DPLoS%2520Biol.%26date%3D2020%26volume%3D18%26doi%3D10.1371%2Fjournal.pbio.3000904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Holm-Hansen, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Midgley, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, T. K.</span></span> <span> </span><span class="NLM_article-title">Global emergence of enterovirus D68: a systematic review</span>. <i>Lancet Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">e64</span>â <span class="NLM_lpage">e75</span>, <span class="refDoi">Â DOI: 10.1016/S1473-3099(15)00543-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2FS1473-3099%2815%2900543-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=26929196" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2016&pages=e64-e75&author=C.+C.+Holm-Hansenauthor=S.+E.+Midgleyauthor=T.+K.+Fischer&title=Global+emergence+of+enterovirus+D68%3A+a+systematic+review&doi=10.1016%2FS1473-3099%2815%2900543-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS1473-3099%2815%2900543-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1473-3099%252815%252900543-5%26sid%3Dliteratum%253Aachs%26aulast%3DHolm-Hansen%26aufirst%3DC.%2BC.%26aulast%3DMidgley%26aufirst%3DS.%2BE.%26aulast%3DFischer%26aufirst%3DT.%2BK.%26atitle%3DGlobal%2520emergence%2520of%2520enterovirus%2520D68%253A%2520a%2520systematic%2520review%26jtitle%3DLancet%2520Infect.%2520Dis.%26date%3D2016%26volume%3D16%26spage%3De64%26epage%3De75%26doi%3D10.1016%2FS1473-3099%2815%2900543-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological characterization of the mechanism of action of R523062, a promising antiviral for enterovirus D68</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">2260</span>â <span class="NLM_lpage">2270</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.0c00383</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.0c00383" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWnt7jK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=2260-2270&author=C.+Maauthor=Y.+Huauthor=J.+Zhangauthor=J.+Wang&title=Pharmacological+characterization+of+the+mechanism+of+action+of+R523062%2C+a+promising+antiviral+for+enterovirus+D68&doi=10.1021%2Facsinfecdis.0c00383"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological Characterization of the Mechanism of Action of R523062, a Promising Antiviral for Enterovirus D68</span></div><div class="casAuthors">Ma, Chunlong; Hu, Yanmei; Zhang, Jiantao; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2260-2270</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is a re-emerging virus that causes moderate to severe respiratory diseases in children.  In severe cases, EV-D68 infection can lead to neurol. complications called acute flaccid myelitis (AFM).  There is currently no antiviral or vaccine available for EV-D68.  The goal of this study is to delineate the mechanism of action of a promising antiviral drug candidate R523062 that was identified through a phenotypic cytopathic effect (CPE)-based high-throughput screening.  R523062 inhibits multiple contemporary EV-D68 strains with single-digit micromolar EC50 values and is less effective against the enterovirus A71 strains.  Resistant mutants identified through serial viral passage expts. were mapped to four viral proteins including VP1-G178S, 2A-V112I, 2C-I227L/Q322R, and 3A-V54A.  The involvements of VP1-G178S, 2A-V112I, and 3A-V54A mutants in drug resistance were ruled out by the drug time-of-addn. expt., protease enzymic assay, and the plaque assay with recombinant virus, resp.  In contrast, recombinant virus encoding the 2C-I227L/Q322R double mutants confers significant drug resistance, which is consistent with the result from serial passage expts.  The thermal shift binding assay showed R523062 binds to the wild-type EV-D68 2C and 2C-Q322R but not 2C-I227L or 2C-I227L/Q322R, confirming 2C as the direct drug target of R523062 and 2C-I227L alone confers drug resistance.  The 2C inhibitor R523062 also showed additive antiviral activity with the viral 2A protease inhibitor telaprevir as well as the viral capsid VP1 inhibitor R856932.  Collectively, this study identified a promising EV-D68 antiviral drug candidate R523062 with a confirmed mechanism of action by targeting the viral 2C protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZhzC8qdFuQ7Vg90H21EOLACvtfcHk0lhL9NNqNECidQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWnt7jK&md5=1ceafdc337627131ab3c49153aee685d</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.0c00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.0c00383%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DPharmacological%2520characterization%2520of%2520the%2520mechanism%2520of%2520action%2520of%2520R523062%252C%2520a%2520promising%2520antiviral%2520for%2520enterovirus%2520D68%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2020%26volume%3D6%26spage%3D2260%26epage%3D2270%26doi%3D10.1021%2Facsinfecdis.0c00383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">A novel capsid binding inhibitor displays potent antiviral activity against Enterovirus D68</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1952</span>â <span class="NLM_lpage">1962</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.9b00284</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.9b00284" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslWnu73I" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&pages=1952-1962&author=C.+Maauthor=Y.+Huauthor=J.+Zhangauthor=R.+Musharrafiehauthor=J.+Wang&title=A+novel+capsid+binding+inhibitor+displays+potent+antiviral+activity+against+Enterovirus+D68&doi=10.1021%2Facsinfecdis.9b00284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A Novel Capsid Binding Inhibitor Displays Potent Antiviral Activity against Enterovirus D68</span></div><div class="casAuthors">Ma, Chunlong; Hu, Yanmei; Zhang, Jiantao; Musharrafieh, Rami; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1952-1962</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Enterovirus D68 (EV-D68) is a respiratory viral pathogen that primarily infects children under the age of 8.  Although EV-D68 infection typically leads to moderate to severe respiratory illnesses, recent years have seen increasing cases of EV-D68 triggered neurol. complications such as acute flaccid myelitis (AFM).  There is currently no vaccine or antiviral available for EV-D68; we therefore aimed to develop potent and specific small mol. antivirals against EV-D68.  We report our discovery of a viral capsid inhibitor R856932 (I) that inhibits multiple contemporary EV-D68 strains with single-digit to submicromolar efficacy.  Mechanistic studies have shown that the tetrazole compd. R856932 binds to the hydrophobic pocket of viral capsid protein VP1, thereby preventing viral uncoating and release of viral genome in the infected cells.  The mechanism of action of R856932 was confirmed by time-of-addn., Western blot, RT-qPCR, viral heat inactivation, serial viral passage, and reverse genetics expts.  A single mutation located at VP1, A129V, confers resistance against R856932.  However, a recombination virus encoding VP1-A129V appeared to have compromised fitness of replication compared to the wild-type EV-D68 virus as shown by the competition growth assay.  Overall, the hit compd. identified in this study, R856932, represents a promising starting point with a confirmed mechanism of action that can be further developed into EV-D68 antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrtMBV63YPeObVg90H21EOLACvtfcHk0lhL9NNqNECidQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslWnu73I&md5=d23f8d3a528caccbfc25c9dca1104902</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.9b00284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.9b00284%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMusharrafieh%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DA%2520novel%2520capsid%2520binding%2520inhibitor%2520displays%2520potent%2520antiviral%2520activity%2520against%2520Enterovirus%2520D68%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2019%26volume%3D5%26spage%3D1952%26epage%3D1962%26doi%3D10.1021%2Facsinfecdis.9b00284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of a soluble fragment of poliovirus 2CATPase</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">e1007304</span> <span class="refDoi">Â DOI: 10.1371/journal.ppat.1007304</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1371%2Fjournal.ppat.1007304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30231078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1MXmt1Ghsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&author=H.+Guanauthor=J.+Tianauthor=C.+Zhangauthor=B.+Qinauthor=S.+Cui&title=Crystal+structure+of+a+soluble+fragment+of+poliovirus+2CATPase&doi=10.1371%2Fjournal.ppat.1007304"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of a soluble fragment of poliovirus 2CATPase</span></div><div class="casAuthors">Guan, Hongxin; Tian, Juan; Zhang, Chu; Qin, Bo; Cui, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1007304/1-e1007304/24</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Poliovirus (PV) 2CATPase is the most studied 2C protein in the Picornaviridae family.  It is involved in RNA replication, encapsidation and uncoating and many inhibitors have been found that target PV 2CATPase.  Despite numerous investigations to characterize its functions, a high-resoln. structure of PV 2C has not yet been detd.  We report here the crystal structure of a sol. fragment of PV 2CATPase to 2.55Ã, contg. an ATPase domain, a zinc finger and a C-terminal helical domain but missing the N-terminal domain.  The ATPase domain shares the common structural features with EV71 2C and other Superfamily 3 helicases.  The C-terminal cysteine-rich motif folds into a CCCC type zinc finger in which four cysteine ligands and several auxiliary residues assist in zinc binding.  By comparing with the known zinc finger fold groups, we found the zinc finger of 2C proteins belong to a new fold group, which we denote the "Enterovirus 2C-like" group.  The C-terminus of PV 2CATPase forms an amphipathic helix that occupies a hydrophobic pocket located on an adjacent PV 2CATPase in the crystal lattice.  The C-terminus mediated PV 2C-2C interaction promotes self-oligomerization, most likely hexamerization, which is fundamental to the ATPase activity of 2C.  The zinc finger is the most structurally diverse feature in 2C proteins.  Available structural and virol. data suggest that the zinc finger of 2C might confer the specificity of interaction with other proteins.  We built a hexameric ring model of PV 2CATPase and visualized the previously identified functional motifs and drug-resistant sites, thus providing a structure framework for antiviral drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrh1-3jVzsgtLVg90H21EOLACvtfcHk0lgIB6zPAtc0fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXmt1Ghsrg%253D&md5=9cb85a7c66db92245e74c1c7aa6cc3f1</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1007304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1007304%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DCui%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520a%2520soluble%2520fragment%2520of%2520poliovirus%25202CATPase%26jtitle%3DPLoS%2520Pathog.%26date%3D2018%26volume%3D14%26doi%3D10.1371%2Fjournal.ppat.1007304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wojdyla, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of 2C helicase from enterovirus 71</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>3</i></span>, <span class="NLM_elocation-id">e1602573</span> <span class="refDoi">Â DOI: 10.1126/sciadv.1602573</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1126%2Fsciadv.1602573" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28508043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvVCqtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2017&author=H.+Guanauthor=J.+Tianauthor=B.+Qinauthor=J.+A.+Wojdylaauthor=B.+Wangauthor=Z.+Zhaoauthor=M.+Wangauthor=S.+Cui&title=Crystal+structure+of+2C+helicase+from+enterovirus+71&doi=10.1126%2Fsciadv.1602573"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Crystal structure of 2C helicase from enterovirus 71</span></div><div class="casAuthors">Guan, Hongxin; Tian, Juan; Qin, Bo; Wojdyla, Justyna Aleksandra; Wang, Bei; Zhao, Zhendong; Wang, Meitian; Cui, Sheng</div><div class="citationInfo"><span class="NLM_cas:title">Science Advances</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e1602573/1-e1602573/9</span>CODEN:
                <span class="NLM_cas:coden">SACDAF</span>;
        ISSN:<span class="NLM_cas:issn">2375-2548</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Enterovirus 71 (EV71) is the major pathogen responsible for outbreaks of hand, foot, and mouth disease.  EV71 nonstructural protein 2C participates in many crit. events throughout the virus life cycle; however, its precise role is not fully understood.  Lack of a high-resoln. structure made it difficult to elucidate 2C activity and prevented inhibitor development.  We report the 2.5 Ã-resoln. crystal structure of the sol. part of EV71 2C, contg. an ATPase (ATPase) domain, a cysteine-rich zinc finger with an unusual fold, and a carboxyl-terminal helical domain.  Unlike other AAA+ ATPases, EV71 2C undergoes a carboxyl terminus-mediated self-oligomerization, which is dependent on a specific interaction between the carboxyl-terminal helix of one monomer and a deep pocket formed between the ATPase and the zinc finger domains of the neighboring monomer.  The carboxyl terminus-mediated self-oligomerization is fundamental to 2C ATPase activity and EV71 replication.  Our findings suggest a strategy for inhibition of enterovirus replication by disruption of the self-oligomerization interface of 2C.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoo7VMbRjdNQ7Vg90H21EOLACvtfcHk0lgIB6zPAtc0fw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvVCqtrw%253D&md5=1bbe6b7fa4f6a18e5c3daaff9a270b6e</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.1602573&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.1602573%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DH.%26aulast%3DTian%26aufirst%3DJ.%26aulast%3DQin%26aufirst%3DB.%26aulast%3DWojdyla%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DCui%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%25202C%2520helicase%2520from%2520enterovirus%252071%26jtitle%3DSci.%2520Adv.%26date%3D2017%26volume%3D3%26doi%3D10.1126%2Fsciadv.1602573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hua, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span> <span> </span><span class="NLM_article-title">The Structure, function, and mechanisms of action of Enterovirus non-structural protein 2C</span>. <i>Front. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">615965</span> <span class="refDoi">Â DOI: 10.3389/fmicb.2020.615965</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.3389%2Ffmicb.2020.615965" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33381104" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A280%3ADC%252BB3svjsl2jtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=S.+H.+Wangauthor=K.+Wangauthor=K.+Zhaoauthor=S.+C.+Huaauthor=J.+Du&title=The+Structure%2C+function%2C+and+mechanisms+of+action+of+Enterovirus+non-structural+protein+2C&doi=10.3389%2Ffmicb.2020.615965"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">The Structure, Function, and Mechanisms of Action of Enterovirus Non-structural Protein 2C</span></div><div class="casAuthors">Wang Shao-Hua; Zhao Ke; Du Juan; Wang Kuan; Hua Shu-Cheng; Du Juan</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in microbiology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">615965</span>
        ISSN:<span class="NLM_cas:issn">1664-302X</span>.
    </div><div class="casAbstract">Enteroviruses are a group of RNA viruses belonging to the family Picornaviridae.  They include human enterovirus groups A, B, C, and D as well as non-human enteroviruses.  Enterovirus infections can lead to hand, foot, and mouth disease and herpangina, whose clinical manifestations are often mild, although some strains can result in severe neurological complications such as encephalitis, myocarditis, meningitis, and poliomyelitis.  To date, research on enterovirus non-structural proteins has mainly focused on the 2A and 3C proteases and 3D polymerase.  However, another non-structural protein, 2C, is the most highly conserved protein, and plays a vital role in the enterovirus life cycle.  There are relatively few studies on this protein.  Previous studies have demonstrated that enterovirus 2C is involved in virus uncoating, host cell membrane rearrangements, RNA replication, encapsidation, morphogenesis, ATPase, helicase, and chaperoning activities.  Despite ongoing research, little is known about the pathogenesis of enterovirus 2C proteins in viral replication or in the host innate immune system.  In this review, we discuss and summarize the current understanding of the structure, function, and mechanism of the enterovirus 2C proteins, focusing on the key mutations and motifs involved in viral infection, replication, and immune regulation.  We also focus on recent progress in research into the role of 2C proteins in regulating the pattern recognition receptors and type I interferon signaling pathway to facilitate viral replication.  Given these functions and mechanisms, the potential application of the 2C proteins as a target for anti-viral drug development is also discussed.  Future studies will focus on the determination of more crystal structures of enterovirus 2C proteins, which might provide more potential targets for anti-viral drug development against enterovirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRoDCmBfl-Q6jDnmmyUf5qOfW6udTcc2eYtvq8h45CMw7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3svjsl2jtQ%253D%253D&md5=e9e9b352fc23e19891f526046a8f1dc5</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.3389%2Ffmicb.2020.615965&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffmicb.2020.615965%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%2BH.%26aulast%3DWang%26aufirst%3DK.%26aulast%3DZhao%26aufirst%3DK.%26aulast%3DHua%26aufirst%3DS.%2BC.%26aulast%3DDu%26aufirst%3DJ.%26atitle%3DThe%2520Structure%252C%2520function%252C%2520and%2520mechanisms%2520of%2520action%2520of%2520Enterovirus%2520non-structural%2520protein%25202C%26jtitle%3DFront.%2520Microbiol.%26date%3D2020%26volume%3D11%26doi%3D10.3389%2Ffmicb.2020.615965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volochnyuk, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryabukhin, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plaskon, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dmytriv, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grygorenko, O. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mykhailiuk, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krotko, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pushechnikov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tolmachev, A. A.</span></span> <span> </span><span class="NLM_article-title">Approach to the library of fused pyridine-4-carboxylic acids by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles</span>. <i>J. Comb. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">510</span>â <span class="NLM_lpage">517</span>, <span class="refDoi">Â DOI: 10.1021/cc100040q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cc100040q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVOisrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=510-517&author=D.+M.+Volochnyukauthor=S.+V.+Ryabukhinauthor=A.+S.+Plaskonauthor=Y.+V.+Dmytrivauthor=O.+O.+Grygorenkoauthor=P.+K.+Mykhailiukauthor=D.+G.+Krotkoauthor=A.+Pushechnikovauthor=A.+A.+Tolmachev&title=Approach+to+the+library+of+fused+pyridine-4-carboxylic+acids+by+Combes-type+reaction+of+acyl+pyruvates+and+electron-rich+amino+heterocycles&doi=10.1021%2Fcc100040q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Approach to the library of fused pyridine-4-carboxylic acids by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles</span></div><div class="casAuthors">Volochnyuk, Dmitriy M.; Ryabukhin, Sergey V.; Plaskon, Andrey S.; Dmytriv, Yuri V.; Grygorenko, Oleksandr O.; Mykhailiuk, Pavel K.; Krotko, Dmitriy G.; Pushechnikov, Alexei; Tolmachev, Andrey A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Combinatorial Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">510-517</span>CODEN:
                <span class="NLM_cas:coden">JCCHFF</span>;
        ISSN:<span class="NLM_cas:issn">1520-4766</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A library of fused pyridine-4-carboxylic acids (including pyrazolo[3,4-b]pyridines, isoxazolo[5,4-b]pyridines, furo[2,3-b]pyridines, thieno[2,3-b]pyridines, and pyrido[2,3-d]pyrimidines) was generated by Combes-type reaction of acyl pyruvates and electron-rich amino heterocycles followed by hydrolysis of the ester.  The library members were also demonstrated to undergo the std. combinatorial transformations including amide coupling and esterification, as well as less common heterocyclizations to 1,2,4-triazoles and 1,2,4-oxadiazoles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJgt2hTXsbyrVg90H21EOLACvtfcHk0ljn_zo1PgzaXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVOisrw%253D&md5=7d593f0d469e366a9b7931e3677b7962</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fcc100040q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcc100040q%26sid%3Dliteratum%253Aachs%26aulast%3DVolochnyuk%26aufirst%3DD.%2BM.%26aulast%3DRyabukhin%26aufirst%3DS.%2BV.%26aulast%3DPlaskon%26aufirst%3DA.%2BS.%26aulast%3DDmytriv%26aufirst%3DY.%2BV.%26aulast%3DGrygorenko%26aufirst%3DO.%2BO.%26aulast%3DMykhailiuk%26aufirst%3DP.%2BK.%26aulast%3DKrotko%26aufirst%3DD.%2BG.%26aulast%3DPushechnikov%26aufirst%3DA.%26aulast%3DTolmachev%26aufirst%3DA.%2BA.%26atitle%3DApproach%2520to%2520the%2520library%2520of%2520fused%2520pyridine-4-carboxylic%2520acids%2520by%2520Combes-type%2520reaction%2520of%2520acyl%2520pyruvates%2520and%2520electron-rich%2520amino%2520heterocycles%26jtitle%3DJ.%2520Comb.%2520Chem.%26date%3D2010%26volume%3D12%26spage%3D510%26epage%3D517%26doi%3D10.1021%2Fcc100040q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R.</span>; <span class="NLM_string-name">Ma, C.</span>; <span class="NLM_string-name">Zhang, J.</span>; <span class="NLM_string-name">Hu, Y.</span>; <span class="NLM_string-name">Diesing, J. M.</span>; <span class="NLM_string-name">Marty, M. T.</span>; <span class="NLM_string-name">Wang, J.</span></span><span> </span><span class="NLM_article-title">Validating enterovirus D68-2A(pro) as an antiviral drug target and the discovery of telaprevir as a potent D68-2A(pro) inhibitor</span> <i>J. Virol.</i><span class="NLM_year">2019</span> <span class="NLM_volume">93</span><span class="refDoi">Â DOI: 10.1128/JVI.02221-18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FJVI.02221-18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=30674624" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=R.+Musharrafieh&author=C.+Ma&author=J.+Zhang&author=Y.+Hu&author=J.+M.+Diesing&author=M.+T.+Marty&author=J.+Wang&title=Validating+enterovirus+D68-2A%28pro%29+as+an+antiviral+drug+target+and+the+discovery+of+telaprevir+as+a+potent+D68-2A%28pro%29+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FJVI.02221-18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1128%252FJVI.02221-18%26sid%3Dliteratum%253Aachs%26aulast%3DMusharrafieh%26aufirst%3DR.%26atitle%3DValidating%2520enterovirus%2520D68-2A%2528pro%2529%2520as%2520an%2520antiviral%2520drug%2520target%2520and%2520the%2520discovery%2520of%2520telaprevir%2520as%2520a%2520potent%2520D68-2A%2528pro%2529%2520inhibitor%26jtitle%3DJ.%2520Virol.%26date%3D2019%26volume%3D93%26doi%3D10.1128%2FJVI.02221-18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor</span>. <i>Emerging Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">317</span>â <span class="NLM_lpage">330</span>, <span class="refDoi">Â DOI: 10.1080/22221751.2021.1888660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1080%2F22221751.2021.1888660" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33560940" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3MXltlegtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2021&pages=317-330&author=Y.+Huauthor=X.+Mengauthor=F.+Zhangauthor=Y.+Xiangauthor=J.+Wang&title=The+in+vitro+antiviral+activity+of+lactoferrin+against+common+human+coronaviruses+and+SARS-CoV-2+is+mediated+by+targeting+the+heparan+sulfate+co-receptor&doi=10.1080%2F22221751.2021.1888660"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor</span></div><div class="casAuthors">Hu, Yanmei; Meng, Xiangzhi; Zhang, Fushun; Xiang, Yan; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Microbes & Infections</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">317-330</span>CODEN:
                <span class="NLM_cas:coden">EMIMC4</span>;
        ISSN:<span class="NLM_cas:issn">2222-1751</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Coronavirus disease 2019 (COVID-19) is an ongoing pandemic that lacks effective therapeutic interventions.  SARS-CoV-2 infects ACE2-expressing cells and gains cell entry through either direct plasma membrane fusion or endocytosis.  Recent studies have shown that in addn. to ACE2, heparan sulfate proteoglycans (HSPGs) also play an important role in SARS-CoV-2 cell attachment by serving as an attachment factor.  Binding of viral spike protein to HSPGs leads to the enrichment of local concn. for the subsequent specific binding with ACE2.  We therefore hypothesize that blocking the interactions between viral spike protein and the HSPGs will lead to inhibition of viral replication.  In this study, we report our findings of the broad-spectrum antiviral activity and the mechanism of action of lactoferrin (LF) against multiple common human coronaviruses as well as SARS-CoV-2.  Our study has shown that LF has broad-spectrum antiviral activity against SARS-CoV-2, HCoV-OC43, HCoV-NL63, and HCoV-229E in cell culture, and bovine lactoferrin (BLF) is more potent than human lactoferrin.  Mechanistic studies revealed that BLF binds to HSPGs, thereby blocking viral attachment to the host cell.  The antiviral activity of BLF can be antagonized by the HSPG mimetic heparin.  Combination therapy expt. showed that the antiviral activity of LF is synergistic with remdesivir in cell culture.  Mol. modeling suggests that the N-terminal pos. charged region in BLF (residues 17-41) confers the binding to HSPGs.  Overall, LF appears to be a promising drug candidate for COVID-19 that warrants further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-KJMYvpJE-LVg90H21EOLACvtfcHk0ljn_zo1PgzaXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXltlegtrg%253D&md5=a5c5c402b46462fe9a0cc836f5b90d9d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1080%2F22221751.2021.1888660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F22221751.2021.1888660%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DF.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DThe%2520in%2520vitro%2520antiviral%2520activity%2520of%2520lactoferrin%2520against%2520common%2520human%2520coronaviruses%2520and%2520SARS-CoV-2%2520is%2520mediated%2520by%2520targeting%2520the%2520heparan%2520sulfate%2520co-receptor%26jtitle%3DEmerging%2520Microbes%2520Infect.%26date%3D2021%26volume%3D10%26spage%3D317%26epage%3D330%26doi%3D10.1080%2F22221751.2021.1888660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">586</span>â <span class="NLM_lpage">597</span>, <span class="refDoi">Â DOI: 10.1021/acsinfecdis.0c00761</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.0c00761" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BB3MXlt1ShtLw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2021&pages=586-597&author=Y.+Huauthor=C.+Maauthor=T.+Szetoauthor=B.+Hurstauthor=B.+Tarbetauthor=J.+Wang&title=Boceprevir%2C+calpain+inhibitors+II+and+XII%2C+and+GC-376+have+broad-spectrum+antiviral+activity+against+coronaviruses&doi=10.1021%2Facsinfecdis.0c00761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Boceprevir, Calpain Inhibitors II and XII, and GC-376 Have Broad-Spectrum Antiviral Activity against Coronaviruses</span></div><div class="casAuthors">Hu, Yanmei; Ma, Chunlong; Szeto, Tommy; Hurst, Brett; Tarbet, Bart; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2021</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">586-597</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As the COVID-19 pandemic continues to unfold, the morbidity and mortality are increasing daily.  Effective treatment for SARS-CoV-2 is urgently needed.  We recently discovered 4 SARS-CoV-2 main protease (Mpro) inhibitors including boceprevir, calpain inhibitors II and XII, and GC-376 with potent antiviral activity against infectious SARS-CoV-2 in cell culture.  In this study, we further characterized the mechanism of action of these 4 compds. using the SARS-CoV-2 pseudovirus neutralization assay.  GC-376 and calpain inhibitors II and XII have a dual mechanism of action by inhibiting both viral Mpro and host cathepsin L in Vero cells.  To rule out the cell-type dependent effect, the antiviral activity of these 4 compds. against SARS-CoV-2 was also confirmed in type 2 transmembrane serine protease-expressing Caco-2 cells using the viral yield redn. assay.  In addn., we found that these 4 compds. have broad-spectrum antiviral activity in inhibiting not only SARS-CoV-2 but also SARS-CoV, and MERS-CoV, as well as human coronaviruses (CoVs) 229E, OC43, and NL63.  The mechanism of action is through targeting the viral Mpro, which was supported by the thermal shift-binding assay and enzymic fluorescence resonance energy transfer assay.  We further showed that these 4 compds. have additive antiviral effect when combined with remdesivir.  Altogether, these results suggest that boceprevir, calpain inhibitors II and XII, and GC-376 might be promising starting points for further development against existing human coronaviruses as well as future emerging CoVs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRHKMIw3urjrVg90H21EOLACvtfcHk0ljn_zo1PgzaXQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3MXlt1ShtLw%253D&md5=9fbd5c46edbba079726dd936696ac745</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.0c00761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.0c00761%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DSzeto%26aufirst%3DT.%26aulast%3DHurst%26aufirst%3DB.%26aulast%3DTarbet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DBoceprevir%252C%2520calpain%2520inhibitors%2520II%2520and%2520XII%252C%2520and%2520GC-376%2520have%2520broad-spectrum%2520antiviral%2520activity%2520against%2520coronaviruses%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2021%26volume%3D7%26spage%3D586%26epage%3D597%26doi%3D10.1021%2Facsinfecdis.0c00761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_volume"><i>118</i></span>, <span class="NLM_elocation-id">e2024420118</span> <span class="refDoi">Â DOI: 10.1073/pnas.2024420118</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1073%2Fpnas.2024420118" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33568498" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=2021&author=C.+Maauthor=J.+Wang&title=Dipyridamole%2C+chloroquine%2C+montelukast+sodium%2C+candesartan%2C+oxytetracycline%2C+and+atazanavir+are+not+SARS-CoV-2+main+protease+inhibitors&doi=10.1073%2Fpnas.2024420118"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.2024420118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.2024420118%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDipyridamole%252C%2520chloroquine%252C%2520montelukast%2520sodium%252C%2520candesartan%252C%2520oxytetracycline%252C%2520and%2520atazanavir%2520are%2520not%2520SARS-CoV-2%2520main%2520protease%2520inhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2021%26volume%3D118%26doi%3D10.1073%2Fpnas.2024420118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sacco, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lagarias, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Townsend, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dube, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitamura, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarbet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolocouris, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against M(pro) and cathepsin L</span>. <i>Sci. Adv.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">eabe0751</span> <span class="refDoi">Â DOI: 10.1126/sciadv.abe0751</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1126%2Fsciadv.abe0751" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=33158912" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&author=M.+D.+Saccoauthor=C.+Maauthor=P.+Lagariasauthor=A.+Gaoauthor=J.+A.+Townsendauthor=X.+Mengauthor=P.+Dubeauthor=X.+Zhangauthor=Y.+Huauthor=N.+Kitamuraauthor=B.+Hurstauthor=B.+Tarbetauthor=M.+T.+Martyauthor=A.+Kolocourisauthor=Y.+Xiangauthor=Y.+Chenauthor=J.+Wang&title=Structure+and+inhibition+of+the+SARS-CoV-2+main+protease+reveal+strategy+for+developing+dual+inhibitors+against+M%28pro%29+and+cathepsin+L&doi=10.1126%2Fsciadv.abe0751"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1126%2Fsciadv.abe0751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fsciadv.abe0751%26sid%3Dliteratum%253Aachs%26aulast%3DSacco%26aufirst%3DM.%2BD.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLagarias%26aufirst%3DP.%26aulast%3DGao%26aufirst%3DA.%26aulast%3DTownsend%26aufirst%3DJ.%2BA.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DDube%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DKitamura%26aufirst%3DN.%26aulast%3DHurst%26aufirst%3DB.%26aulast%3DTarbet%26aufirst%3DB.%26aulast%3DMarty%26aufirst%3DM.%2BT.%26aulast%3DKolocouris%26aufirst%3DA.%26aulast%3DXiang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DStructure%2520and%2520inhibition%2520of%2520the%2520SARS-CoV-2%2520main%2520protease%2520reveal%2520strategy%2520for%2520developing%2520dual%2520inhibitors%2520against%2520M%2528pro%2529%2520and%2520cathepsin%2520L%26jtitle%3DSci.%2520Adv.%26date%3D2020%26volume%3D6%26doi%3D10.1126%2Fsciadv.abe0751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musharrafieh, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hau, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">103</span>â <span class="NLM_lpage">113</span>, <span class="refDoi">Â DOI: 10.1016/j.antiviral.2017.07.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1016%2Fj.antiviral.2017.07.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=28778830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1yltrvF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2017&pages=103-113&author=Y.+Huauthor=J.+Zhangauthor=R.+G.+Musharrafiehauthor=C.+Maauthor=R.+Hauauthor=J.+Wang&title=Discovery+of+dapivirine%2C+a+nonnucleoside+HIV-1+reverse+transcriptase+inhibitor%2C+as+a+broad-spectrum+antiviral+against+both+influenza+A+and+B+viruses&doi=10.1016%2Fj.antiviral.2017.07.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of dapivirine, a nonnucleoside HIV-1 reverse transcriptase inhibitor, as a broad-spectrum antiviral against both influenza A and B viruses</span></div><div class="casAuthors">Hu, Yanmei; Zhang, Jiantao; Musharrafieh, Rami Ghassan; Ma, Chunlong; Hau, Raymond; Wang, Jun</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-113</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The emergence of multidrug-resistant influenza viruses poses a persistent threat to public health.  The current prophylaxis and therapeutic interventions for influenza virus infection have limited efficacy due to the continuous antigenic drift and antigenic shift of influenza viruses.  As part of our ongoing effort to develop the next generation of influenza antivirals with broad-spectrum antiviral activity and a high genetic barrier to drug resistance, in this study we report the discovery of dapivirine, an FDA-approved HIV nonnucleoside reverse transcriptase inhibitor, as a broad-spectrum antiviral against multiple strains of influenza A and B viruses with low micromolar efficacy.  Mechanistic studies revealed that dapivirine inhibits the nuclear entry of viral ribonucleoproteins at the early stage of viral replication.  As a result, viral RNA and protein synthesis were inhibited.  Furthermore, dapivirine has a high in vitro genetic barrier to drug resistance, and its antiviral activity is synergistic with oseltamivir carboxylate.  In summary, the in vitro antiviral results of dapivirine suggest it is a promising candidate for the development of the next generation of dual influenza and HIV antivirals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrja8AYHlAdj7Vg90H21EOLACvtfcHk0lh1h5Q7pfaexg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1yltrvF&md5=d5f0838b6c1127a6e13266cd6834bad8</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2017.07.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2017.07.016%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DMusharrafieh%26aufirst%3DR.%2BG.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHau%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520dapivirine%252C%2520a%2520nonnucleoside%2520HIV-1%2520reverse%2520transcriptase%2520inhibitor%252C%2520as%2520a%2520broad-spectrum%2520antiviral%2520against%2520both%2520influenza%2520A%2520and%2520B%2520viruses%26jtitle%3DAntiviral%2520Res.%26date%3D2017%26volume%3D145%26spage%3D103%26epage%3D113%26doi%3D10.1016%2Fj.antiviral.2017.07.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pekosz, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shuck, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinto, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, R. A.</span></span> <span> </span><span class="NLM_article-title">Influenza a virus M2 ion channel activity is essential for efficient replication in tissue culture</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">1391</span>â <span class="NLM_lpage">1399</span>, <span class="refDoi">Â DOI: 10.1128/JVI.76.3.1391-1399.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=10.1128%2FJVI.76.3.1391-1399.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=11773413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;key=1%3ACAS%3A528%3ADC%252BD38XnvFCqsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2002&pages=1391-1399&author=M.+Takedaauthor=A.+Pekoszauthor=K.+Shuckauthor=L.+H.+Pintoauthor=R.+A.+Lamb&title=Influenza+a+virus+M2+ion+channel+activity+is+essential+for+efficient+replication+in+tissue+culture&doi=10.1128%2FJVI.76.3.1391-1399.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Influenza A virus M2 ion channel activity is essential for efficient replication in tissue culture</span></div><div class="casAuthors">Takeda, Makoto; Pekosz, Andrew; Shuck, Kevin; Pinto, Lawrence H.; Lamb, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1391-1399</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The amantadine-sensitive ion channel activity of influenza A virus M2 protein was discovered through understanding the two steps in the virus life cycle that are inhibited by the antiviral drug amantadine: virus uncoating in endosomes and M2 protein-mediated equilibration of the intralumenal pH of the trans Golgi network.  Recently it was reported that influenza virus can undergo multiple cycles of replication without M2 ion channel activity.  An M2 protein contg. a deletion in the transmembrane (TM) domain (M2-del29-31) has no detectable ion channel activity, yet a mutant virus was obtained contg. this deletion.  Watanabe and colleagues reported that the M2-del29-31 virus replicated as efficiently as wild-type (wt) virus.  The authors have investigated the effect of amantadine on the growth of four influenza viruses: A/WSN/33; N31S-M2WSN, a mutant in which an asparagine residue at position 31 in the M2 TM domain was replaced with a serine residue; MUd/WSN, which possesses seven RNA segments from WSN plus the RNA segment 7 derived from A/Udorn/72; and A/Udorn/72.  N31S-M2WSN was amantadine sensitive, whereas A/WSN/33 was amantadine resistant, indicating that the M2 residue N31 is the sole determinant of resistance of A/WSN/33 to amantadine.  The growth of influenza viruses inhibited by amantadine was compared to the growth of an M2-del29-31 virus.  The authors found that the M2-del29-31 virus was debilitated in growth to an extent similar to that of influenza virus grown in the presence of amantadine.  Furthermore, in a test of biol. fitness, it was found that wt virus almost completely outgrew M2-del29-31 virus in 4 days after cocultivation of a 100:1 ratio of M2-del29-31 virus to wt virus, resp.  It is concluded that the M2 ion channel protein, which is conserved in all known strains of influenza virus, evolved its function because it contributes to the efficient replication of the virus in a single cycle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq831U_z_ksu7Vg90H21EOLACvtfcHk0lh1h5Q7pfaexg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnvFCqsg%253D%253D&md5=920f5cad01fde5442b20d8fafc3e4934</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1128%2FJVI.76.3.1391-1399.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.76.3.1391-1399.2002%26sid%3Dliteratum%253Aachs%26aulast%3DTakeda%26aufirst%3DM.%26aulast%3DPekosz%26aufirst%3DA.%26aulast%3DShuck%26aufirst%3DK.%26aulast%3DPinto%26aufirst%3DL.%2BH.%26aulast%3DLamb%26aufirst%3DR.%2BA.%26atitle%3DInfluenza%2520a%2520virus%2520M2%2520ion%2520channel%2520activity%2520is%2520essential%2520for%2520efficient%2520replication%2520in%2520tissue%2520culture%26jtitle%3DJ.%2520Virol.%26date%3D2002%26volume%3D76%26spage%3D1391%26epage%3D1399%26doi%3D10.1128%2FJVI.76.3.1391-1399.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00758">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_27147"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00758?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00758</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">HPLC traces for the final products (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_001.pdf">jm1c00758_si_001.pdf (3.77 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00758/suppl_file/jm1c00758_si_002.csv">jm1c00758_si_002.csv (3.98 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00758&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00758%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-12%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00758" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                9MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ab7252f7e22c0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
